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This research project examines the degree of transparency of the Canadian Federal 
Government’s decision-making processes and institutions with respect to the human 
consumption of animals produced through modern biotechnology (biotechnology-produced 
animals). It provides a timely study of the Federal Government’s decision-making process; as of 
January 2013 the government has yet to determine whether, and how, biotechnology-produced 
animals are to be approved for human consumption. Foods that contain genetically modified 
organisms (GMOs) are already commercially widely available in Canada. Research is well 
underway to see if biotechnology-produced animals may also be developed and introduced into 
the food system. 
Government decisions regarding the human consumption of biotechnology-produced 
animals have the potential to revolutionize food systems globally and nationally. This thesis 
offers an analysis of primary and secondary data focusing on the degree of federal transparency 
with respect to regulating GMO foods generally and, more specifically, the emerging policy 
issues around biotechnology-produced animals. This exploration sets the stage for the following 
investigation of barriers as well as opportunities to fostering federal transparency with respect to 
policy and regulatory decisions regarding GMO foods. Findings are directed towards members 
of the communities of interest who are interested in questions relating to the degree of federal 
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* Foreword: For this thesis, genetically engineered (GE), genetically modified (GM) and 
biotechnology-produced are used interchangeably to refer to organisms that have been produced 
through genetic changes at the gene level unless noted otherwise (i.e. in a Private Member’s 




Chapter 1:  Foods Derived through Modern Biotechnology, Transparency and 
the Canadian Federal Government: Introduction 
1.1 Context 
Food Democracy is an issue of growing concern globally and domestically in Canada 
(Food Secure Canada, 2011; Hassanein, 2003; Johnson, Biro & MacKendrick, 2009; Lang, 1999; 
Navdanya, 2009; Small Planet Institute, 2012; UN News Center, 2008). Yet surprisingly in 
Canada the general public knows very little about how genetically engineered (GE) foods are 
managed, produced and regulated. For example, the last major inquiry commissioned by the 
Canadian Federal Government was in 2001 by the Royal Society of Canada. As discussed below, 
the recommendations in this inquiry were largely ignored. This thesis explores the degree of 
transparency that exists with respect to Federal Government policies, decision-making processes, 
institutions, and regulations surrounding foods produced through modern biotechnology. It does 
so in the context of food democracy. As stated by a former NDP MP “There is no better area to 
study in terms of lack of government transparency and accountability than these foods” (NDP-J). 
1.1.1. The Key Issues 
Many issues with respect to regulations concerning the human consumption of animals produced 
through modern biotechnology (i.e. biotechnology-produced animals) are confidential or have 
not been considered in the Canadian Government’s current policy approaches. These issues 
include, but are not limited to: 
- The confidential nature of the regulatory processes.  
- The question of how and whether economic, ethical, and social risks or impacts will be 
considered by the Federal Government. 
- The lack of public knowledge about whether policies for foods produced through modern 
biotechnology will be considered.  
- If it will be mandatory to label food products that contain biotechnology-produced 
animals. 
- How regulators will assess the scientific data submitted by an applicant.  
- How regulators will decide what scientific data needs to be submitted by applicants. 
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- Whether the public will be notified if an application is being, or has been, submitted.  
As the following discussion elaborates, Government transparency is needed when dealing with 
these issues: all of which have serious ethical, socio-ecological and governance implications. 
First, however, some background information provides context for the discussion. 
The Canadian Environmental Protection Act (1999) defines biotechnology as "the 
application of science and engineering to the direct or indirect use of living organisms or parts or 
products of living organisms, in their natural or modified forms." In Canada the term "animal 
biotechnology" is considered to be an extension of the definition of biotechnology. As directly 
stated on the Canadian Food Inspection Agency’s website the term may include, but is not 
limited to, the following categories of animals, 
1. Genetically engineered or modified animals in which genetic material has 
been added, deleted, silenced or altered to influence expression of genes and 
traits. 
2. Clones of animals derived by nuclear transfer from embryonic and somatic 
cells. 
3. Chimeric animals that have received transplanted cells from another animal. 
4. Interspecies hybrids produced by any methods employing biotechnology. 
5. Animals derived by in vitro cultivation such as maturation or manipulation of 
embryos. (Canadian Food Inspection Agency, 2012a) 
 
The definition includes animals that have been produced through genetic changes at the 
organism level (through traditional biotechnology techniques such as selective breeding and 
hybridization), as well as animals that have been produced through genetic changes at the gene 
level (through modern biotechnology techniques such as recombinant DNA techniques (genetic 
engineering) (Government of Canada, 2008b). This research paper focuses on animals derived 
through modern biotechnology. 
In order to manufacture, import or sell an animal derived from modern biotechnology (a 
biotechnology-produced animal) in Canada, the producer or manufacturer must notify 
Environment Canada “so that the animal undergoes a safety assessment for potential impacts to 
the environment” (Canadian Food Inspection Agency, 2012a). The assessments are co-
administered by Environment Canada and Health Canada under the Canadian Environmental 
Protection Act, 1999 (CEPA, 1999) and the New Substance Notification Regulations 
(Organisms) NSNR (Organisms). The environmental aspects of the notification are evaluated by 
Environment Canada and the human health aspects are evaluated by Health Canada (CFIA, 
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2012a). Manufacturers or importers of new substances in products regulated by the Food and 
Drugs Act, including food products derived from biotechnology-produced animals, are also 
required to submit notification under the NSNR (Organisms) so that an environmental assessment 
may be conducted (Health Canada, 2010b). 
As of December 2012, no food products derived from biotechnology-produced animals 
had been approved for release into the food chain in Canada. These food products are classified 
as “novel foods” under Division 28, Part B, of the Food and Drug Regulations.
1
 Health Canada 
is the primary department in charge of approving the release of novel foods into the food supply 
chain. 
Novel foods are subject to a pre-market safety notification conducted by Health Canada 
to assess the food’s human health safety and nutritional adequacy. The criteria for Health 
Canada’s scientific evaluation are described in Health Canada’s Guidelines for the Safety 
Assessment of Novel Foods (Volumes I and II). Guidelines “provide transparency in decision-
making and fill in details sometimes missing from the strict nature of legal language in laws or 
regulations” (Health Canada, 2010d). As of December 2012, the Guidelines for the Safety 
Assessment of Novel Foods (Volumes I and II) were last updated in 2006. The guidelines state 
that the section for Novel Foods Derived from Animals is “Under Development” (Health 
Canada. Food Directorate Health Products and Food Branch, 2006). According to Health 
Canada’s website “safety assessment criteria for novel foods derived from animals are under 
development” (Health Canada. Food Directorate. Health Products and Food Branch, 2006, p. 5). 
Health Canada uses the concept of substantial equivalence as a guide in the safety 
assessment of novel foods (Health Canada, 2006d). The food product is compared to its 
conventional counterpart already found in the food supply which has a history of safe use. The 
focus is placed on similarities and differences in composition, including nutritional value and 
toxicity. Substantial equivalency is determined through comparing the novel food to its 
conventional counterpart’s set of molecular, compositional and nutritional data, if one exists 
(Andree, 2002; Health Canada, 2006d).It is unknown how the concept of substantial equivalence 
will be applied to assess the safety and nutritional adequacy of a food product that contains 
biotechnology-produced animals before it can be sold in Canada. 
                                                 
1
 The Food and Drug Regulations can be found on the Department of Justice Canada website 
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February 2010, the genetically engineered (GE) Enviropig™, a biotechnology-produced 
animal, was approved for reproduction and exportation for the first time in Canada. The 
Enviropig™ was created at the University of Guelph in 1999 with the intent to reduce levels of 
phosphorous found in pig excrement (University of Guelph, 2010). The University had submitted 
paperwork to Environment Canada in January 2009. This was the first time that Environment 
Canada had been directly involved in the approval of a genetically engineered organism. 
Environment Canada was given the responsibility for assessing the environmental risks of the 
Enviropig™ because there are no specific regulations for biotechnology-produced animals in 
Canada. 
In 2009 the University of Guelph had also submitted a notification to Health Canada to 
approve its Enviropig™ for human consumption (Mann, 2011). The University had not received 
a mandatory or acknowledged deadline for a decision (Mann, 2011). As of August 2012 Health 
Canada had not released a decision concerning the University’s notification (the notification 
process is discussed further in Chapter 2). 
There is no publicly available information about regulation or decisions regarding the 
human consumption of biotechnology-produced animals. One assumes that it will become 
available once a decision is made, but even that is not known. Due to the confidential nature of 
the submission of an application to Health Canada it was unknown whether Health Canada has 
received or has been working on similar applications. In the case of the Enviropig™ application 
the University of Guelph had released information that it had submitted an application to Health 
Canada (Mann, 2011). At time of writing, there was also no publicly-available information 
regarding the depth, or scientific accuracy of the information Health Canada used to inform its 
decisions, as well as any potential risks it might be investigating (Personal communication with 
Federal Employee; Health Canada. Food Directorate. Health Products and Food Branch, 2006; 
Health Canada 2006d; Health Canada 2011c). 
It is possible that AquaBounty Technologies, Inc has submitted an application to Health 
Canada to approve its genetically engineered (GE) AquAdvantage® salmon for human 
consumption. The company developed the salmon at a research facility in Prince Edward Island 
(P.E.I.) using technology developed by scientists at Memorial University. The salmon have been 
genetically engineered with the intent to grow faster than their natural counterpart (AquaBounty 
Technologies Inc, 2012a). As of December 2012, AquaBounty Technologies, Inc. had not 
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released information on whether it has submitted an application to Canada’s regulatory 
authorities to approve its salmon for human consumption. 
 Information is also unavailable regarding whether or not Health Canada has ever 
received an application to approve a cloned animal for human consumption. Cloned animals are 
produced through modern biotechnology and any food products from these animals would be 
classified as “novel foods” under Division 28, Part B, of the Food and Drug Regulations. The 
limited publicly-available information raises serious questions about transparency of Federal 
Government decisions regarding the Canadian food system (discussed further in Chapter 3.3.6). 
The Boundaries of the Regulatory Framework 
The New Substance Notification Regulations (NSNR) were created to address the potential risks 
to the Canadian environment and human health posed by the large scale (industrial) use of 
commercial chemicals. They were not developed for substances regulated under the Food and 
Drugs Act (Health Canada, 2010b). Since 2001 Health Canada has been in the process of 
developing new Environmental Assessment Regulations (EARs) to replace the NSNR with 
respect to new substances in products regulated under the Food and Drugs Act (Health Canada, 
2010b). There is no indication when work on these EARs will be completed.  
Current regulatory processes are based on substantial equivalence, are limited to 
assessing risks that are science-based and do not take into consideration any social, ethical or 
economic impacts that citizens might feel are critical to the debate on human consumption of 
biotechnology-produced animals. Regulatory departments do not conduct long term health or 
safety studies as “there is no current evidence to indicate that long term studies are needed to 
ensure the safety of foods produced using this technology” (Health Canada, 2006d). Canada also 
does not have a mandatory labeling standard for identifying whether foods contain products 
derived through modern biotechnology. As such, it is unknown whether, if approved, mandatory 
labeling would be implemented for food products that contain biotechnology-produced animals. 
The Regulation of Food Products Derived through Modern Biotechnology  
Food products derived through modern biotechnology do not readily fit within existing 
regulatory frameworks. This situation has created a need for regulations and guidelines to 
continuously be updated to take into account any new risks. This patchwork regulatory 
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framework continues to be tested as new food products derived through modern biotechnology 
enter the market and new risks are made apparent.  
Regulatory processes to assess the risk of consuming food products are also product- 
based and do not examine whether any new risks are created through the process of 
biotechnology. At the time of the writing of this thesis it was unknown how, and if, policies and 
regulations will be updated to include the assessment of potential risks unique to consuming 
biotechnology-produced animals. For example, it was unknown how potential new risks 
concerning the health and safety aspects of consuming biotechnology-produced animals will be 
considered in Health Canada’s safety assessment. 
In short, technology is racing ahead of the Federal Government’s ability or willingness to 
develop and or to share policies with the general public with respect to the introduction of novel 
foods into the Canadian food system. 
Given that citizens may not know a food product has been approved for sale until it has 
already entered the market place, it is important to know who is making the decisions and how 
they are being made. As more biotechnology-produced animals near commercialization and 
regulations are being updated it is important to consider decision-making processes and the 
transparency of regulatory institutions and processes. A multitude of decisions will have to be 
made by the Canadian Federal Government regarding whether and how biotechnology-produced 
animals are to be approved for human consumption in Canada. Despite the magnitude of the 
decisions involved, the Federal Government is virtually silent with respect to how it will be 
addressing these issues. 
1.1.2 Research Question, Academic Rationale and Conceptual Framework 
To shed light on the above issues, this thesis considers the following question: 
 
How transparent are the Federal Government’s decision-making processes and 
institutions with respect to the human consumption of animals produced through 
biotechnology throughout the policy and decision-making process? If transparency is an 




Through an exploration of these questions the goal of this research project is to provide a 
timely study of the Federal Government’s decision-making processes to determine the degree of 
transparency in a topic of notable public interest: the human consumption of biotechnology-
produced animals  
The transparency and accountability of decision-making processes and institutions are 
increasingly important as food products from biotechnology-produced animals are being 
considered for human consumption. This project highlights potential issues concerning 
transparency throughout the Federal Government’s decision-making processes before policies 
are finalized. This is especially useful as Federal Government decisions regarding the human 
consumption of biotechnology-produced animals in the following months and years have the 
potential to revolutionize food systems on the national and international levels. 
Defining Transparency in the Context of Food Democracy 
Transparency “is widely associated with more accountable, legitimate, democratic and 
effective governance, partly based on an assumption that it can empower those at its receiving 
end” (Gupta, 2010a, p. 32). According to Aarti Gupta, a lecturer in International Environmental 
Politics “such associations and assumptions require much more sustained scrutiny” (Gupta 
2010a, p. 32).  Gupta noted “the embrace and institutionalization of transparency in specific 
instances plays out within a broader global governance context shaped by a liberal democratic 
push for individual liberty, choice and participation; but also by a neoliberal privileging of 
market-based solutions to environmental and social challenges and support for ‘light touch’ 
regulation of the private sector” (Gupta, 2010b, p. 6). 
Transparency as a concept is subject to contested definitions. As its simplest, 
transparency is defined as the disclosure of information (Mol, 2010, p. 132). With regards to 
transparency in domestic policy, there are “wide variations in the ability of information 
disclosure to produce the outcomes it is supposed to achieve” (Haufler, 2010, p. 55). Director of 
Global Communities Living-Learning Program at University of Maryland, Virginia Haufler, has 
identified, as stated by Gupta, “various disfunctionalities of disclosure that pose hurdles to 
stakeholder empowerment or environmental improvements, including unreliable data, shirking of 
disclosure obligations, lack of capacity to interpret and use disclosed data or lack of civil society 
or other intermediaries to render disclosed information useful” (Gupta, 2010b, p.5). A reliance 
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on transparency as a tool of governance can also “be subverted in practice via the phenomenon 
of ‘drowning in disclosure’ or provision of too much information, where the relevant is buried in 
the irrelevant and hard to find, if provided at all” (Gupta, 2010a, p. 39). A central aspect of 
governance by disclose also raises the question of transparency: for whom and to what end 
(Gupta, 2010a, p. 46).  
Often evoked goals of transparency also include “empowering the weak and holding 
accountable the powerful” (Gupta, 2010b, p. 1). Whether transparency furthers such goals is 
under-scrutinized (Gupta, 2010b, p.1). As well, the ideal of transparency often remains contested 
(Gupta, 2010b, p. 7). Haufler wrote “As Fenster argued ‘Transparency theory’s flaws result from 
a simplistic model of linear communication that assume that information, once set free from the 
state that creates it, will produce an informed, engaged public that will hold officials 
accountable’”(2010, p. 55). 
Haufler also noted “Democracy itself is founded on the principle of transparent 
governance” (2010, p. 55). As stated by Chair and professor, Director of Wageningen School of 
Social Sciences at Wageningen University, Arthur P.J. Mol, the concepts of transparency, 
democracy and participation are related to each other in environmental politics and governance, 
although the three do not always mutually strengthen each other (2010, p. 133).  
The formal institutional notion of transparency is not sufficient within the context of food 
democracy. The paper expands the formal institutional notion of transparency in response to 
public democracy and issues of governance. The essential elements of transparency being 
examined for this research paper include: the disclosure of information; the outcomes produced 
by the disclosure (or lack of disclosure) of information; the capacity of interested parties to 
interpret and utilize disclosed information; whether public officials are being held accountable; 
connections between participation, transparency, and democracy; whether opportunities are 
provided for interested parties to provide feedback, analysis and system improvement; the 
accountability, legitimacy, democratic nature, and effectiveness of governance; whether 
transparency initiatives empower those at the receiving end and; hurdles to stakeholder 
empowerment. These different aspects of transparency as understood in the context of food 
democracy will be explored in this thesis. Of specific concern here is the Canadian federal 
government’s regulatory and policy approach regarding biotechnology-produced animals. 
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Without transparency, Canadians collectively have a limited ability to hold decision-
makers accountable to ensure both food security and food democracy. Food policy analyst Tim 
Lang (1999) referred to food democracy as “the demand for greater access and collective benefit 
from the food system” (p. 218). Environmental policy professor, Neva Hassanein, (2003) noted 
“food democracy is a method for making choices when values and interests come into conflict 
and when the consequences of decisions are uncertain” (p. 83). Hassanein argues that “all 
members of an agro-food system have equal and effective opportunities for participation in 
shaping that system, as well as knowledge about the relevant alternative ways of designing and 
operating the system” (2003 p. 83) and that “citizens having the power to determine agro-food 
policies and practices locally, regionally, nationally, and globally” (2003 p. 79). 
Advocates of food democracy seek to expose and challenge any antidemocratic forces 
that control the agro-food system. The term food democracy also implies that the prevailing 
economic rules and regulations should encourage communities to “safeguard the soil, water, and 
wildlife on which all our lives and futures depend (Small Planet Institute, 2012).   
Transparency, in a democratic government and country such as Canada, implies 
accountability. Transparency provides assurance to citizens and other affected stakeholders that 
powerful actors, such as governments or corporations can be held accountable (Fuchs & Clapp, 
2009 p. 93). Transparent decision-making allows citizens to hold public officials accountable by 
making judgments about the effectiveness of their government. Transparency provides a means 
for governments to demonstrate to the public that they are spending money wisely and making 
decisions that ensure the safety and protection of its citizens (Right to Know Community, 2008 
p. 2). Fund and Weil argue that transparency can help citizens understand harms and risks to 
individuals and protect themselves (2010 p. 108). Further, transparency can be used to press 
organizations, including national governments and corporations, to behave in more socially 
responsible ways and decreases opportunities for authorities to abuse the system in their own 
interest (Fung & Weil, 2010 p. 108). 
An informed public is essential to democracy and can help to create a more effective, 
accountable government. Governments “need to provide information to make their own activities 
more transparent to citizens, in order to promote accountability and to enable citizens to 
determine how well the political system and civil society is functioning” (MacKinnon et al. 2003 
p. xii). Transparency is essential if all affected stakeholders are to make informed decisions; in 
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other words, it “is based on the notion that stakeholders would make different choies if they had 
less complete information” (Dingwerth & Eichinger, 2010, p. 79). As well, “transparency will 
only work when the quality and reliability of information is guarded and guaranteed” (Mol 2010, 
p. 138). 
Effective transparency goes beyond disclosing documents through Freedom of 
Information legislation and the Access to Information Act, where it is often up to the citizens to 
independently obtain information through a formal request. It also goes beyond focusing 
primarily on accountability (Fung & Weil, 2010, p. 106). As stated in The Right to Know 
Community, Moving towards a 21st century right to know agenda: Recommendations to 
President-Elect Obama and Congress (2008) 
Effective transparency means that the public has access to accurate information in a 
timely manner....No one policy change or action will suddenly make government 
completely transparent. The solution is not as simple as instituting guidance to agencies 
to disclose as much information as possible under Freedom of Information Act requests, 
although most certainly that must be done. (p. 2) 
 
Furthermore, transparency is considered as being most effective when it is part of  
A disciplined process that sets priorities, assesses probable impacts of alternative or 
complementary government measures, minimizes unintended consequences, and 
generates feedback, analysis, and system improvement over time. (Graham, Weil & 
Fung, 2007, p. 181) 
 
The Federal Government cannot be held accountable if its decision-making processes 
lack transparency. Druke notes that accountability is the fundamental principle of a transparent 
society and a cornerstone of modern democracy (2007 p. 60). Kernaghan and Siegel (1995) 
suggest that accountability is concerned with “the legal, institutional and procedural means by 
which bureaucrats can be obliged to answer for their actions” (p. 314) and that it is one of “the 
most important and most contentious of the traditional public service values” (p. 668).   
An examination of the degree of transparency in the Canadian Federal Government’s 
decision-making processes and institutions regarding the Enviropig™ and AquAdvantage® 
Salmon provides a good indication of the current direction the Government is taking concerning 
the human consumption of foods produced through modern biotechnology. It also offers an 
understanding of the transparency, or lack thereof, in Federal Government decision-making 
processes in areas that are of significant public concern.  
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Graham et al. (2007) stated that transparency benefits associated with advancing 
technologies are not automatic and depend heavily on the willingness of information users, 
disclosures, and government officials to assume new responsibilities (p. 165). The way the 
Canadian Government has addressed (or failed to address) foods produced through modern 
biotechnology (GE foods) has resulted in non-government organizations (NGOs), including the 
Canadian Biotech Advisory Network (CBAN), and MPs, including Fisheries and Oceans Critic 
Fin Donnelly (NDP), becoming increasingly concerned over the lack of accountability and 
transparency (discussed further in chapters 3 and 4).  
Canada has not introduced unique regulations to specifically deal with the socio-
ecological, health and policy implications of the human consumption of products developed 
through modern biotechnology. Canadian citizens may want to know more about the risks being 
considered in regulatory decision-making processes regarding the consumption of 
biotechnology-produced animals and how Federal Government institutions are evaluating these 
risks during decision-making processes.  
Exploring the state of food democracy through the decision-making processes provides 
information on the direction the Federal Government is taking that goes beyond conventional 
notions of transparency held by a representative democracy. The specific issues with food adds a 
layer of complexity in terms of transparency as some stakeholders may feel they should have a 
bigger role in shaping their food systems, particularly considering new food products derived 
through advancing technologies that have never been introduced into the food system are nearing 
the stage of commercialization.  
It should be noted that the market for the human consumption of biotechnology-produced 
animals is not a foregone conclusion. In April of 2012, the University of Guelph began closing 
down its active research on the Enviropig™. The hog industry group, Ontario Pork, the largest 
contributor to the project, had decided to redirect its funding away from research on the 
Enviropig™ (Leung, 2012). The Enviropig™ research had received contributions around $1.2-
million from Ontario Pork over the past decade. Leung (2012) also wrote that Bona Hunt, a 
spokesperson for University of Guelph, had said the University would keep active the 
applications the University had submitted to various Governments to approve the animal for 
human consumption until the University decides otherwise, or a regulatory decision is made. The 
University is preserving the genetic material of the Enviropig™ in long-term storage and stated it 
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will continue to research the animal and is looking for another sponsor or organization that 
would be willing to adopt the technology (Leung, 2012).  
Conceptual Framework: Food Democracy and Transparency 
As stated, transparency as a concept is subject to contested definitions. Food democracy provides 
a lens for viewing transparency that goes beyond the formal institutional definition to include 
considerations such as inclusiveness and empowerment. This research project explores the issue 
of food democracy through an examination of the degree of transparency in the Canadian Federal 
Government’s decision-making with respect to the human consumption of biotechnology-
produced animals. The difference between the formal institutional concepts of transparency and 
what is needed to ensure food democracy highlights specific issues that surround decision-
making concerning the food system that add a layer of complexity in terms of transparency. Even 
if decision-making were transparent in the traditional formal sense, the Federal Government 
might still be at odds with expectations from stakeholders who believe the issue of food is such 
an important and complex one that more transparency than is formally required is necessary for 
decision-making. Stakeholders may in fact be demanding increasing amounts of transparency 
that might very well be at odds with the current Federal Government approach to questions of 
transparency and accountability.  
Rationale for Choosing the Canadian Federal Government as Key Actor  
The Federal Government was chosen as the focus of this thesis because the international arena 
shapes the decision-making arena of major players in the agro-food industry. The international 
trade of foods produced through biotechnology is being negotiated extensively at the 
international level. International agreements signed by the Federal Government such as the North 
American Free Trade Agreement can overrule policies made at municipal, provincial and Federal 
levels (NAFTA Secretariat, 2012). The role of Federal-provincial relations will be examined 
because the way in which a jurisdiction is split can affect transparency unless there is good 
coordination.  
The thesis is focused on Canada, a hub for biotechnology research. Canada’s research 
community has developed both the Enviropig™ and AquAdvantage® salmon. Canada has the 
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potential to pave the way for both developing and creating regulations for biotechnology-
produced animals.  
The Canadian Federal Government is also the focus for this thesis due to its controversial 
history of decision-making with regard to food products derived through modern biotechnology 
(discussed further in Chapter 3). In addition, Canada is a significant player in the sector, globally 
speaking, more for its adoption, than for its development, of biotechnology (Pechlaner & Otero, 
2008 p. 360). Lastly, in regards to the regulation of animal biotechnology because there is 
currently no definitive, comprehensive Canadian position, there is much room for analysis.  
In the international arena, Canada is a strong voice advocating for biotechnology. In 
2011, according to the International Service for the Acquisition of Agri-biotech Applications, 
twenty-nine countries had elected to grow crops derived through modern biotechnology. Canada 
ranked fifth in the area of land planted with biotechnology crops, as seen in Table 1.1. (James, 
2011). The gap between the top five producers of biotechnology and the rest of the world in 
regard to growing biotechnology crops is clearly evident, as is Canada’s place concerning 
biotechnology in the international arena.  
Table 1.1. Global Area of Biotech Crops in 2011 by Country 




1 USA 69 Maize, soybean, cotton, canola, sugar beet, 
alfalfa, papaya, squash 
2 Brazil 30.3 Soybean, Maize, Cotton 
3 Argentina 23.7 Soybean, Maize, Cotton 
4 India 10.6 Cotton 
5 Canada 10.4 Canola, Maize, Soybean, sugar beet 
6 China 3.9 Cotton, papaya, poplar, tomato, sweet pepper 
12 Australia 0.7 Maize 
27 Sweden <0.1 Potato 
28 Costa Rica <0.1 Cotton, soybean 
29 Germany <0.1 Potato 
Source: Adapted from James (2011) 
1.1.3. Assumptions, Limitations and Boundaries 
An assumption of this research project is that food policies surrounding controversial issues 
should be governed in a transparent manner consistent with that of a democratic polity. This 
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research project also assumes that food democracy is a valid concept when examining a 
country’s approach to a controversial food topic. The focus for this research project is on 
contemporary events in order to build on previous work. This thesis builds on work on the 
governance of genetically engineered foods in Canada at the Federal level that the researcher 
completed for her undergraduate degree through the University of Waterloo. 
Information on the Canadian Food Inspection Agency (CFIA) website concerning novel 
feed from biotechnology derived animals does not say how Canadian’s would be informed if this 
type of feed had been approved, or was going through the approval process (CFIA, 2006). The 
CFIA website does have a list of approved novel feeds from PNTs, last updated in April 2012 
(CFIA, 2012c). Information can also be found on applications concerning novel feeds derived 
from PNTs through the CFIA’s voluntary notice of submission project (CFIA, 2012b). The 
assessment of novel feed from biotechnology derived animals is beyond the scope of this thesis. 
Although the researcher has done her best to control for biases, they need to be 
acknowledged. In March of 2012, while working on this research paper, the researcher signed a 
petition that was distributed by the Canadian Biotechnology Action Network (CBAN) and 
directed at the University of Guelph entitled “Stop the Genetically Modified ‘Enviropig™’” The 
researcher also signed CBAN petitions regarding GE alfalfa and GE salmon. The researcher is 
also part of a Toronto-based food action and awareness initiative that formed in April of 2012. 
Although the researcher has a position, it has not prevented her from being open to exploring 
other points of views.  
1.2. Thesis Structure 
1.2.1. Methodology 
This thesis uses a five-part methodology in order to effectively answer the research question. A 
combination of methods includes a grounded, inductive approach. First, government structures 
are considered with respect to their public accountability concerning the human consumption of 
biotechnology-produced foods. This analysis offers an understanding of transparency in the 
traditional formal institutional sense and sheds light on transparency within the Federal 
Government’s structures and institutions. Second, the paper explores limitations to transparency 
that have arisen concerning the Federal Government’s decision-making processes and 
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institutions with respect to foods derived through modern biotechnology. A historical analysis 
reveals an enduring lack of transparency and accountability regarding the Federal Government’s 
decision-making processes and institutions for foods derived through modern biotechnology; this 
situation has continued to the present day throughout both Conservative and Liberal governing 
mandates. Third, interviews were undertaken with key stakeholders. A snowball sampling 
approach was used to identify stakeholders. A grounded approach was used to identify major 
issues and themes that emerged from those interviews with respect to transparency and the 
implications of consuming biotechnology-produced animals. Fourth, a comparative assessment 
was made between limitations to transparency raised in the interviews and throughout the 
literature. It allowed for an examination of current issues surrounding the human consumption of 
biotechnology-produced animals in order to assess and analyze the transparency of the Federal 
Government’s decision-making processes and institutions, and to explore challenges and 
opportunities for increasing transparency. Lastly, the paper provides recommendations for future 
research. 
Data Collection  
Information about biotechnology-produced animals and transparency was gathered using 
multiple sources of evidence. According to Yin (2003), in his Case Study Research: Design and 
Methods 3rd Edition, this approach is often referred to as “triangulation” and allows for 
information to be cross-checked through a variety of sources (p. 97). The sources of evidence 
are: (1) literature produced by the agro-food industry and its critiques; (2) academic literature 
concerning the topics of genetically engineered (GE) foods, biotechnology-produced animals, 
transparency and Canada’s policy-making structure; (3) Government publications and primary 
records and; (4) interviews with key-informants including scholars and Government officials. 
Information was collected through an examination of private and public websites and 
publications, by attending conferences, through academic and trade journals, Access to 
Information requests, academic papers and interviews.  
Publications produced by the agro-food (biotechnology) industry as well as publications 
that critiqued the point of view of the agro-food industry were obtained to determine what 
information exists on biotechnology-produced animals and whether issues of transparency have 
arisen. This allowed for the identification of biotechnology-produced animals that are at or are 
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nearing commercialization both domestically and internationally. It also allowed for the 
identification of potential applications to assess a biotechnology-produced animal for human 
consumption through examining research and development projects concerning biotechnology-
produced animals. 
Federal Government documents including publications and primary records as well as 
Federal Government websites were examined to determine Canada’s Federal policy-making 
structure in regard to the human consumption of biotechnology-produced animals. Looking at 
these documents allowed for the collection of information on what the Government is doing in 
terms of making the decision-making processes transparent. The research also examines what 
animals have gone through policy processes in Canada for other reasons, including 
environmental release, to shed light on potential applications. This allowed for an examination of 
how Canadian formal institutions have been used to raise awareness of issues of transparency 
and how biotechnology is promoted in Canada. 
Interviews were undertaken with a spokesman from a large Canadian food distributing 
company, a consumer affairs reporter from a major news outlet, representatives of non-
government organizations, scholars, elected officials and public servants at the federal level to 
gain an understanding of what key stakeholders identified as important themes and issues. This 
information was compared with the issues identified in the literature to see where they diverged 
or corresponded. The findings shed light on the transparency of the Federal Government’s 
decision-making processes and institutions concerning foods products that are or contain 
biotechnology-produced animals. 
Data Analysis 
The grounded theory (GT) method developed by sociologists Glaser and Strauss was utilized for 
this paper to identify major themes in interviews. Glaser and Strauss’s approach “showed us how 
to treat qualitative data as a serious source of scientifically derived knowledge about social and 
psychological processes” (Bernard, 2010, p. 267). The approach, which uses open-ended 
interviews, uncovers “many patterns the participant does not understand or is not aware of” 
(Glaser, 2002, p. 5).  
As defined by Glaser (1992) coding is “conceptualizing data by the constant comparison 
of incident with incident, and incident with concept to emerge more categories and their 
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properties” (p. 38). Coding occurs in two stages: substantive (open) and theoretical. According to 
Glaser (1992) “open coding is the initial step of theoretical analysis that pertains to the initial 
discovery of categories and their properties” (p. 39). Following the direction of Glaser (1992), 
during open coding data is broken down into incidents and is closely examined and compared for 
similarities and differences (p. 39). For this paper, data from the interviews was simultaneously 
collected and analyzed. Transcripts were analyzed in sentences or groups of sentences that reflect 
single ideas. The data was analyzed for increasing levels of abstraction through the use of 
constant comparative procedures, through negative case analysis and through the researcher 
asking questions about her own data. Concepts were identified within the data. How the concepts 
might relate to larger more inclusive concepts, referred to as “categories” in the language of GT, 
was examined (Bernard, 2010, p. 271). 
Categories concerning the interview data were identified and connected and a theory was 
formed to aid in answering the research question. Categories were based on all data collected 
through interviews, observations, and the researcher’s notes. Categories were linked together as 
they emerged in theoretical models around a central category (Bernard, 2010, p. 275). As stated 
by Glaser (1992) “open coding comes to an end when it yields a core category” (p. 39).  
The coding stage is the “refitting and refinement of categories which integrate around 
emerging core” (Heath & Cowley, 2004, p. 146). 
Common to all grounded theorists is the knowledge that one ceases the relentless pursuit 
of data when theoretical saturation is achieved: (1) no new or relevant data are emerging 
regarding a category (2) development of the category’s properties and dimensions can 
withstand variations in the context of the phenomenon, (3) the relationships amongst 
categories are well established (Morse, 1995). (Boychuk Duchscher & Morgan p. 610)  
Through the emergence of categories and the core category the researcher identified barriers to 
transparency relevant to the research topic. 
The researcher used this approach to develop major themes through interviews. These 
themes became the core of the final grounded theory. These themes were then compared with the 
limitations to transparency identified in the literature in order to answer the research question. 
This data was analyzed to identify any serious questions of transparency and serious concerns 
about the human consumption of biotechnology-produced animals. Collected data also was 
analyzed to determine any similarities and divergences among the literature produced by the 
agro-food industry, its critiques, academic literature, Federal Government documents, and 
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interviews. This analysis served to identify any lack of connection between what the Federal 
Government is doing, what it says it is doing, and the critiques of what it is doing. Any lack of 
connection helped to identify challenges and opportunities for transparency in the Federal 
Government’s decision-making processes. It also allowed for the identification of any serious 
health or democratic issues.  
1.2.2.  Chapter Outlines 
This thesis is structured into seven chapters. 
Chapter one introduces the reader to the research project (i.e. the research question, 
rationale, boundaries, contributions and assumptions, and methodology). 
Chapter two examines who in the Federal Government is making decisions concerning 
the human consumption of biotechnology-produced animals and how these decision makers are 
held accountable. 
Chapter three offers an overview of issues of transparency with respect to Federal 
policy-making processes for foods produced through modern biotechnology. It also provides 
background information and a linear progression on the creation and evolution of Federal 
Government policies that deal with the human consumption of biotechnology-produced animals, 
leading to the current situation. 
Chapter four consists of primary research findings. It outlines the research approach 
taken to conduct interviews and discusses the emerging themes concerning transparency 
identified in the interviews through the use of the ground theory method.  
Chapter five provides an analysis of the findings through comparing limitations to 
transparency raised by the interviewees with those identified by the literature review. It discusses 
current issues with biotechnology-produced animals that outline the decreasing transparency and 
accountability of the Canadian Government. It identifies the biggest institutional impediments to 
transparency.  
Chapter six provides examples of existing and potential opportunities to increase 
transparency identified in interviews and through the literature. 
Chapter seven concludes the thesis by providing a summary of the research project, 
contributions, and recommendations for future research.   
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Chapter 2: Canadian Public Policy and Public Administration in the Context 
of Biotechnology-Produced Animals 
2.1. Introduction 
The Canadian Federal Government is responsible for making policies and regulations with 
respect to the human consumption of biotechnology-produced animals. Decisions are made 
through both the elected and non-elected arms of the Federal Government. Federal Government 
institutions, non-government organizations (NGOs), private sector bodies, and media outlets can 
be utilized to ensure Federal Government transparency in decision-making. This chapter 
examines how the Federal Government is structured and held accountable with respect to making 
policies and regulations concerning the human consumption of biotechnology-produced animals. 
2.2. Decision-Makers in the Federal Government 
In order to untangle who is in charge of what decisions with respect to the human consumption 
of biotechnology-produced animals, it is necessary to explore the basic structures of decision-
making and their impact on questions of transparency and accountability in this topic area. 
2.2.1. Cabinet and Parliament:  Elected Representatives Responsible for Biotechnology-
Produced Animals 
Canada has a centralized system of Federal Government concerning decision-making for the 
human consumption of biotechnology-produced animals. The elected arm of the Federal 
Government, beginning with the Prime Minister, the Cabinet, and the elected members of 
Parliament, are at the centre of policy-making. The Prime Minister can announce the policy of 
the Federal Government even if most or all of the Cabinet Ministers are opposed.  
The Prime Minster determines the existence and responsibilities of all cabinet committees 
except for the Treasury Board. Cabinet committees help coordinate policies and programs, 
allocate human and financial resources, and control the bureaucracy. For example, with respect 
to food produced through biotechnology, the Cabinet Committee on Economic Prosperity and 
Sustainable Growth’s role could include ensuring that policies were in line with Canada’s long-
term priorities and commitments.  
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House of Commons  
Elected Members of Parliament (MP) in the House of Commons create, debate, and vote on bills 
and legislation concerning foods produced through modern biotechnology. For example, in 2009, 
Alex Atamanenko, MP for BC Southern Interior and the NDP Agriculture Critic at the time, 
introduced Private Members Bill C-474. The bill, which was defeated, called for amendments to 
the Seed Regulations “to require that an analysis of potential harm to export markets be 
conducted before the sale of any new genetically engineered seed is permitted” (Bill C-474: An 
Act respecting the Seeds Regulations (analysis of potential harm), 2009). 
The Senate and Senate Committees 
The Senate reviews legislation, investigates national issues and represents regional, provincial 
and minority interests (Canada. Parliament, n.d.). Senate committees in the current session that 
could impact decision-making for the human consumption of biotechnology-produced animals 
include Fisheries and Oceans, Agriculture and Forestry, and Social Affairs, Science and 
Technology. The Senate and Senate Committees can play a role with respect to GMOs. 
However, it did not play an important role during the time frame under examination. 
2.2.2. Public Service: Central Agencies and Line Departments in Charge of Regulatory 
Decision-Making concerning Biotechnology-produced animals 
Central Agencies 
Central agencies have a substantial amount of authority to intervene in and direct the activity of 
Federal Government departments (Kernaghan & Siegal, 1995, p. 197). The advice they provide 
to the Prime Minister, Cabinet, and Cabinet Committees can deal with the use of resources as 
well as policy direction. Central Agencies can also be used as a source to provide accountability 
in any decision-making process. They can be linked to departments and task forces through 
projects, initiatives and action plans.  
There are four central agencies: Prime Minister’s Office; Privy Council Office; 
Department of Finance; and Treasury Board. They are all influential. If the United States 
approved a biotechnology-produced animal for human consumption, for example, the 
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Department of Finance might intervene in Canada’s policy development process to streamline 
regulations with its largest trading partner. 
Line Departments  
Along with the elected arm of Federal Government, Health Canada; the Canadian Food 
Inspection Agency (CFIA); Environment Canada; and the Department of Fisheries and Oceans 
hold responsibility and authority regarding decision-making concerning the human consumption 
of biotechnology-produced animals. Each of these departments and agencies has its own role in 
enforcing, creating, or updating regulations and guidelines that pertain to these food products. 
They also feed information upwards to the executive arm of the Federal Government. Health 
Canada ensures the safety of foods derived from modern biotechnology before they enter the 
Canadian food system through a pre-market notification under the Food and Drug Regulations 
and an environmental assessment under the Canadian Environmental Protection Act (1999) 
(CEPA). Environment Canada assists Health Canada with the assessments and conducts 
environmental assessments under CEPA before a biotechnology-produced animal can be 
manufactured, sold, or imported into Canada. Health Canada shares responsibility with the CFIA 
for all federal food labeling policies under the Food and Drugs Act. The CFIA also inspects fish 
before they can be sold as food. The Department of Fisheries and Oceans administers the New 
Substance Notifications for biotechnology-produced fish and undertakes risk assessments. Table 
2.1 provides a summary of the responsibilities of each department and agency. The roles of the 





Table 2. 1. Responsible Department and Agencies for Food Products that contain Biotechnology-produced 
animals: for Human Consumption 
Product Regulated: biotechnology-produced animal for human consumption  
Responsibility  Federal Department(s) and Agencies Legislation  




Food Directorate, Health Products 
and Food Branch  (HPFB) of Health 
Canada 
Food and Drugs Act and 
Regulations 
Pre-market environmental safety 
assessment of new substances in 
products regulated by the Food and 
Drugs Act 
Environmental Assessment Unit of 
the New Substance Assessment and 
Control Bureau in the Healthy 
Environments and Consumer Safety 
Branch of Health Canada (HECSB) 
(aided by Environment Canada) 
 
Canadian Environmental Protection 
Act 1999(CEPA 1999) and 
 










Environmental Impact Initiative 
within the HPFB and HECSB of 
Health Canada (aided by 
Environment Canada) 
Environmental Assessment 
Regulations (EARs) (proposed) 
under CEPA 1999 or the Food and 
Drugs Act (to replace NSNR 
(Organisms) for products under the 
Food and Drugs Act) 
Develop federal food labeling policy 
and set standards related to health 
and safety issues 
 
Health Canada  Food and Drugs Act 
Non-safety related product labeling 
 
 
Canadian Food Inspection Agency 
(CFIA) 
Food and Drugs Act 
Labeling (Packaging, labeling and 
advertising of foods, inspection and 
enforcement) 
 






Health of Animals Act and 
Regulations  
Source: adapted from CFIA (2012e) 
Table 2. 2. Responsible Department and Agencies for Food Products that contain Biotechnology-Produced 
Animals: for Manufacture, Import or Sale 
Product Regulated: biotechnology-produced animal for manufacture, import or sale  




Environment Canada, Health Canada CEPA 1999, NSNR (Organisms) 
Animal Health CFIA (aids Environment Canada) Health of Animals Act and 
Regulations  





Table 2. 3. Responsible Department and Agencies with direct Decision-Making Responsibilities regarding 
Food Products that contain Biotechnology-produced Aquatic Organisms for Commercial Purposes  
Product Regulated: biotechnology-produced aquatic organisms for commercial purposes  
Responsibility   Federal Department(s) and Agencies 
 
Legislation  
Administer the NSNR for 
biotechnology-produced fish 
 
Fisheries and Oceans CEPA 1999, NSNR  
(Organisms) 
Undertake risk assessments 
 
 
Fisheries and Oceans CEPA 1999, NSNR  
(Organisms) 
New Substance Notification for fish 
products of biotechnology (under 
development) 
 
Fisheries and Oceans Fisheries Act and Regulations 
Provide guidelines for transgenic 
aquatic organisms (i.e. potential 
environmental release) (under 
development) 
 
Fisheries and Oceans Fisheries Act and Regulations 
Notification and compliance with the 
NSNR under CEPA 1999 
 
Fisheries and Oceans / Environment 
Canada 
CEPA 1999, NSNR (Organisms) 
Approve Fish for use as a food (Fish 
Inspection Program) 
CFIA Food and Drugs Act 
Source: adapted from CFIA (2012e) 
 
Pre-market Notification under Food and Drug Regulations 
Health Canada is responsible for ensuring that foods derived from biotechnology-produced 
animals are safe before they enter the Canadian food system. Prior to the marketing, sale, or 
advertising of these food products the company that wants to sell the product must follow a 




Under Health Canada’s Health Products and Food Branch (HPFB), the Novel Foods 
Section (formally the Office of Food Biotechnology) within the Bureau of Microbial Hazards’ 
Microbiology Evaluation Division is the coordinating office for processing the pre-market 
notifications. The Novel Foods Section distributes material submitted with the notifications to 
relevant Food Directorate bureaus for review, specifically the Bureau of Chemical Safety, the 
Bureau of Microbial Hazards, and the Bureau of Nutritional Sciences (Health Canada, 2006f). If 
evaluators consider the food product as novel under section B.28.001 of the Food and Drug 
                                                 
2
 The Food and Drug Regulations can be found on the Department of Justice Canada website 
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Regulations, a safety assessment is conducted as outlined in the Guidelines for the Safety 
Assessment of Novel Foods (Health Canada, 2006f; Food Directorate Health Products and Food 
Branch, 2006). Figure 2.1. outlines the organizational structure of these entities.  
Figure 2. 1. Health Canada’s Organizational Structure concerning the Assessment of the Safety of Novel 
Foods 
 
Source: Health Canada (2006g) 
If no health risks associated with the consumption of the food product in question are 
found through the safety assessment (evaluators can make requests for additional information 
from the applicant) “a proposal to permit the sale of the novel food is drafted and presented to 
the Food Rulings Committee”(Health Canada, 2006f). The Committee is chaired by the Director 
General of the Food Directorate and includes senior managers of Food Directorate and 
representatives from the Canadian Food Inspection Agency which enforces Health Canada's 
decision (Health Canada, 2002). If the proposal is accepted the company is given written 
notification by the Director General that Health Canada has no objection to the sale of the novel 
food (Health Canada, 2002, Health Canada, 2006f). A decision document “describing the novel 
food and summarizing the safety information used to determine its safety as a food is posted on 
the Novel Foods and Ingredients page of Health Canada's Web site” (Health Canada, 2005b).  
Figure 2.2. outlines how a novel food notification is processed. 
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Source: Health Canada (2006g) 
New Substance Notification Regualtions under the Canadian Environmental Protection Act 
(1999)  
Health Canada ensures the safety of food products derived through modern biotechnology before 
they enter the Canadian food system through pre-market notification under the Food and Drug 
Regulations described above. Manufactures or importers of these food products also have to 
submit notification under the New Substance Notification Regulations (NSNR) and the enabling 
Manufacturer of 
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statutory authority of the Canadian Environmental Protection Act, 1999  (CEPA 1999) in order 
that an environmental assessment may be conducted (Health Canada, 2010b). The NSNR applies 
to products not regulated under other Federal legislation. The NSNR were not developed for 
substances regulated under the Food and Drugs Act. As stated on Health Canada’s website the 
NSNR 
were developed with industrial substances in mind, such as floor cleaners and fire 
retardants ...some substances regulated under the Food and Drugs Act have unique 
properties and exposure patterns that require a different approach to environmental 
assessment than what is currently required under the New Substance Notification 
Regulations. (Health Canada, 2011c) 
 
A 2001 agreement between Environment Canada and Health Canada gave the latter 
responsibility to conduct the full assessment of these substances. Since 2001, Health Canada has 
been in the process of developing new Environmental Assessment Regulations (EARs) to replace 
the NSNR with respect to new substances in products regulated under the Food and Drugs Act, 
including foods that are or contain biotechnology-produced animals (Health Canada, 2010d). As 
of December 2012 the regulations have not been completed.  
Regulating Biotechnology-produced animals for Manufacture, Import or Sale 
A safety assessment under the New Substance Notification Regulations (Organisms) must also be 
completed before a biotechnology-produced animal can be manufactured, imported or sold in 
Canada. The producer or manufacturer must notify Environment Canada “so that the animal 
undergoes a safety assessment for potential impacts to the Environment” (Canadian Food 
Inspection Agency, 2012a). The assessments are co-administered by Environment Canada and 
Health Canada under the Canadian Environmental Protection Act, 1999 (CEPA, 1999) and the 
New Substance Notification Regulations (Organisms). The environmental aspects of the 
notification are evaluated by Environment Canada and the human health aspects are evaluated by 
Health Canada (CFIA, 2012a). 
Applicants must support their application to manufacture, import, or sell to Canada any 
biotechnology-produced animals with technical documentation related to the animal's health. The 
CFIA gets consulted by Environment Canada regarding animal health matters during the process 
of assessing biotechnology-produced animals (CFIA 2012a).The CFIA gets its jurisdiction from 
the Health of Animals Act. 
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The Regulation of Biotechnology-produced Fish 
The New Substance Notification Regulations (Organisms) NSNR (Organisms) also apply to any 
request to develop biotechnology-produced fish for commercial purposes. The Department of 
Fisheries and Oceans Canada (DFO) administers New Substance Notifications for fish products 
of biotechnology and undertakes risk assessments for these organisms (Fisheries and Oceans 
Canada, 2011).The DFO is working with Environment Canada to have any products that contain 
biotechnology-produced fish for commercial purposes, including manufacture, import and sale, 
assessed for notification and compliance with the NSNR under CEPA 1999 (CFIA 2012a). The 
DFO is also developing regulations for biotechnology-produced aquatic organisms (Lupescu & 
Evans, 2012, p. 6). A timeline has not been given regarding when these regulations will be 
published (Lupescu & Evans, 2012, p. 6).  
A biotechnology-produced fish would also have to meet the requirements of the CFIA’s 
Fish Inspection Program before it can be approved for use as a food. The Inspection Program 
ensures that fish and seafood products meet food safety and quality standards. The CFIA is in the 
process of developing “new inspection tools, policies and compliance strategies...In order to 
effectively manage the introduction of approved novel food fish products to the Canadian 
marketplace” (CFIA, 2009b).  
Labeling for foods that contain Biotechnology-produced Material 
Health Canada shares the responsibility with the Canadian Food Inspection Agency (CFIA) for 
all food labeling policies under the Food and Drugs Act. Health Canada is responsible for 
developing policy and setting standards for required labeling related to health and safety issues 
(i.e. allergenicity, changes in nutritional composition). The CFIA is responsible for non-safety 
related product labeling (i.e. voluntary labeling and consumer fraud issues) and for applying 
Health Canada’s policies and enforcing its regulations (CFIA, 2012d; Health Canada, 2005b). 
In Canada mandatory food labels are required to address alterations in foods that pose 
health and safety risks that might be mitigated through labeling (CFIA, 2012d). Labels are not 
mandatory to identify a method of production, including modern gene technologies. As stated on 
the CFIA website “Voluntary labeling is permitted in order to provide consumers with 
information that is not related to the safety of the product” (CFIA, 2012d). 
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In April of 2004 a Canadian standard entitled Voluntary Labeling and Advertising of 
Foods that Are and Are Not Products of Genetic Engineering was implemented to address non-
health and safety concerns (Health Canada, 2008). The voluntary standard refers to genetic 
engineering as “techniques by which the genetic material of an organism is changed in a way that 
does not occur naturally by multiplication and/or natural recombination” (Canadian General 
Standards Board, 2004, p. 2). The voluntary labeling standard was not intended to address health 
and safety concerns as these are already addressed by the Food and Drugs Act and Regulations. 
The standard specified voluntary regulations for products that were and were not products of 
genetic engineering with a 5% allowance of GE crops in food products not considered to be 
derived from genetic engineering (Canadian General Standards Board, 2004). 
2.3.  Mechanisms of Accountability 
Federal Government institutions, non-government organizations (NGOs), private sector bodies, 
and media outlets can all serve to ensure Federal Government transparency in decision-making. 
Federal Government institutions include the Cabinet, the House of Commons, the Courts, the 
public service; regulatory agencies; non-departmental organizations and; advisory groups. 
NGOs, the private sector, members of academia, and members of the media also examine 
transparency in Federal Government decision-making and institutions regarding the human 
consumption of biotechnology-produced animals.  
2.3.1.  Federal Institutional Mechanisms 
A number of Federal Government institutions could be mandated to enhance the transparency of 
policy-making processes and institutions with respect to the human consumption of 
biotechnology-produced animals through the introduction of legislation and enabling regulations. 
Federal Government institutional bodies within the elected and the non-elected arms of 
government can be utilized to ensure transparency with respect to decision-making regarding the 
human consumption of biotechnology-produced animals. Such instruments can be used to 





Parliament and Accountability Mechanisms 
The ability to hold the elected Federal Government accountable in order to ensure that food is 
traceable and that decisions are transparent depends extensively on governing structures 
beginning with the elected legislative arm. This is done through legislative procedures in the 
House of Commons, “watchdog” agencies, and legislative committees. 
Legislative Procedures in the House of Commons  
Proceedings in the House of Commons including motions, debates, order paper questions, and 
question periods provide opportunities for Member of Parliament (MP) to hold Federal 
Government accountable including Ministers, the Cabinet, Central Agencies, and the Prime 
Minister.  For example, in 2011, Fin Donnelly, MP for New Westminster—Coquitlam and the 
NDP Fisheries and Oceans Critic, tabled a motion (M-648) “asking for transparency and more 
study before genetically modified (GM) Atlantic salmon are approved for human consumption” 
(CBAN, 2011a). The motion did not pass.  
Ministers are also answerable to the House of Commons for the policy and conduct of the 
Cabinet as a whole. They “are expected to take responsibility for, and defend, all Cabinet 
decisions” (Parliament of Canada, 2010). Ministers and Ministers of State must also “strictly 
uphold the confidentiality of Cabinet decision-making” (Privy Council Office, 2011, p. 1). 
Watchdog Agencies  
The use of watchdog agencies such as ombudsmen and auditors also assist legislators in ensuring 
responsibility in Federal Government through controlling or influencing bureaucratic actions 
(Kernaghan & Siegal, 1995, p. 421). The Office of the Auditor General of Canada, the 
Information Commissioner, and the Public Service Commissioner are three such agencies that 
can be used to foster transparency and accountability in federal policy-making processes and 
institutions.  
The Office of the Auditor General of Canada 
The Office of the Auditor General reports directly to Parliament and “provides objective 
information, advice, and assurance that legislatures can draw on in their scrutiny of Federal 
Government spending and performance” (Office of the Auditor General of Canada, 2007). The 
only other Federal watchdog agency that reports in this manner, instead of through a Minister, is 
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the Official Languages Commissioner (Kernaghan & Siegal, 1995, p. 423). The Auditor 
General’s audit findings and annual reports to Parliament can be widely publicized in the media 
(Kernaghan & Siegal, 1995, pp. 423, 424). Recent transparency and accountability issues that 
have been raised by the Auditor General show that a lack of accountability with respect to GE 
foods is not without precedent. Such examples include the ongoing controversy surrounding the 
Department of National Defense over the cost of purchasing F-35 stealth fighter jets and 
inappropriate spending by Conservative Cabinet Minister Tony Clement in choosing which 
projects were selected for the multi-million dollar G8 legacy fund (Berthiaume, 2012; Smith, 
2012). In 1995 amendments made to the Auditor General Act gave the Auditor General’s Office 
an environmental and sustainable development mandate. The amendments, as directly stated on 
the Auditor General’s Office website 
 created the position of Commissioner of the Environment and Sustainable 
Development within the Office of the Auditor General of Canada, giving the 
Commissioner specific monitoring and reporting duties, on the Auditor 
General’s behalf;  
 added environmental impact to what the Auditor General takes into account 
when determining what to report to the House of Commons;  
 required federal departments and agencies to prepare sustainable 
development strategies and update them every three years; and   
 authorized the Auditor General to receive petitions on environmental and 
sustainable development matters and required ministers to respond to them. 
(Office of the Auditor General of Canada, 2012) 
 
The Commissioner of the Environment and Sustainable Development reports to Parliament on 
behalf of the Auditor General “on the environmental petitions process, sustainable development 
strategies, and any other matters that the Commissioner believes should be brought to its 
attention” (Office of the Auditor General of Canada, 2007b). 
It is part of the Commissioner’s responsibilities to monitor departmental and agency 
responses to petitions. The Commissioner of the Environment and Sustainable Development 
“monitors the status of these petitions and the Government's response to them” (CFIA, 2012g) 
and “makes sure that the questions that Canadians pose and the issues that they raise are 
addressed by Federal ministers and their departments” (Commissioner of the Environment and 
Sustainable Development, 2001, p. 1). Former Commissioner of the Environment and 
Sustainable Development, Johanne Gelinas stated 
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Canadians have a fundamental right to know what their Government is doing to protect 
the environment and promote sustainable development. Petitions can provide them with 
this information. (Commissioner of the Environment and Sustainable Development, 
2002, p. 3) 
A representative from the Office of the Auditor General of Canada said that petitions play an 
important role in the overall audit planning process (OAG representative, personal 
communications, May 2012). Audit teams across the office review petitions and petition 
responses when they are preparing their long-term audit plans of departments and agencies and 
when they are embarking on individual performance audits (OAG representative, personal 
communications, May 2012). In some cases the Office will audit issues raised by petitioners and 
commitments made by ministers in their responses to petitions. In 2008–09 for example, the 
Office audited departmental progress related to the development of the Air Quality Health Index. 
The results of this work were reported to Parliament in the CESD’s Status Report in March 2009 
(Office of the Auditor General of Canada, 2009, p. 33) 
The Auditor General’s website also has a petitions catalogue that includes the full text of 
most petitions and Federal Government responses (Office of the Auditor General of Canada, 
2010). Some departments and agencies, including the CFIA, post these responses on their 
websites (CFIA, 2012g).  
As will be discussed further in Chapter 3, the petitions process has been used several 
times to shed light on issues of transparency and accountability regarding decision-making 
surrounding GE Foods. For example Greenpeace submitted a petition on Genetically Engineered 
fish in 2001 and a follow-up petition on genetically engineered fish in 2003. Government 
responses to these petitions were audited and findings were included in the 2004 Report of the 
Commissioner of the Environment and Sustainable Development as well as the 2008 March 
Status Report of the Commissioner of the Environment and Sustainable Development 
(Commissioner of the Environment and Sustainable Development, 2004a; Commissioner of the 
Environment and Sustainable Development, 2008). The purpose of the audits was to verify 
whether the Department of Fisheries and Oceans was making progress in developing regulations 




In the follow-up audit of DFO’s 2002 response for petition 38A on Genetically 
Engineered Fish, the Commissioner of the Environment and Sustainable Development set out to 
determine whether the department was making progress in developing specific regulations for 
transgenic fish. It found that the department had not followed through with its commitment as 
regulations had not been finalized. The 2004 report noted that all timelines set by the Fisheries 
and Oceans Department for completing regulations had been missed and included an insert on 
the timelines that had been set by the Department (Commissioner of the Environment and 
Sustainable Development, 2004a; Commissioner of the Environment and Sustainable 
Development, 2004b). An employee from the Office of the Auditor General of Canada also 
stated  
it is recognized that having the NSNR as a catch all for innovative organisms is not 
appropriate. The government has acknowledged that departments are best placed to 
develop and administer regulations that are within their area of expertise. For GE fish this 
would be DFO. As we noted in our audit, ‘The Department has the expertise to deal with 
fish and other aquatic organisms and is therefore seen by the government as best placed 
to manage a regulatory system geared specifically to meeting the complex challenges 
associated with GE fish’. (OAG representative, personal communications, May 2012) 
 
The petitions and follow-up audits draw attention to the need for regulations for biotechnology-
produced animals and for regulatory oversight. As of December 2012 unique regulations 
specifically designed for biotechnology-produced animals, including fish, have not been 
developed. 
The Information Commissioner 
Residents of Canada can also submit a request for information through the Access to Information 
Act. The Office of the Information Commissioner of Canada is a watchdog agency that 
administers the Access to Information Act by investigating complaints against denial of access to 
government information. If an Access to Information (ATI) request is submitted concerning the 
decision-making processes and institutions regarding biotechnology-produced animals, the 
person who made the submission can complain to this Office if they feel that information was 






The Public Service Commissioner  
The Public Service Commission is another important watchdog agency serving Parliament “as 
the guardian of the merit principle in human resource management” (Kernaghan & Siegal, 1995, 
p. 423). If there were questions surrounding decision-makers that had authority over decisions 
being made regarding biotechnology-produced animals and conflicts of interest, political 
interferences, or political neutrality, the Public Service Commission would look into the matter. 
Both the Office of the Information Commissioner and the Public Service Commissioner report to 
Parliament through the Department of Justice (Kernaghan & Siegal, 1995, p. 421).   
Parliamentary Committees 
Parliamentary committees are the third major means by which the legislature can exercise 
control or influence over the bureaucracy and foster transparency in decision-making. Special, 
joint, standing and legislative committees can all serve to foster transparency in decision-making 
processes concerning foods produced through modern biotechnology. For example both the 
Standing Committee on Health as well as the Standing Committee on Agriculture and Agri-Food 
has been used in the past to study the issue of biotechnology in Canada (as discussed in Chapter 
3). The Standing Joint Committee for the Scrutiny of Regulations can also be used to foster 
transparency in policy-making. Any regulations being updated or created, including the proposed 
Environmental Assessment Regulations for new substances and products regulated under the 
Food and Drugs Acts would be assessed by this Committee. 
Federal Legislative Acts 
The Federal Government has developed and enacted legislation to foster transparency in 
decision-making. Departments and agencies must comply with the legislation. Some legislation 
specifically measures the accountability of decision-makers; other acts measure how accountable 
decision-makers are to society at large (i.e. sustainability). Examples include the Federal 
Accountability Act enacted in 2006 and the 2007 Public Servants Disclosure Protection Act 
(PSDPA). Both Acts, among other things, attempt to increase protection for whistleblowers. 
Another act that can foster transparency is the 2008 Federal Sustainable Development Act 
(FSDA). This Act provides the legal framework for the Government of Canada to develop and 
implement “a Federal Sustainable Development Strategy [FSDS] that will make environmental 
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decision-making more transparent and accountable to Parliament” (Federal Sustainable 
Development Act, 2008). A requirement of the Act is that “Federal Government departments and 
agencies develop sustainable development strategies to support the FSDS” (Health Canada, 
2012b). Acts can also followed by or have companion actions plans that include supporting 
policy, benchmarks, and other non-legislative measures. Whether responses to these Acts have 
increased transparency in decision-making regarding biotechnology-produced animals will be 
explored in this research paper.  
Federal Consultations, Departments and Agencies 
A mandatory component of a policy or regulation-making process is consultation. Information 
on past, upcoming or ongoing consultations can be found through the Government of Canada’s 
Consulting with Canadians website (Government of Canada, 2011a), as well as through the 
Federal Government’s Canadian Gazette website (Government of Canada, 2012b). The Federal 
Government has also created the website, BioPortal.gc.ca as “your window to biotechnology @ 
the Federal Government” (Government of Canada, 2012a). Under the heading “about this site” 
the website states  
As part of their work, the departments and agencies of the Government provide a vast 
amount of online information about biotechnology. The BioPortal is a tool to help you 
locate information on biotechnology from these different Federal departments and 
agencies. (Government of Canada, 2005a) 
 
Departments also undertake initiatives to inform interested parties about upcoming or ongoing 
consultations. For example Health Canada provides information about ongoing regulatory 
initiatives on the Public Involvement section of its website (Health Canada, 2012g). 
Consultations that have taken place concerning regulation and policy-making that apply to the 
human consumption of biotechnology-produced animals are discussed in Chapter 3 and 4. 
Federal departments and agencies can have specific offices and divisions tasked with 
examining issues of transparency. An example is the Food and Drugs Act Liaisons Office 
launched in March 2008 “to improve relations between external stakeholders and representatives 
of Health Canada, as well as to increase the openness and transparency in the regulatory process” 
(Health Canada, 2012c). The office is listed as “an impartial and confidential resource for 
individuals, business and organizations when they experience problems with how Health Canada 
35 
 
administers the Food and Drugs Act” (Health Canada, 2012c). The degree of impartiality, 
however, depends on the lens used by the observer and their perceptions of the validity and 
comprehensiveness of the literature presented. 
The Public Service of Canada 
Unlike Ministers, the Deputy Ministers and public servants are answerable, but not directly 
accountable, to Parliament and its committees for their decisions and recommendations 
(Kernaghan & Siegal, 1995, p. 419). Public servants are “directly accountable only to political 
and administrative superiors, to the courts, and to any internal Governmental authorities (e.g. 
central agencies) to which accountability is required by law or the administrative hierarchy” 
(Kernaghan & Siegal, 1995, p. 357). Although they are not directly accountable to the 
legislature, to pressure groups, to the news media, or to the general public, public servants “are 
generally required to explain their decisions and actions to those entities” (Kernaghan & Siegal, 
1995, p. 357). If public servants felt that there were issues of transparency in decision-making 
processes concerning biotechnology-produced animals, they could also use these venues to shed 
light on issues concerning transparency and accountability. 
Regulatory Agencies 
Regulatory agencies are set up to enforce standards and legislation and have “the ability to make 
general rules or regulations, in the form of delegated legislation that have the force of law” 
(Economic Council of Canada, p. 56). Regulatory agencies have statutory authority, consist of a 
panel of members and are formed as a result of enabling legislation. Analysts Kernaghan and 
Siegel define a regulatory agency as a  
statutory body charged with responsibility to administer, to fix, to establish, to control, or 
to regulate the economic, cultural, environmental, or social activity by regularized and 
established means in the public interest and in accordance with general policy guidelines 
specified by the government. This body is under the general direction of the legislature 
and a responsible minister with regard to policy matters but possesses relative autonomy 
in making individual decisions within those policy guidelines. (Kernaghan & Siegal, 
1995, pp. 250, 251) 
 
Some regulatory agencies also have direct administrative responsibility for operating programs. 
An example of a regulatory agency is the Canadian Food Inspection Agency (CFIA). The CFIA 
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both regulates and promotes food products produced through biotechnology (discussed further in 
chapter 3). This is rare in regulatory agencies because it can create a conflict of interest when an 
agency must operate a program affecting an industry while regulating that same industry.   
Non-Departmental Organizations 
Non-Departmental Organizations can also be used to foster transparency in Federal Government 
decision-making. These organizations can shed light on issues of uncertainty and provide advice 
and guidance to the Cabinet and individual ministers beyond that provided by public servants. 
These organizations “are more involved in advising, consulting, and/or researching then in 
implementing or doing” (Kernaghan & Siegal, 1995, p. 286). The accountability and success of 
these organizations can be judged through an examination of their membership, what advice is 
given, and whether and how the organization’s recommendations are considered during policy-
making processes.  
Royal commissions, task forces and advisory councils are non-departmental 
organizations. Royal commissions and task forces are temporary and are “constituted to 
investigate either specific incidents or general policy concerns and report to Government” 
(Kernaghan & Siegal, 1995, p. 287). Advisory councils are composed of private citizens and 
“created by the Government to provide an independent source of advice to a minister” 
(Kernaghan & Siegal, 1995, p. 296). Advisory councils sit on some boards such as the Canadian 
Food Inspection Agency. 
The Federal Court of Canada  
A matter of public policy can be challenged before the courts. The Federal Government has to 
defend that policy and in doing so the Government can provide transparency. During interviews 
for this paper a Liberal MP said “The court has the power to demand answers and the 
government has to talk to the court” (LMP-2). Another participant, a Green Party shadow cabinet 
member said going to court forces information to be made available (GP-1).   
Advisory Groups 
Advisory groups can be established by departments to provide advice and act as sounding boards 
to the branch and to other officials in the department. Advisory groups include working groups 
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and advisory committees, expert panels, roundtable forums and ministerial advisory boards. 
Advisory groups that have been established by the Health Products and Food Branch of Health 
Canada include the Environmental Assessment Working Group (EAWG), the Food Expert 
Advisory Committee (FEAC), and the Public Advisory Committee (PAC). 
Working Groups and Advisory Committees 
The Environmental Assessment Working Group (EAWG) meets three to four times a year. One 
of the purposes of the group is “to provide broad, strategic advice on policy, technical, 
operational and regulatory issues to Health Canada and Environment Canada on the development 
of appropriate Environmental Assessment Regulations for new substances contained in products 
regulated under the Food & Drugs Act” (Health Canada, 2010c). Whether the EAWG has 
increased accountability concerning the development of the EARs, which would apply to foods 
derived from biotechnology-produced animals, will be explored further through primary research 
findings in Chapter 4. 
The Food Expert Advisory Committee (FEAC) meets twice a year and provides the Food 
Directorate with “broad expert strategic policy advice on the safety of food products” (Health 
Canada, 2011b). The impact of the FEAC on decision-making regarding biotechnology-produced 
animals will be pursued further in Chapter 4.   
Health Canada’s Public Advisory Committee (PAC) was formed in 2002 “as a 
public/consumer involvement forum that advised on issues and initiatives as requested by the 
[Health Products and Food Branch of Health Canada]. It is a component of the Branch's strategy 
to increase transparency and public involvement through the consultation processes” (Health 
Canada, 2007). The PAC was shut down in 2004. What has replaced the committee with regards 
to the human consumption of biotechnology-produced animals will be explored through the 
following chapters. 
Expert Panels 
Independent expert panels can also be used by the Federal Government to provide expert advice 
to departments and agencies. The reports of these panels are often high profile and can shed light 
on the accountability of decision-makers and the decision-making process. For example in 
December of 1999 the Royal Society of Canada, Canada’s senior national body of distinguished 
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Canadian scientists and scholars, established the Expert Panel on the Future of Food 
Biotechnology at the request of Health Canada, the CFIA and Environment Canada. The Expert 
Panel was “to provide advice on the Canadian regulatory system and the scientific capacity the 
Federal Government requires in to the 21
st
 century to ensure the safety of new food products 
being developed through biotechnology” (Royal Society of Canada, 2001, Prefatory Note). The 
Expert Panel released its findings in its report Elements of Precaution: Recommendations for the 
Regulation of Food Biotechnology in Canada in February of 2001.  
When independent expert panels formed at the request of Federal Government do shed 
light on accountability, the panels’ findings might not lead to significant changes or can be 
overlooked. The Federal Government does not have to act on the findings. The Federal 
Government’s response to the Royal Society of Canada’s Expert Panel report was made through 
an Action Plan and series of progress reports, discussed further in Chapter 3 and 4. 
Roundtable Forums 
Roundtable forums are another type of advisory group that can aid in increasing transparency in 
decision-making. They allow interested parties to voice their opinions on the development of 
decision-making processes and whether decision-makers can be held accountable under the 
chosen decision-making process. The forums can be directed at citizens and/or industry 
representatives. For example the Consumer Association Roundtable was launched by Agriculture 
Minister Gerry Ritz in December 2010 to give consumers “an additional opportunity to raise 
concerns and discuss ways to further improve Canada's food safety system” (CFIA, 2010b). 
Another example is Agriculture and Agri-Food Canada’s Pork Value Chain Roundtable. The 
roundtable is “a collaborative effort between government and industry” and “provides an 
important platform for discussing ideas, priorities, and solutions and contributes to the success of 
Canada's pork industry” (AAFC, 2011). 
Ministerial Advisory Boards  
Ministerial advisory boards (MAB) can also be used to foster transparency in the decision-
making process by providing advice to Ministers. For example in November 2010 Agriculture 
Minister Gerry Ritz appointed seven advisors to the MAB of the CFIA. This MAB “includes a 
diverse range of experts from the food, animal and plant health sectors who will advise the 
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Minister on food safety and other issues related to the CFIA’s mandate” (CFIA, 2010a). 
Examining who was appointed to a MAB can aid in keeping ministers accountable.  
2.3.2. Non - Governmental Organizations and Private Sector Bodies 
Actors outside of the Federal Government can be used to hold decision-makers and decision-
making processes accountable. Non-Governmental organizations (NGOs), members of 
academia, and the private sector exercise influence over both the development and 
implementation of public policies through lobbying. They can participate in Federal Government 
initiatives in order to provide advice, ask for information on decision-making or to question the 
accountability and transparency of a decision-making process. This can be done through 
communicating with public officials, speaking before committees as witnesses, boycotting a 
policy-making process, submitting ATI requests and filing petitions with the Auditor General’s 
Office. These actors also participate in non-departmental organizations. Advisory bodies can also 
“be used for direct interaction between citizens and public officials, especially bureaucrats” 
(Kernaghan & Siegal, 1995, p. 500). In some cases participants are invited to join the 
undertaking, in other cases they can volunteer or apply to participate. The usual targets of their 
activity are Cabinet Ministers, public servants, and legislators (Kernaghan & Siegal, 1995, p. 
479).  
In addition to participating, or declining to participate, in Federal Government 
institutional processes, NGOs, academics, and members of the private sector can undertake their 
own initiatives to attempt to participate in decision-making. They can support House of 
Commons Bills and Motions and utilize avenues within and outside of Federal Government to 
follow House of Commons Procedures. This includes using independently run sites like 
openparliment.ca, as suggested by a Liberal MP (LMP-2). Various groups have been active in 
attempting to hold the Federal Government accountable regarding GE food policies through 
websites and grey literature and more formal academic publications, many of which can be 
found in this research paper’s bibliography. Chapters 4, 5 and 6 include a discussion about 
whether the transparency issues and recommendations raised in these publications have been 




 NGOs also release reports that examine transparency in the Federal Government. 
Examples of publications include the Canadian Policy Research Network report Transparency, 
Trust and Citizen Engagement, What Canadians are saying About Accountability (2005) and the 
Federal Accountability Initiative for Reform (FAIR), a charity whose aim is to protect 
whistleblowers, publication What’s Wrong with Canada’s Federal Whistleblower Legislation? 
2.3.3.  Media 
The media play a critical role as two-way channels of communication between the governors and 
the governed to both reflect and influence public opinions (Kernaghan & Siegal, 1995, p. 503). 
Members of the media can serve as watchdogs of the public interest and as an important voice 
for whistleblowers. Members of the media can gain entry into different places and can become 
the conduits for information. They are in a position to conduct interviews and to write articles 
that appeal to a variety of audiences through a number of forums (magazines, TV shows, 
newspapers, exposés, and academic journals), publicize documents obtained through Access to 
Information requests, and conduct and discuss polls. For example, between 2010 and 2012 
reporter Sarah Schmidt wrote articles concerning regulations for biotechnology-produced 
animals based on documents she obtained through ATI requests.  
2.4.  Conclusion 
Decision-makers do have the capacity to improve transparency and accountability. As examined 
in this chapter, numerous institutional bodies could theoretically improve both transparency and 
accountability with respect to biotechnology-produced animals and the food system. The next 
two chapters explore institutionally-related issues related to transparency by reviewing the 





Chapter 3: Barriers to Transparency: A History of Decision-Making with 
Respect to Foods Derived through Modern Biotechnology 
3.1. Introduction 
The following review of the academic literature respecting Federal Government transparency 
reveals numerous limitations that constrain effective policy-making with respect to the human 
consumption of biotechnology-produced animals. These limitations include regulatory 
inadequacy with respect to as well as parliamentary ineffectiveness in dealing with these 
animals. This chapter explores the history of policy and regulation with respect to genetically 
engineered food as well as various limiting factors present within, and external to the 
government, that constrains transparency of the governing regime. 
3.2. Guiding Policies and Principles Respecting the Human Consumption of Genetically 
Engineered Foods 
3.2.1. Departments, Agencies and Core Principles (1980s – 1998)
3
 
Canadian Federal departments and agencies have not been created to deal specifically with 
products of biotechnology. In the mid-1980s, regulatory authority over products derived through 
rDNA techniques (modern biotechnology) was given to Federal Government departments that 
held authority over the same products made from traditional techniques (Moore 2000, p. 96). The 
three central regulatory departments were Agriculture, Environment, and Health and Welfare. By 
1987, these departments agreed on several working principles that included building on existing 
legislation and internationally developed guidelines, regulating the product as opposed to the 
process, and using risk-assessment principles (Kneen, 1999 p. 135).  
These working principles, including the use of existing laws and regulatory departments 
to avoid duplication, endured when Canada created a Federal Regulatory Framework (1993) to 
ensure that “the benefits of biotechnology products and processes are realized in a way that 
protects health, safety, and the environment” (Health Canada, 2012d).  
                                                 
3
See Appendix A for timeline of events discussed in this chapter 
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They also remained in place when Canada’s first National Biotechnology Strategy (1983) 
was replaced by the Canadian Biotechnology Strategy in 1998. The 1998 Strategy placed an 
emphasis on strengthening interdepartmental coordination as well as public awareness and 
participation (Moore, 2000, p. 117). Through the Strategy the Canadian Biotechnology Advisory 
Committee (CBAC) was created to “provide expert advice to the Federal Government on ethical, 
social, regulatory, economic, scientific, environmental and health aspects of biotechnology” 
(Health Canada, 2006d). The impartiality of the CBAC was considered suspect as the CBAC 
resided in the Office of the Canadian Biotechnology Secretariat within Industry Canada, a 
department that promotes biotechnology (Council of Canadians, 2002).  
3.2.2. The CFIA’s Role of Regulating and Promoting the Biotech Industry 
Consolidation of regulatory functions resulted in the establishment of the Canadian Food 
Inspection Agency (CFIA) in 1997. The CFIA, which operates under Agriculture and Agri-Food 
Canada (AAFC), was given the roles of both promoter and regulator of biotech products. Some 
CFIA initiatives have been questioned for being pro-biotechnology. For example, the CFIA 
funded information inserts that appeared in the October and November 1999 issues of Canadian 
Living magazine that critics claimed promoted biotechnology (see Appendix A). The connection 
to the CFIA was not identified in the communication. Another example also perceived to be 
biased, included a CFIA pamphlet “Food Safety and You” mailed to Canadian households in 
March 2000 at an alleged cost to taxpayers of $2.53 million (Kneen, 2000). 
3.2.3. Genetically Engineered Food Policy Consultations 
Public consultations regarding the formation of Federal biotech policies included workshops in 
1993 and 1994 which served as the basis for Canada’s regulations for GE foods (Moore, 2000 p. 
157). Brewster Kneen outlined multiple occasions where his involvement in the 1993 and 1994 
consultations had been used by “industry flacks” to legitimize the consultative process: 
 
There has been nothing democratic about the process of developing public policy for 
biotechnology…I was there only because I insisted on being present as one of the very 
few members of the public who had any idea of what was going on in Ottawa… I did this 
on my own time, and at my own expense. (Kneen, 2000) 
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Kneen also stated “that there was nothing public or democratic about the so-called consultative 
process of forming biotech policy and that there never was a consensus on the emerging policy” 
(Kneen, 2000). 
3.3. The Evolution of GE Food Regulations and Guidelines 
3.3.1. The Environmental Assessment of Genetically Engineered Foods (2001-2006) 
Up until 2001, new substances found in products regulated under the Food and Drugs Act were 
exempt from the requirements of the Canadian Environmental Protection Act, 1999 (CEPA 
1999). In September 2001, those substances became subject to the notification and assessment 
requirements under the New Substance Notification Regulations (NSNR) of CEPA 1999. As 
discussed in the previous chapters, the NSNR were not developed for substances regulated under 
the Food and Drugs Act (Health Canada, 2010b). An agreement signed between Environment 
Canada and Health Canada gave Health Canada the responsibility to conduct the full assessment 
of these substances.  
In September 2001, Health Canada’s Environmental Impact Initiative (EII) began 
formulating Environmental Assessment Regulations (EARs) for new substances in products 
regulated under the Food and Drugs Act (Health Canada, 2010b). Between 2001 and 2006 the 
EII held multiple consultations regarding the creation of the EARs (listed in Appendix B). Why 
consultations and publications regarding the EARs stopped in 2006 and what work has happened 
regarding the EARs since 2006 is unclear. It is also unclear in the literature when work on the 
EARs will be completed and how appropriate it is to assess the human consumption of 
biotechnology-produced animals through the NSNR. 
3.3.2. Health Canada’s Safety Assessment of Novel Foods 
When genetically engineered (GE) foods first came into the market in the early 1990s, 
developers were responsible for the voluntary safety assessment of their GE food product(s). In 
1994 Health Canada released the Guidelines for the Safety Assessment of Novel Foods – Volume 
I, and Volume II: Genetically Modified Microorganisms and Plants to assist developers in their 
product assessments.  
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Health Canada’s guidelines referred to GE food as novel foods, and GE plants as Plants 
with Novel Traits (PNTs) (Food Directorate Health Protection Branch, 1994). In 1995, Health 
Canada proposed the establishment of a new division in the Food and Drug Regulation “that will 
define the concept of a novel food and provide for notification prior to the sale or advertising the 
sale of such food products” (Health Canada, 1995, p. 2987). The Novel Food Regulations 
appeared in Canadian Gazette II in October 1999 and made a pre-market safety assessment 
mandatory for the sale of all foods that had met Health Canada’s definition for novel food. 
Health Canada’s definition for novel foods found in these regulations extends beyond products 
that have been derived through modern biotechnology.
4
 
If any new risks appear in novel food products approved through the safety assessment it 
is up to the manufacturer to make Health Canada aware of the changes. The identification of new 
risks is limited by the willingness of manufacturers to test their products and to share results with 
the Federal Government.  
As of December 2012, the Guidelines for the Safety Assessment of Novel Foods 
(Volumes I and II) had last been updated in 2006 and stated that the section for Novel Foods 
Derived from Animals is “Under Development” (Health Canada, Food Directorate Health 
Products and Food Branch, 2006). According to Health Canada’s website “safety assessment 
criteria for novel foods derived from animals are under development” (Health Canada, 2006d). It 
is unclear when the guidelines will be updated and what work has been completed on them since 
2006. It is also unclear what information Health Canada would need to assess the safety of food 
products derived through biotechnology-produced animals and what risks the department will be 
looking at during the assessment process. This is a cause for concern for in 2009 the University 
of Guelph submitted a notification to Health Canada to approve its Enviropig™ for human 
consumption (Mann, 2011). As of December 2012, there was no publicly-available information 
about whether or not Health Canada has reached a decision on the notification. 
Critiques surrounding the safety assessment of novel foods have focused on (1) Health 
Canada’s scientific assessment of risks including the use of substantial equivalence and (2) the 
ability for the regulatory process to take into account new risks introduced by evolving 
technologies. Health Canada uses the concept of substantial equivalence as a guide in the safety 
                                                 
4
 The definition of novel foods is included in Division 28, Part B of the Food and Drug Regulations. The 
Regulations can be found on the Department of Justice Canada website 
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assessment of novel foods (Health Canada, 2006d). The concept of substantial equivalence 
narrows the safety risks to those already found in the food system. The Royal Society of 
Canada’s Expert Panel on the Future of Food Biotechnology (2001) “rejected the use of 
substantial equivalence as a decision threshold to exempt new GM products from rigorous safety 
assessments on the basis of superficial similarities” (Royal Society of Canada, 2001, p. 204, 
206). At time of writing, no information is available about how concept will be used in Health 
Canada’s safety assessment of the Enviropig™. 
Health Canada’s testing of food products derived from biotechnology includes a 
scientific assessment of risks that, among other things, look at allergenicity and toxicity (Health 
Canada, 2005). In January 2000 GE Alert, a group of scientists and academics, released a report 
that revealed testing of the toxicity and allergenicity of GE crops by Health Canada had not been 
conducted on 70% of the 42 GE crops the department had approved (McKenzie, 2002, p. 170). 
Dr E. Ann Clark, a Professor at the University of Guelph and member of GE Alert said that the 
analysis "supports the need for a fundamental reassessment of the process by which the safety of 
GE food is tested in Canada" (Council of Canadians, 2000). 
Health Canada’s scientific assessment is also focused on product, not process based risks. 
In June 2009 a biotech maize named Smartstax™ with eight different gene coding for several 
pest resistant and herbicide tolerant traits was approved by the CFIA for release in Canada. The 
Smartstax™ corn is the first GM crop that has more than three GM traits ‘stacked’ together. As 
each of the eight GM traits had been individually approved in earlier crops by Health Canada the 
maize was not classified as a novel food. According to an article by the Canadian Biotechnology 
Action Network, Health Canada had said a safety evaluation was not needed as new risks are not 
created through the combination of GM traits (CBAN, 2012a).  
 A recent laboratory study of rats raised question about the safety of GE maize (Seralini, 
et al., 2012). Studies of this kind also raise questions about Health Canada’s chosen approach. 
The French group of Gilles-Eric Seralini conducted a peer-reviewed study in 2012 that described 
harmful effects on rats fed on diets containing GE maize (Seralini, et al., 2012). This study was 
the first biotechnology-produced animal feeding trial that had been conducted over the lifetime 
of laboratory rats (two years) to test Monsanto's GM corn NK603 and its herbicide Roundup, 
approved in Canada in 2001. This length of time far surpasses the one required by Health 
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Canada. The study found tumors, multiple organ damage and premature death that happened 
after the typical 90-day period often employed by such laboratory experiments.  
Health Canada published a three-page summary of its approval on the GE maize in a 
2001 Decision Document based on information provided by Monsanto without its own testing 
(Health Canada, 2001; CBAN, 2012d). The Seralini study is the first of its kind. Its findings lead 
one to question both Health Canada’s assessment period and requirements of scientific data from 
companies regarding the length of studies. 
3.3.3. Labeling Genetically Engineered Foods in Canada 
 In Canada, companies are not required to label the process a food product went through, 
including the use of modern biotechnology techniques (i.e. genetic engineering). As more 
genetically engineered foods entered the market the Government of Canada recognized that “for 
many Canadians, labeling of foods derived from biotechnology is an important issue of 
consumer preference or choice” (Health Canada, 2005b). In September 1999, the Canadian 
General Standards Board (CGSB) and the Canadian Council of Grocery Distributers (CCGD) 
established a multi-stakeholder committee to develop a voluntary labeling standard for foods 
derived from biotechnology.  
Some Canadian advocacy groups believe that given that labeling is based on a voluntary 
labeling standard, the Canadian Government was putting business and trade interests above 
consumer welfare. Canadian NGOs released multiple documents obtained through the Access to 
Information Act that showed controversial ties between the departments responsible for the 
labeling standard project and proponents of the biotechnology industry.
5
 Objections were raised 
by both public and private actors over the extent of influence that proponents of the 
biotechnology industry had over the decision to make the labeling standard’s project voluntary 
(Wasylycia-Leis, 2001). A number of NGOs also believed that recommendations outlined by the 
Royal Society of Canada Expert Panel on the Future of Food Biotechnology were not 
acknowledged in Federal Government publications, including the CGSB Committee’s 
Consultation Document Regulation of Genetically Modified Food (2001).  
                                                 
5
 Thousands of documents had been obtained through the ATI Act by Bradford Duplisea, a member of the 
Canadian Health Coalition. (B. Duplisea, Personal communications. October 21, 2011). 
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Private Member’s Bill (C-287) for a Mandatory Labeling Standard for GE Foods (2001) 
On February 27
th
 2001, the same month in which the Royal Society of Canada’s Expert Panel on 
the Future of Biotechnology’s Report was released, Charles Caccia, Liberal MP for Davenport 
Ontario, introduced private members Bill C-287 to amend the Food and Drugs Act and make a 
mandatory labeling standard for GE foods. The amendment also sought to have the Government 
carry out studies on the long-term effects of GE foods on human health. On October 17
th
, 2001 
when Liberal MPs showed up to the House of Commons to vote on Bill C-287 they found a 
pamphlet entitled, “vote against bill C-287 and support Canada’s Agri-food business” on each of 
their desks (Freeman, 2001).  Bill C-287 was defeated 129 to 91, indicating a divided House of 
Commons.
 
MP Policy Briefing “Government’s Biotech Strategy Supports Biotech Corporations” (2001) 
Subsequently, in May 2001 Judy Wasylycia-Leis, NDP MP for Winnipeg North Centre and a 
member of the Health Committee introduced Bill C-310 into the House of Commons favouring 
mandatory labeling. It never reached a vote. Wasylycia-Leis also wrote a policy briefing entitled 
Government’s Biotech Strategy Supports Biotech Corporations that appeared in The Hills’ 
September 24
th
, 2001 issue. She wrote that public opposition “from the very heart of Canada’s 
agriculture sector is huge.” She referred to an open letter to the Prime Minister “calling for a 
moratorium on the development of GE wheat.” The letter had come from a “broad coalition of 
more than 200 consumer, environmental, and farm producer groups.” Wasylycia-Leis observed 
that the appeal and the Royal Society of Canada’s Expert Panel Report on the Future of Food 
Biotechnology “provide a picture of what a functional regulatory system could look like and a 
dramatic sense of what is now lacking” (Wasylycia-Leis, 2001). She asserted that these were two 
“very public blow[s] to the Government pro-corporate biotechnology policy” (Wasylycia-Leis, 
2001). 
After reviewing the Royal Society’s recommendations, Wasylycia-Leis said that it was 
apparent why environmental, health and consumer groups had boycotted the CBAC as being too 
closely tied to industry. For example, in April 2001, sixty-one civil society groups sent letters to 
the Prime Minister’s Office boycotting CBAC and describing it as being fundamentally flawed 
(Glover, Keeley, Newell, & McGee, 2003). As well, more than fifty NGOs boycotted an 
invitation to participate in CBAC's consultation as they believed it would legitimize CBAC's 
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mandate and process, which they believed to be a poor substitute for a more democratic process 
such as Parliamentary debates and hearings (Council of Canadians, 2002). Wasylycia-Leis felt 
that reports from the CBAC and CGSB had not recommended changes 
to answer the public’s doubts and concerns over the testing, monitoring or even 
identification of GE ingredients…The Federal Government has consistently supported 
the corporate desire for as little regulation as possible, with little public discussion as 
possible, maximum secretiveness, minimal labeling and millions of dollars in direct and 
indirect funding. (Wasylycia-Leis, 2001) 
The Standing Committee on Health undertakes public hearings on the Labeling of GE Food 
(2002, 2003) 
The Standing Committee on Health adopted a proposal to study the issue of GE food labeling on 
October 23
rd
, 2001, six days after Bill C-287 was defeated. The proposal was suggested through 
a letter sent to the Committee on October 12 by the Ministers of Industry, Health, and 
Agriculture. Between January and April 2002, the Standing Committee on Health held four 
public hearings. Almost twenty groups, representing the various components of the agriculture 
and Agri-food industry as well as members of NGOs and MPs, made use of these hearings to 
raise concerns over the conflicting role of the CFIA and funding that had been used to promote 
biotechnology (See Appendix A). Debate during the hearings occurred over the government’s 
support of the biotechnology industry, cost of a labeling standard and the potential effects on 
trade (Wilson, 2002; Greenpeace, 2002; Stewart 2002a). The Committee’s study entitled 
Labeling of genetically modified foods and its impact on farmers was completed in June 2002. 
The Committee’s study resumed in March 2003 with participation from Health Canada. 
In May 2003 the Standing Committee on Health agreed not to pursue its study further after 
hearing an update from the chair of the CGSB that they were developing a voluntary labeling 
standard (Health Canada, 2006b). 
Labeling and Canadian Biotechnology Advisory Council’s Final Report (2002) 
On August 26
th
, 2002, the CBAC released its report entitled Improving the Regulation of 
Genetically Modified Foods and Other Novel Foods in Canada. The report recommended the 
development of a voluntary standard for the labeling of genetically modified foods for reasons 
other than health and safety. The report acknowledged the polarized views about the issue of GE 
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foods. CIELAP Executive Director Anne Mitchell, one of the twenty- committee members, 
noted “a majority of respondents to our Interim Report urged a mandatory system” (CBAC, 
2002, p. xi). Stakeholders criticized the CBAC’s final report as being biased towards 
biotechnology (Council of Canadians, 2002). The report recommended that the voluntary 
labeling standard be reviewed five years after its implementation for adequacy and effectiveness 
in providing consumer choice, at which time other options including mandatory labeling could 
be considered (CBAC, 2002).The CBAC’s mandated ended in May 2007 with the release of the 
Government of Canada's Science and Technology Strategy under the auspices of Industry 
Canada.  
Enactment of the Voluntary labeling standard and Review of the Voting Committee (2004) 
The National Standard of Canada’s Voluntary Labeling and Advertising of Foods That Are and 
Are Not Products of Genetic Engineering was adopted by the Government of Canada in April 
2004. Some actors saw both the voluntary nature of the Voluntary Labeling Standard Project as 
well as the CGSB voting committee for the standard as being biased towards the biotechnology 
industry. Since 2004, interest in having a dialogue over the labeling of GE foods has continued. 
For example the topic has been formally raised in Private Member’s Bill C-517 in 2008 to 
require the mandatory labeling of GE food and in Petition No. 305: Accountability for Labeling 
of Genetically Modified Organisms in 2010. In October 2011 the first reading occurred for NDP 
MP Atamanenko’s Private Member’s Bill C-257 to amend the Food and Drugs Act for the 
mandatory labeling of genetically modified foods (Bill C-257, 2011). The issue also continues to 
be discussed through the media as answers to labeling GE foods are being decided at the national 
level and in the international community. As of December 2012, the Government has not 
released a review of Canada’s voluntary labeling standard. 
3.3.4.  Federal Government Policy Approach to Food Biotechnology 
At the time of writing, 2001 was the last comprehensive Canadian government commissioned 
report on the biotechnology regulatory framework. This 2001 Royal Society of Canada’s Expert 
Panel on the Future of Food Biotechnology report was entitled Elements of Precaution: 
Recommendations for the Regulation of Food Biotechnology in Canada. It outlined 58 
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recommendations that, among other things, included ways to increase transparency and develop 
regulations for the human consumption of biotechnology-produced animals and the use of 
biotechnology in animal production systems (Royal Society of Canada, 2001, p. 87-107). The 
report also called for discussions that went beyond the mandate of the Expert Panel (Royal 
Society of Canada, 2001). The Government responded with an Action Plan and a series of 
progress reports. 
The last chapter of the Royal Society report entitled “Issues in the science-based 
regulation of biotechnology” discussed conflicts of interest in the regulatory framework, 
confidentiality versus transparency in Canadian regulatory science, the validation of science, the 
increasing commercialization of university scientific research in biotechnology, and the labeling 
of GM Foods (Royal Society of Canada, 2001). All of these issues involve transparency. The 
panel noted that there was no way to determine the extent that information requirements were 
met during the approval process and that there was an inability to evaluate the scientific rigor of 
the assessment process: 
The Panel concludes that the lack of transparency in the current approval process, leading 
as it does to an inability to evaluate the scientific rigor of the assessment process, 
seriously compromises the confidence that society can place in the current regulatory 
framework used to assess potential risks to human, animal and environmental safety 
posed by GMOs. (Royal Society of Canada, 2001, p. 215) 
 
The report proposed the establishment of a “super regulator” agency with responsibility 
for the wider issues surrounding genetic modification (Leiss & Tyshenko, 2003, p. 337). It 
further recommended “Canadian regulatory agencies and officials exercise great care to maintain 
an objective and neutral stance with respect to the public debate about the risks and benefits of 
biotechnology in their public statements and interpretations of the regulatory process” (Royal 
Society of Canada, 2001, p. xi). It suggested “Canadian regulatory agencies seek ways to 
increase the public transparency of the scientific data and the scientific rationales upon which 
their regulatory decisions are based” (Royal Society of Canada, 2001, p. xi). It called for clear 
evidence of the absence of risks and recommended that GE crops and foods should be more 
rigorously tested and independently reviewed. In February 2001 Dr. Brian Ellis (then Associate 
Director of University of British Columbia's Biotechnology Laboratory, joint head of the Royal 
Society of Canada Scientific Panel on Food Biotechnology, and Co-Chair of the Expert Report) 
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stated the “issue is not with methodology itself but the secrecy that surrounds it” (McDonald, 
2001). 
The Government response to the Royal Society’s findings was published in the form of 
an Action Plan in November 2001. The Action Plan recognized the need to continually enhance 
the regulatory processes and protocols, and the scientific knowledge that support them (Health 
Canada, 2006a). Subsequent Progress Reports were released in January 2002, May 2002, 
December 2002, June 2003, December 2003, August 2004, February 2005, and June 2005. A 
technical discussion report was also released in April 2002. The reports outlined ways to increase 
transparency and provided timelines.  
The Government’s Action Plans and Progress Reports identified strategies and timelines 
surrounding the creation of regulations for biotechnology-produced animals. The last Action 
Plan, released in 2005, included a section on genetically modified animals and on tasks that had 
yet to be completed regarding the regulation of food products from these animals. It also 
included a timeline for release of updates and said that Health Canada would draft a paper on the 
assessment for biotechnology-produced animals (Government of Canada, 2005b p. 9, 11, 12).  
Little progress appears to have been made. As of October 2012, the researcher has been 
unable to discover any activities of the Federal Government regarding the Royal Society of 
Canada’s report after 2005. Dr. Peter Andrée, Carleton University, concluded that, “while some 
efforts have indeed been made, the Government of Canada continues to fall far short of meeting 
the RSC Panel’s expectations in key areas, including food safety, environmental assessment, 
peer review, transparency, and monitoring and surveillance” (Andrée, 2006, p. 1). Why the 
Government stopped producing reports is unknown, especially since there was no indication in 
the 2005 report that it was going to be the final report. 
Government response to the Royal Society of Canada’s Expert Panel Report resulted in a 
number of initiatives by NGOs, media outlets and members of academia. Concerns were raised 
that the Royal Society recommendations were being ignored in the Federal Government’s Action 
Plans and that when transparency initiatives were undertaken they did not acknowledge the key 
issues raised by the Royal Society (Andrée and Sharratt, 2004; Wasylycia-Leis, 2001). 
In October 2004, Dr. Peter Andrée and Lucy Sharratt, CBAN’s coordinator, released a 
53-page report that tracked what the Government had and had not done to implement the RSC 
Panel’s recommendations and stressed the fact that there had not been a public debate (Andrée 
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and Sharratt, 2004). With regard to the assessment of biotechnology-produced animals the 
authors noted the emphasis on science–based concerns and raised concern that “there is virtually 
no participation by civil society organizations representing the public interest in the process of 
developing regulations” (Andrée and Sharratt, 2004, p. 20). The authors also noted that the 
CFIA’s Animal Biotechnology Focus Group Meeting in March 2004 was presented as an effort 
to “streamline” the regulatory approach to animal biotechnology, which they thought 
inappropriate as no regulatory approach existed. 
3.3.5. Biotechnology in the Spotlight: Private Member’s Bill C-474 (2009) to amend the Seed 
Act. 
The House of Commons continues to debate the selling of genetically engineered foods. In 2009, 
MP Alex Atamanenko, then MP for BC Southern Interior and the NDP Agriculture Critic, 
introduced Private Member’s Bill C-474. The bill proposed to “amend the Seed regulations to 
require an analysis of potential harm to export markets be conducted before the sale of any new 
genetically engineered seed is permitted” (Bill C-474, 2009). The bill was “a response to the fact 
that the introduction of certain genetically engineered (GE) organisms can put Canada’s export 
markets at risk but that current regulation does not consider this question of potential negative 
economic impacts” (CBAN, n.d.1). In April 2010, a majority of MPs voted in favour of the Bill. 
On December 1
st
, 2010, the New Democratic Party used an obscure rule to secure an extended 
debate in the House of Commons of up to five hours on Bill C-474 for early in 2011. As stated 
by CBAN’s coordinator Lucy Sharratt: “In our 15-year history with GE crops, a five-hour debate 
in the House of Commons on the issue is unprecedented...Even if the Bill is not passed, the 
debate and the public pressure around it has been a huge victory for democracy” (Sharratt, 2011). 
A study on biotechnology, to be completed by the Standing Committee on Agriculture 
and Agri-food, was suggested in September 2010 by Conservative MP, Randy Hoback, a 
member of the Standing Committee on Agriculture and Agri-Food during a Committee meeting. 
Hoback suggested the standing committee travel across Canada to visit Universities “where this 
technology is primarily being undertaken” and then recommend “legislative, policy, and 
regulatory changes in order to foster an innovative and fertile biotechnology industry in Canada; 
and that we report our findings as a committee to the House of Commons” (Canada. Standing 
Common on Agriculture and Agri-Food, 2010). The CBAN believed that the study “is clearly 
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not designed to ask farmers for their views but will instead provide the industry a public relations 
platform” (Sharratt, 2011). Lucy Sharratt, the coordinator of CBAN, observed “public pressure 
to support the Bill has been so strong, however, that, while escaping more hearings on the Bill, 
the Liberals and Conservatives took action so they could tell constituents they were still 
examining the controversial issue” (Sharratt, 2011). 
The House of Commons Agriculture Committee held 10 public hearings on Bill C-474 between 
December 2010 and March 2011. The committee members 
hoped to gather information on the various stakeholders in the sector, the opportunities 
biotechnology creates for the Canadian agriculture and Agri-food industry, and problems 
stakeholders encounter in developing biotechnologies. The Committee also hoped to 
determine what public policy is needed for the sector to be productive, competitive and 
innovative and to benefit the Canadian agriculture and Agri-food sector. (Standing 
Committee on Agriculture and Agri-Food, 2012,  p.  45) 
 
The need for greater transparency was one of the themes addressed during the hearings (see 
Appendix A).  
While many Agriculture Committee members were on the road for the study, Bill C-474 
was debated and voted on in the House of Commons in February 2011 (CBAN, 2012b). The bill, 
defeated in its third reading, had gone farther in the Parliamentary process than any previous 
piece of legislation on GE. Interest in biotechnology continued with the introduction of a Motion 
for a Moratorium on GE Alfalfa by Liberal Agriculture Critic Wayne Easter in March 2011. 
The Committee’s study ended with the May 2011 election of the 41st Parliament. A full report 
was not completed but a summary of the results was included in the Standing Committee on 
Agriculture and Agri-Food report Growing Forward 2 (2012). Appendix A of the report includes 
the Agriculture Committee hearings on the biotechnology industry (Standing Committee on 
Agriculture and Agri-Food, 2012). The New Democratic Party attached a dissention opinion to 
Growing Forward 2 that outlined recommendations, including the creation of an independent 
body to peer-review relevant scientific data, and to introduce transparency in the scientific 
reviews and approval processes (discussed further in Appendix A). Regarding the Committee 
Hearings the NPD Dissenting Opinion outlined how numerous times the “gaps and oversights in 
Canada’s regulations governing this technology were pointed out which are seen to have not kept 
up with the growth of the industry” (Standing Committee on Agriculture and Agri-Food, 2012, p. 
80). The Dissenting Opinion was as follows: 
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It is no small matter that under the current science based approach to our regulations, 
which relies on privately owned science and a secretive decision-making process, there is 
no mechanism to allow for consideration of market rejection, or even a special category 
dealing with genetically engineered animals. (Standing Committee on Agriculture and 
Agri-Food, 2012, p. 80). 
 
This situation raises concerns about the regulation of biotechnology-produced animals if they are 
to be produced in Canada. 
3.3.6. Health Canada’s Interim Policy on Foods from Cloned Animals (2004 – present) 
Health Canada’s Food Directorate has had an Interim Policy on Foods from Cloned Animals in 
place since 2004. Cloned animals are produced through modern biotechnology and any food 
products from these animals would be classified as “novel foods” under Division 28, Part B, of 
the Food and Drug Regulations. Developers of cloned animals are requested to “withhold novel 
food notifications until requirements are determined and further guidance is available” (Health 
Canada, 2003). In the meantime, Health Canada is obligated to review any submitted application. 
Information is not publicly available about whether the Canadian government has ever received 
an application to approve a cloned animal for human consumption and such applications are 
considered confidential. However, cloned animals have been approved for human consumption 
in the United States. Canada does not appear to have a method in place to track or to monitor 
whether food products derived from cloned animals have entered Canada’s food supply. An 
example of these concerns can be illustrated by examining current regulatory processes regarding 
biotechnology-produced fish.  
3.3.7 Limitations of Regulatory Approval Processes Regarding Biotechnology-produced Fish 
Inadequate transparency and accountability mechanisms regarding biotechnology-produced fish 
regulations could result in the unintentional introduction of biotechnology-produced fish into the 
food supply through an egg hatchery or research facility. Limitations also result from the 
public’s inability to know or affect what decisions are being made about the production of 




The Commercial Production of Genetically Engineered Fish Eggs 
In September 2010, the United States Food and Drug Administration held public hearings 
regarding an environmental assessment application that AquaBounty Technologies Inc. had 
submitted regarding its AquAdvantage® salmon. Documents released by the Food and Drug 
Administration revealed the company’s plan to produce the eggs in Prince Edward Island and 
have them shipped to Panama for grow-out. The final product would then be sold in the United 
States (Patterson, 2011). 
The company currently has a research facility in P.E.I. The application process to request 
approval to commercially produce GE salmon eggs falls under the Canadian Environmental 
Protection Act (Patterson, 2010). Whether Environment Canada is looking at an application is 
confidential. In November 2010 the P.E.I. Coalition for a GMO Free Province, an NGO, sent a 
letter to P.E.I. Premier Robert Ghiz stating  
[N]either the Government of P.E.I. nor residents will be notified by Environment Canada 
if AquaBounty requests approval for production of GE salmon eggs on the Island... 
Environment Canada will assess the environmental risks of producing the GE salmon 
eggs in 120 days in a completely secret process...There is no public input, and no 
notification to the province or public disclosure. This process is flawed. (Broderick, 
Labchuk & Boyd, 2010)  
 
The group asked the Premier “in the interest of fairness, transparency, and fisheries 
conservation” to, among other things:  
insist Environment Canada notify Prince Edward Island when AquaBounty requests 
approval for commercial production of GE Atlantic salmon eggs, that the province be 
consulted on environmental risk questions and be notified immediately if approval is 
granted (or refused). (Broderick, Labchuk & Boyd, 2010) 
 
As of December 2012, no information is available about whether the company has submitted any 
requests or whether requests are under review.  
In January 2011 a coalition of opponents to AquaBounty Technologies Inc’s plans met 
with P.E.I.’s Premier and P.E.I.’s Provincial Environment Minister to address “growing 
opposition to AquaBounty's development of GMO salmon in P.E.I” (CBC News, 2011). The 
coalition asked for public consultations on AquaBounty’s export plan. Premier Ghiz agreed to 
pursue more transparency around AquaBounty’s export plans. Leo Broderick of the Council of 
Canadians noted the following: 
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We did get a commitment from the Premier that he would play a more active, positive 
role in trying to get Environment Canada to be more transparent... And so, he is going to 
write Environment Canada asking whether or not AquaBounty has requested approval for 
commercial production of GMO Atlantic salmon, salmon eggs on P.E.I. And he's going 
to ask that the P.E.I. government be part of the environmental risk study. That's very 
good. (CBC News, 2011) 
 
Broderick said the Premier agreed to take the group's demands for a consultation process to the 
Liberal Caucus. As yet, there is not written information available about what has since 
transpired. 
Limitations to the Regulatory Process Regarding the Production of GE Fish  
Internal records obtained under Access to Information legislation reveal that Environment 
Canada acknowledged it “isn’t sure it can fully protect wild fish stocks if it approves the 
commercialization of the hatchery for genetically engineered salmon eggs” (Schmidt 2011b). In 
consideration of a hatchery application from AquaBounty, Environment Canada “has to 
determine whether to concern itself only with the production and transportation of GE fish eggs 
from P.E.I.” or “whether the Federal Government also has a duty to consider wider potential 
effects GE fish could have on this country or the global environment if the fish ever escaped the 
Panamanian facilities and migrated into Canadian or international waters” (Schmidt 2011b). 
According to the internal records  
Environment Canada concluded that the narrower oversight option - while ‘easily 
enforceable by inspecting shipments at the port of export’ in Canada – ‘falls short’ of 
meeting Canada's legal obligations under CEPA ‘because it does not fully consider 
potential effects within Canada’. (Schmidt 2011b) 
 
As there is a “broad legislative requirement under CEPA to assess potential risks to the global 
environment," Environment Canada recommended that the scope of the environmental risk 
assessment take a "fulsome approach... for the full protection of the Canadian environment, in 
particular Canadian fish stocks" (Schmidt, 2011b). According to Schmidt this could be “beyond 
the capability of Canadian authorities” (Schmidt, 2011b).  
Internal records also obtained through the ATI Act revealed that two senior scientists 
specializing in biotechnology and aquaculture from the Department of Fisheries and Oceans 
(DFO) are concerned about “limits and possible constraints of the current Canadian regulations 
for GE fish” (Schmidt, 2011c). DFO officials voiced concern in 2010 during consultations with 
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AquaBounty officials and scientists from the DFO, Environment Canada, and Health Canada 
(Schmidt, 2011c). According to minutes released under the ATI Act 
DFO clarified that while the risk assessment will focus on potential effects in Canada, 
there is potential risk of fish migrating back to affect Canadian fish stocks... DFO 
requested that containment and limitations to which companies in other countries will 
have to comply be clearly outlined in the notification. (Schmidt, 2011c) 
 
Two government experts raised issues through email correspondence regarding the 
meetings draft minutes about Canada’s regulatory approvals process to approve GE fish. The 
experts cited are Caroline Mimeault, a scientific adviser at DFO's Biotechnology and Aquatic 
Animal Health Science, and Robert Devlin, a DFO scientist who studies risk assessment of GE 
fish at the department's Centre for Aquaculture and Environmental Research in West Vancouver 
(Schmidt, 2011c). Devlin co-authored a journal article “that found dispersal behaviour has been 
affected by introducing an outside gene into a fish, so GE fish may venture into habitat 
previously not used by wild fish” (Schmidt, 2011c). 
Mimeault wrote that the Government “may be constrained” by regulations concerning 
information that can be requested by a company wanting to commercialize GE fish (Schmidt, 
2011c). According to Schmidt’s article, Lucy Sharratt from CBAN “is worried inadequate 
regulations could hamper the ability of DFO scientists to carry out a comprehensive risk 
assessment of a GE fish application... This could be a case of good scientists inside departments 
constrained by regulations" (Schmidt, 2011c). 
With limited public information about the safety assessments of biotechnology-produced 
animals, any information that the regulatory departments do provide to the public takes on extra 
importance. Internal DFO media notices prepared in May 2009 in the event of journalists' 
questions about AquaBounty, stated that Canadian regulations "currently provide an effective 
regulatory framework for protecting the environment from potential risks of GE fish” (Schmidt, 
2011c). A draft of the media notice prepared by the CFIA in August of 2010, stated: "The GE 
salmon are bred in contained, land-based systems and are reproductively sterile females, 
eliminating the threat of interbreeding amongst them or with native populations” (Schmidt, 
2011c). DFO scientist Mimeault reviewed the media lines and stated 
I would rather use a less definitive term such as 'significantly reducing‚' as opposed to 
'eliminating‚' as we know that the possibility for accident release can never be completely 
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eliminated and that the technology to render the fish reproductively sterile is not 100 per 
cent efficient. (Schmidt, 2011c) 
 
CBAN’s coordinator Sharratt said "the documents confirm the fish cannot be contained, 
infertility cannot be 100 per cent achieved, and when fish escape, there's a risk it will come back 
to affect our fish stocks" (Schmidt, 2011c).  
Public Responses to the Commercial Production of Biotechnology-produced Fish 
Many interested stakeholders have attempted to be involved in, or influence, the decision-making 
process. Ruth Salmon, Executive Director of the Canadian Aquaculture Industry Alliance 
(CAIA) said that "the Canadian aquaculture industry does not support the commercial production 
of transgenic fish for human consumption” (Sharratt 2010b).  
In March 2011, Fin Donnelly, NDP MP and Fisheries and Oceans Critic, tabled a motion 
in the House of Commons “asking for transparency and more study before genetically modified 
(GM) Atlantic salmon are approved for human consumption” (CBAN, 2011a). The DFO’s 
ability to regulate was in question as well as whether the regulations in place may be inadequate 
to protect the food supply. Chapter 4 further explores the issues that were raised and what 
happened with Donnelly’s motion. 
3.4.  Additional Limitations to Transparency outside the Regulatory Process 
Limits to transparency outside of the scope of GE food regulations can also hamper the public’s 
ability to hold government accountable in this policy area. These include the limited authority of 
Health Canada and the CFIA’s Notice of Submission Project; a lack of long-term testing and 
traceability initiatives: and the potential to allow for accidental contamination of the food supply.  
3.4.1. The Voluntary Notice of Submission Project (2004) 
It is not mandatory for regulatory departments to release information concerning notifications 
they have received from companies concerning novel foods (CFIA, 2009a). The CFIA and 
Health Canada launched a project in 2004, 
to post on the CFIA website ‘notices of submission’ that describe the product and the 
data they receive from certain product developers who have requested safety assessments 
59 
 
of plants with novel traits (PNTs) for unconfined release and safety assessments of novel 
feeds and novel foods derived from PNTs. (CFIA, 2009a) 
The Voluntary Notice of Submission Project applies to companies that are part of 
Croplife Canada, an industry association that represents approximately 85% of plant 
biotechnology developers in Canada. Comments can be made to the CFIA and Health Canada on 
the content of the notices of submissions. How comments are taken into consideration is 
unknown. There is nothing in place for posting notices of submissions from product developers 
who have submitted notifications concerning novel foods derived from biotechnology-produced 
animals. 
3.4.2. A Lack of Long-Term Testing 
Health Canada does not appear to conduct long-term tests on food products derived from 
biotechnology. According to Health Canada, “there is no current evidence to indicate that long- 
term studies are needed to ensure the safety of foods produced using this technology” (Health 
Canada, 2006d). Health Canada’s website states 
Should developments in the technology result in modifications that provide significantly 
different nutrient combinations or other novel food characteristics not previously 
encountered in the food supply, such foods may require additional considerations to 
address long term health effects. In such cases long term studies may be a valid approach 
to include in the assessment of the overall safety of such products. At this time no 
products representing such true novelty to the food supply have been proposed for 
commercialization. (Health Canada, 2006d) 
 
As the above paragraph indicates, there appears to no publicly-available information about 
proposed government directions of future policies respecting studies on the introduction of novel 
foods  
3.4.3. A Lack of Traceability Initiatives 
The Government also does not appear to have traceability initiatives specifically set up to 
monitor biotechnology-produced animals. Biotechnology-produced research animals that were 
not approved for human consumption have ended up in the food system. In 2002, the University 
of Guelph sent eleven Enviropig™ piglets to a rendering plant where they were unintentionally 
turned into animal feed (Strass, 2002). Egg farmers, turkey farmers, and broiler chicken 
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producers in Ontario were sold 675 tons of contaminated poultry feed. As then Vice President of 
Research at the University of Guelph Alan Wildeman said “Things you don’t expect to happen 
can happen” (Strauss, 2002). At that time scientists did not have to tell the Federal Government 
about their work if the scientists did not think their research projects would endanger the 
environment (Strauss, 2002). The incident lead the Ministry of the Environment to review the 
procedures for allowing bioengineering research (Strauss, 2002). Two years later, in 2004, 
experimental GM pharma-pigs from the Quebec company TGN Biotech were accidentally turned 
into chicken feed instead of being incinerated (Sharratt, 2010a).  
The Auditor General’s Office’s 2008 report questioned the ability of regulatory bodies to 
effectively regulate biotechnology-produced fish used for and stated: 
Departmental officials have incomplete knowledge of research and development 
activities because proponents are not required to disclose that they are conducting 
research and; there is no mandatory reporting of an accidental release of a research and 
development organism into the environment. Although such a breach is subject to 
Environment Canada’s compliance and enforcement policy, the Department could only 
act on it once it became aware of the breach. The result of these weaknesses is that the 
extent of research under way in Canada and any accidental release of GE fish may not be 
fully known. (Commissioner of the Environment and Sustainable Development, 2008 p. 
4) 
As of December 2012, it still appears to be the case that it is up to a company to inform the 
Federal Government of activities going on in research facilities and any incidences, including 
animals escaping from research facilities and/or the accidental introduction of the animals into 
the food supply. 
Traceability Initiatives surrounding Animals approved for reproduction and exportation 
For the first time in Canada, a GE Animal, the Enviropig™ was approved for reproduction and 
exportation in February 2010 under New Substance Notification Regulations (Organisms). This 
was also the first time that Environment Canada was directly involved in the approval of a 
genetically engineered organism. Environment Canada was given the responsibility for assessing 
the environmental risks of the Enviropig™ because Canada does not have specific regulations 
for biotechnology-produced animals (CBAN& Beyond Factory Farms, 2010). 
In The Risk Assessment Summary Conducted Pursuant to the New Substances 
Notification Regulations (Organisms) for the Enviropig™ “a significant new activity (SNAc) 
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provision was recommended based on the uncertainties regarding possible environmental 
impacts of the notified organism in activities outside the scope of this assessment” (Environment 
Canada, 2012).  Publicly available information is unavailable with respect to whether or not 
traceability measures will be made specifically for biotechnology-produced animals.  
In sum, it appears that the current regulatory and policy framework does not have 
labeling, specific traceability, or human health studies to discover potential problems that could 
occur post-market (Standing Committee on Agriculture and Agri-Food, 2012, p. 81). This lack of 
clarity is also the case with respect to traceability measures, including long-term testing or the 
mandatory labeling of food products derived from biotechnology-produced animals. 
3.4.4. The Issue of Accidental Contamination 
In 2009, the European market closed its doors to Canadian flax because flax exports from 
Canada contain GE flax (CBAN, 2012b). Approved by the CFIA and Health Canada for 
environmental release (1996) and human consumption (1998), the “CDC Triffid” GM flax was 
deregistered in 2001 by the CFIA, making it illegal to sell the seeds (CBAN, 2012b) (see 
Appendix A). The flax was never commercially grown in Canada and all existing stocks of 
Triffid were supposed to have been destroyed following deregistration (CBAN, 2012b). As of 
December 2012 the European market remains closed to Canadian flax.  
Government regulations may be heading in a more lenient direction about accidental or 
unintentional contamination of genetically modified organisms into the food supply. In 2011, the 
Federal Government held consultations on Low Level Presence, “the unintended presence, at low 
levels, of a genetically modified (GM) crop that is authorized for commercial use or sale in one 
or more countries, but is not yet authorized in an importing country” (AAFC, n.d. p. 3). The 
Federal Government has stated it will hold more public consultations (Schmidt, 2012). It is 
unknown whether this would also apply to biotechnology-produced animals.  
3.4.5.  Summary 
Canadian citizens are not informed when a notification to request a safety assessment for novel 
foods is made to regulatory bodies. A biotechnology-produced animal can be approved for 
reproduction and exportation without being approved for human consumption. In a few cases, 
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the current traceability measures have resulted in the unintentional introduction of research 
animals into the food supply. 
3.5. Polls and Surveys: Canadians’ Acceptance of Biotechnology-produced Foods and 
Animals 
A key element of this discussion is the degree to which Canadians themselves are concerned 
about a) GE foods and its regulation and b) whether it is important to have more transparency 
with respect to government decision-making processes in this area. Various polls have been held 
to determine consumer acceptance of food produced through modern biotechnology and modern 
biotechnology in general. A variety of polls conducted between 1994 and 2008 by media outlets, 
Industry Canada (1994) and NGOs all concluded that the majority of citizens polled wanted 
labeling of GE foods and were hesitant about GE foods (Found in Appendix C: Polls). On the 
other hand a 2008 survey by the biotech industry group BIOTECanada, said that 79 percent of 
Canadians agreed that “biotechnology” would bring benefits to agriculture (Martin and Grey, 
2010, p.13).   
More recently, in February 2010, Agriculture Canada commissioned a telephone survey 
“after Government officials hosted a series of meetings with AquaBounty Technologies Inc., as 
part of pre-notification consultations with the company concerning the human consumption of 
the animals” (Schmidt, 2011a). The survey compared its results to one that had been 




Table 3. 1. Comparison of Survey Results from 2006 to 2010: Canadian’s Opinions on Biotechnology-
produced animals 
February 2010- 2006: Percentages of Canadians who agreed they: 2010 2006 
Do not approve of GM fish, except under very special circumstances 
 
37% 24% 
Do not approve of GM animals under any circumstance 
 
29% 21% 
Are not at all confident in Ottawa’s ability to regulate GM animals  
 
27% 23% 
Are not at all confident in the government’s ability to regulate GM fish 
 
23% 16% 
Are extremely or very confident in Ottawa’s regulatory 
 
14% 19%. 




Are extremely or very confident in Ottawa’s regulatory oversight of GM animals 
 
11% 18% 
Approve of GM animals as long as the usual government oversight in place 
 
9%, 14% 
Source: Schmidt (2011a) 
 
The survey “cites ‘some erosion’ in confidence in the Federal Government’s safety and 
regulatory systems for biotechnology and a widening ‘regulatory gap’ in dealing with new 
technologies for the growing skepticism” (Schmidt, 2011a).  
Notable actions regarding the Enviropig™ have been undertaken by the National Farmers 
Union and CBAN. The National Farmers Union of Ontario in 2010 passed a Resolution that they 
“oppose the commercial production of the Enviropig™ in Canada and request that Ontario Pork 
and OMAFRA [Ontario Ministry of Agriculture, Food and Rural Affairs] withdraw support for 
the Enviropig™ and the University of Guelph shut down the project immediately” (NFU 
Ontario, 2010, p.1). In May 2010 CBAN launched a Stop the Enviropig ™ campaign that 
included a petition, letters to be sent to MPs, articles, policy briefings, debates, and speaking 
tours. Lucy Sharratt from the CBAN said that “Enviropig™ was allowed to happen because there 
has never been a democratic debate in Canada about genetic engineering and there is no public 
overview of the direction of public research” (Sharratt, 2010a). Increasing transparency and 
accountability in the regulatory processes could strengthen public confidence in the Federal 





This chapter identified limitations to transparency and accountability in Federal policy-making 
with respect to the human consumption of biotechnology-produced animals. The historical 
analysis in this chapter revealed an enduring lack of transparency and accountability regarding 
the Federal Government’s decision-making processes and institutions for GE foods which has 
continued to the present day. This allows for the identification of barriers to transparency that 
exist within the decision-making structure for GE animals. The chapter outlined specific 
limitations to regulatory processes for biotechnology-produced fish. The chapter also showed 
issues regarding GE crops and food are still being discussed (Chapter 3.6). Also, polls and 
surveys have shown support for biotechnology-produced animals is low. Recommendations to 
increasing transparency and accountability regarding GE foods have also not been taken into 
account.   
The available literature shed little light about how the science-based approach and 
principles will apply for the safety assessment and environmental assessment of foods derived 
from biotechnology-produced animals. Regulations for these animals have not been finalized. 
The Enviropig™ notification for human consumption was still being assessed by Health Canada 
at the time of writing. Issues regarding the evolution of the science based regulatory approach 
have been raised on multiple occasions such as the appropriateness of using the principle of 
substantial equivalency in risk assessments and the reliance on Confidential Business 
Information during the assessment processes for novel foods. Specific concerns relate to the lack 
of timelines for completion of regulations, the ability of regulatory departments to regulate 
biotechnology-produced animals, the lack of public consultations, and the fact that Royal Society 
of Canada’s recommendations have been ignored. Government Action Plan initiatives in 
response to the Royal Society of Canada’s Expert Panel Report on the Future of Food 
Biotechnology also were not fully acted upon. 
The chapter also highlighted the constraints on the ability of the regulatory system to take 
into account identified concerns. Moreover, GE food regulations do not take into consideration 
any social, ethical or economic impacts including determining the impact of approving a novel 
food to export markets. This chapter sets the stage for Chapter 4’s discussion of the issue of 
transparency and human consumption of biotechnology-produced animals based on extensive 
interviews with key stakeholders. 
65 
 
Chapter 4: Primary Research Findings 
This chapter describes the project’s primary research findings. It provides a description of the 
field research undertaken and the major themes identified in the interviews. Field research was 
undertaken to answers questions that could not be found through the literature review. It was also 
undertaken to identify what key stakeholders believe to be barriers or opportunities to 
transparency concerning the human consumption of biotechnology-produced animals. An open 
ended research approach was useful as the amount of information available regarding 
biotechnology-produced animals is limited as policies have not been finalized and decisions have 
not been made. Representative groups were selected based on; their knowledge of what barriers 
and opportunities have existed in the past that might affect the transparency of federal policy 
making for biotechnology-produced animals; their knowledge of the Federal Government’s 
policy making process regarding biotechnology-produced animals and; their connection to 
biotechnology-produced animals. They were selected through a preliminary review of literature, 
the snowballing method, and personal attendance at relevant events. 
Representative groups that the interviewee attempted to contact included:  
- Federal government employees in Health Canada, the CFIA, Environment Canada, the 
Auditor-General’s Office; the Department of Fisheries and Oceans; the Food and Drugs 
Liaison Office. 
- Members of advisory bodies including the Standing Joint Committee on the Scrutiny of 
Regulations and the Environmental Assessment Working Group; the Agri-
Subcommittee on Food Safety and; the Food Expert Advisory Committee. 
- MPs from various political parties including critics and members of various committees. 
- NGOs including consumer groups, citizen’s groups, famer’s organizations and 
environmental and food security organizations. 
- Industry representatives including food distribution company and biotechnology groups. 
- Members of academia who specialize in biotechnology or public policy. 
- Members of the media who have written about the topic of transparency surrounding the 




- Representatives from the University of Guelph and AquaBounty Technologies Inc,. 
4.1. Description of Field Research 
Nineteen adult participants from the representative groups stated above agreed to the use of their 
interview in the research project. The direct positions and affiliations have been removed to 
protect anonymity. As shown in Table 4.1. participants represent a variety of stakeholder groups.  
Table 4. 1. Stakeholder Groups Represented through Interviews 
Group Participant Profile Quantity Code 
Members of Parliament 
 
Liberal MPs 2 LMP 
 
 
Conservative MP, Member of the Standing Committee on 
Agriculture and Agri-Foods 
 
1 CMP 
 A. Atamanenko, NDP MP 
 
1 NDP – A 
 J. Wasylycia-Leis, Former NDP MP and Health Critic 
 
1 NDP - J 
 MP from the Opposition 
 
1 OPP - 1 
 MP from the Opposition 
 
1 OPP-2 
Green Party PEI 
 
Leader, Sharon Labchuk 1 GPPEI 
Green Party Member  
 
1 GP-1 
Federal Public Servant 
 
 
Environment Canada Employee 
 
Federal Government official who works in the area of food 








Environmental and food 
security NGOs 
 
Lucy Sharratt, Canadian Biotechnology Action Network 
(CBAN) Coordinator 
 
1 NGO - 1 
 Council of Canadians representative  
 
1 NGO - 2 
 National Farmers Union (NFU) representative  1 NGO – 3 
 CIELAP Executive Director (1992 – 2009) who 
represented Quakers on the CBAC 
 
1 NGO - C 
Academia 
 
former molecular geneticist  who is now a sociology 
professor at the university of Québec in Montreal who 
researches the sociopolitical implications of the life 
industries and who is a specialist in the study of Canada's 
environmental risk assessment of GMO 
 
1 ACAD-1 
 Rod MacRae, Food Policy Consultant, York University 
Associate Professor 
 
1 ACAD - 2 
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Media / Journalist Consumers affairs reporter from Postmedia News  
 
1 JOUR 





Participants consisted of members of political parties including eight elected officials who have 
discussed and voted on the topic in Parliamentary proceedings and one member of the Green 
Party’s shadow cabinet;  one public servant involved in regulating and updating regulations 
concerning biotechnology-produced animals; one Federal Government official who works in the 
area of food and health policy; representatives of environmental and food security non-
governmental organizations who actively research the topic and/or have raised concern over the 
transparency of regulations and policies surrounding the human consumption of biotechnology-
produced animals; two members of academia who have studied or are studying the issue of GE 
foods in Canada; a consumer’s affairs reporter from a major news outlet who has obtained 
Access to Information documents and written about biotechnology-produced animals and; a 
spokesman from a large Canadian food distributing company. Several participants had 
experience in multiple roles related to the research topic. Participants’ diverse backgrounds 
offered a variety of perspectives with respect to biotechnology-produced animals and associated 
policy-making processes.  
Phone interviews took place November and December 2011 and March through August 
2012. The researcher selected questions from a pre-approved list of open-ended questions (see 
Appendix D) to help direct the interviews. Each participant signed a consent form giving 
permission to the inclusion of identifying information and the use of quotations (either direct or 
anonymous) (See Appendix E for the consent form).  
4.2. Findings / Major Themes 
Following up on questions raised in the literature review, open-ended interviews and grounded 
theory were used by the researcher to identify what participants thought were the most relevant 
barriers and opportunities concerning the transparency and accountability of Federal decision-
making processes and institutions with respect to biotechnology-produced animals. Interview 
transcripts were analyzed to find commonalities that formed into themes. Findings were 
organized in this method so that barriers to transparency emerged through the interviews, rather 
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than the interviewer directing the participants to pre-conceived barriers. This data was organized 
into seven thematic areas. 
A majority of participants discussed the lack of publically available information. Most 
participants pointed out inadequacies in the current policy and regulatory framework. Most 
interviewees also suggested that there is a lack of political will to ensure transparency.  Just over 
half of interviewees hypothesized that this could be due to the Federal Government’s biased 
agenda towards biotechnology and that transparency appeared to be a growing problem due to 
declining avenues for public participation and reduced consultative initiatives. A few participants 
stated transparency appeared to be a growing problem due to a disempowered Parliament and a 
dramatic decline in public servant interactions and communications flow. Table 4.1. lists what 
participants commented on what themes. The remainder of the chapter examines each theme. 
 
Table 4. 2. Major Themes identified by Research Participants 
N=19 
Theme Topic No. of Participants  
1 Lack of Publicly-Available Information 18 
2 Inadequacy of the Current Policy and Regulatory Framework 16 
3 Lack of Political Will to Ensure Transparency 15 
4 Declining Avenues for Public Participation/ Consultative Initiatives 11 
 5 Bias of the Government's Agenda towards Biotechnology 11 
6 Disempowered Parliament 8 
7 Decline in Civil Servant - Public Interaction and Communications Flow 4 
 
4.2.1. Lack of Publicly-Available Information 
The lack of publically-available information concerning federal decision-making processes and 
institutions was mentioned by a majority of participants. This was particularly the case with 
respect to the inability for consumers to identity GE food products that are on the market. 
Concerns were also raised by many participants over the confidential nature of the application 
processes. The Federal Government and biotechnology industry’s release of information was 
also raised by many participants. A few participants noted a lack of public information being 
released through the media in general as well as a lack of public awareness and understanding 
69 
 
regarding biotechnology-produced animals. A few participants noted the lack of publicly-
available information concerning the Federal Government’s assessment of scientific risks. A few 
participants also mentioned the Federal Government’s focus on scientific risks. Some 
participants pointed out difficulties related to obtaining information through the court system and 
Access to Information requests. Also noted was a public inability to gather information on 
research facilities that contain biotechnology-produced animals. A few participants highlighted 
the difficulty in understanding the ambiguous language used by the Federal Government 
regarding genetically engineered food and biotechnology. 
Identifying GE Food Products in the Market 
Participants identified the inability of consumers to identify GE products in the Canadian 
marketplace as a limitation to transparency. A Green party shadow cabinet member maintained 
that consumers should have the ability to choose (GP-1). A Federal Government official who 
works in the area of food and health said that mandatory is the least favourite of the regulatory 
tools and is very difficult to reverse.
6
 The official said that consumers could avoid GE foods by 
buying foods with Canada’s organic labeling standard (PS-2). The former executive director of 
CIELAP and member of CBAC said that without a mandatory labeling standard for GE food 
consumers have to have the knowledge, money, and time to make informed choices (NGO-C).  
A former molecular geneticist and current sociology professor who is a specialist in the study of 
Canada's environmental risk assessment of GMO cautioned that the biotechnology industry 
keeps trying to corrupt the organic standard to include GMOs as it’s “the last frontier for them” 
(ACAD-1). 
An Opposition MP believed that the pro-business Government is currently allowing the 
biotechnology industry to prevent mandatory labeling (OPP-1). Alex Atamanenko, An NDP MP 
and member of the Standing Committee on Agriculture and Agri-Food, said that the huge 
biotech lobby is the reason that there is no labeling (NDP-A). Another MP from the opposition 
who had actively followed these issues confirmed labeling did not appear to have received much 
attention in Ottawa in recent years (OPP-2). A few participants also pointed out that there had 
                                                 
6
 Information on Canada’s Voluntary Labelling and Advertising of Foods That Are and Are Not Products 
of Genetic Engineering  can be found through (Canadian General Standards Board, 2004)  Information on the 




been no assessment of the labeling standard itself and that the CBAC had been shut down before 
it could assess the voluntary labeling standard (NGO-C; NGO-1). A former molecular geneticist 
who is a specialist in the study of Canada's environmental risk assessment of GMO said that 
people are focused on the labeling issue as it is something tangible that consumers can rally 
around because there is no transparency in the regulatory system and no transparency in the 
marketplace (ACAD-1).  
The Confidential Nature of Applications 
The majority of participants noted the confidential nature of the application process for the 
environmental release and/or human consumption of biotechnology-produced animals. They 
mentioned both the assessment of science-based risks, the confidential nature of the application 
itself, the lack of a review process or public debate, and the risk of contamination of the food 
supply. A journalist found it odd that the Government can’t say if they’re reviewing an 
application and that citizens can’t be engaged when regulators are reviewing applications 
(JOUR).  
A representative from the Council of Canadians, an NGO, said that there is no 
involvement in the environmental assessment processes for biotechnology-produced animals by 
the public, the provincial governments, and local experts. The representative mentioned the lack 
of public input, provincial consultations or notification that would be required during the 
application process to convert AquaBounty’s research facility into a commercial egg hatchery 
(NGO-2). The Canadian Biotechnology Action Network (CBAN) coordinator noted that 
Environment Canada would have to gain permission from AquaBounty before discussing any 
applications concerning the AquAdvantage™ salmon (NGO-1). A member of the opposition 
maintained that the provincial government of P.E.I. should be able to ask and respond to 
questions regarding what is going on within the province (OPP-1). 
A Conservative MP asserted that the regulatory process is transparent and pointed out 
that decision documents related to Health Canada and the CFIA’s safety assessments are posted 
on the department websites once a product is approved for market (CMP). The MP said that 
releasing information on all of the applications would be an overload of information and believed 
some people would see it as being a smoke screen in which maybe hidden certain controversial 
applications. The MP pointed out that the regulatory process can take more than ten years and 
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not all products make it through the application process and/or never reach the market. The MP 
believed that the step which determines if the product is safe for humans and/or animal feed is 
the most important step in the eyes of the public (CMP). 
The Federal Government’s Release of Information 
Many research participants identified a lack of federally-released information as a serious 
problem. A reporter talked about the difficulty in gathering information from government 
officials and experts, because the Government’s communications protocol discourages 
interviews in favour of written responses drafted through media relations departments and 
approved by political staff (JOUR). Along the same lines, one professor who is a specialist in the 
study of Canada's environmental risk assessment of GMO described information that is released 
as too little, too late and usually after the product has been approved. The academic said that 
there is no real way of gathering information unless you know what is going on in the 
laboratories (ACAD-1). CBAN’s coordinator said that the burden was placed on the public 
sector to ask, seek and beg for information (NGO-1). Sharon Labchuk, former leader of the 
Green Party of P.E.I. and a member of the NGO Earth Action P.E.I., said that while government 
has a responsibility to provide information, the reality is that it rarely does and when it does, the 
information cannot be trusted as it will have come from industry. It's become the job of NGOs to 
ferret out whatever alternative information is available and try to disseminate it (GPPEI). 
Representatives of NGOs maintained that they did not have the capacity or resources that are 
required to remain informed (NGO-C; NGO-2). A former Executive Director of the Canadian 
Institute for Environmental Law and Policy (CIELAP) said that biotech products are coming out 
“so fast and furious, nobody has the resources or time to pick them off one at a time” (NGO-C). 
The CIELAP representative added that transparency was not possible if information that is 
released by the Federal Government is one-sided. When the Federal Government was developing 
its BioPortal website (BioPortal.gc.ca) the developers were asked, “Where are you going to put 
the other side? Where are going to put some critical information about what the concerns are or 
what the risks might be?” The CIELAP representative said that even though some of the 
bureaucrats were quite concerned their political masters were not (NGO-C). Other participants 
agreed that the information being released by the Federal Government was one-sided. A Green 
Party member maintained that any information coming from the Government is one sided, is not 
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evidence-based and repeats the same information from the biotechnology industry as though it is 
true (GP-1).  
The Biotechnology Industry’s Release of Information 
A few participants identified the minimal amount of information released by the biotechnology 
industry because it owns all of the information as a limitation to transparency. A representative 
of the Council of Canadians stated the lack of transparency from the companies who patent GE 
products is one of the problems with the lack of research on the health and the environmental 
impacts of GE products. The representative also pointed out that that in the past independent 
bodies were able to and did conduct similar research (NGO-2). An MP from the opposition said 
that the biotechnology industry is sensitive about speaking. The MP added: 
I support biotechnology. I am one of those that believe it’s going to ultimately help. I say 
to the industry many times ‘it’s your secrecy that has raised suspicions’ ...they come into 
my office, I say to them you have to demystify and de-cloak and they say ‘yes you’re 
right’ but I’m not sure that much of an effort is made. (OPP-2) 
 
The MP maintained that if the biotech industry made the effort “people will become a little more 
accepting in what it is the industry is trying to achieve and what they’re doing” (OPP-2). 
Information Released through the Media  
A few participants also pointed to a lack of information released through the media and the 
general lack of public awareness and understanding regarding biotechnology-produced animals. 
A reporter who has been following the issue stated she wished media attention was higher as the 
industry is moving along in developing and marketing biotechnology-produced animals as food 
(JOUR). A former member of CBAC and CIELAP said “we are speaking to ourselves” and 
questioned how to connect with consumers (NGO-C). An NDP MP identified the difficulty in 
explaining a complicated situation such as food regulation in a way that the majority of people 
can understand and relate to. The MP said that it is an especially slow process to educate 
consumers when the focus is science. The MP added that often the media has not done an 
excellent job in presenting the case clearly (OPP-1). A NGO representative stated that “you’d 
think fairly educated people who actually access progressive media would be understanding this, 
but they’re not" (NGO-3).  
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The Federal Government’s Assessment of Scientific Risks  
A few participants identified the assessment of scientific data in the risk assessment processes for 
the human consumption and environmental release of biotechnology-produced animals as an 
area of concern. Other identified issues related to transparency with respect to the lack of a third-
party review of submitted data. A representative from the Council of Canadians said that the data 
submitted by companies is not replicated by Health Canada or Environment Canada (NGO-2). A 
Green Party Shadow Cabinet member observed “if the studies are held in confidence there is no 
accountability. If science is not peer-reviewed or published in a journal it is not science” (GP-1).  
One professor who is a specialist in the study of Canada's environmental risk assessment 
of GMO noted that the public doesn’t have much of a chance of holding the Government 
accountable because they don’t have access to any kind of information about how products are 
being regulated (ACAD-1). The professor described information the Government publishes on 
its website as very uninformative, noting “in terms of the scientific data and the data that is being 
used to approve these [GE] crops I think even the scientific community has very little to say 
about these issues because no one has access to documents or to the studies” (ACAD-1).  
A food policy consultant said that when they did get access to data packages for GE crops 
that had been approved under the regulatory framework, the packages “had so many flawed 
assumptions and completely inappropriate data sets, when you look at them you wonder what 
kind of moron would approve this” (ACAD-2). 
When speaking about these kinds of challenges, CBAN’s coordinator noted that 
regulatory departments are restricted in how transparent they can be due to the use of 
confidential business information in the assessment process to approve biotechnology-produced 
animals for human consumption or environmental release (NGO-1). 
The Federal Government’s Publication of Risk Assessment Reports (regarding Scientific 
Risks) 
An Environment Canada employee noted that the department had taken its own initiative, 
partially in response to be consistent with the Cartagena Protocol on Biosafety, but also because 
the department understands the merit of being more transparent, and was posting some risk 
assessment reports/decisions online (PS-1). Due to business information being confidential, the 
applicant needs to approve what information is included in the published report before the 
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decision can be posted on Environment Canada’s website. The employee stated it could take one 
to three years after a regulatory decision was made before the risk assessment report is posted 
(PS-1). 
The Federal Government’s Focus on Scientific Risks  
A few participants criticized the regulatory framework for limiting risk assessment to science-
based risks and not taking into consideration socio-economic, economic or ecological risks. A 
food policy consultant and the former leader of the Green Party of PEI both said that the 
regulatory system was not designed to manage the issues concerning novel technologies that go 
beyond science (ACAD-2; GPPEI). A Federal Government official who works in the area of 
food and health policy said that the use of science-based risks during the application process and 
the separation of politics and science in safety regulations was appropriate. The participant said 
that once Health Canada assesses a product as safe “let the market decide” (PS-2).  
One professor who is a specialist in the study of Canada's environmental risk assessment 
of GMO believes that in terms of biotechnology-produced animals there are other issues 
including ethical issues, animal welfare, animal rights that are slightly different than with GE 
crops. This former geneticist also said that ethical issues related to animal engineering affect 
people in a different way than with GE crops. The former geneticist also noted “you’re dealing 
with a different level of genetic modification with much more complex genomes and more 
unpredictable consequences.” The specialist noted how New Zealand had stopped research on 
GE Sheep as they were so mutated (ACAD-1). 
Obtaining Information through the Court System and Access To Information (ATI) Requests  
A few participants raised the issues of expense and time as impediments to their ability to obtain 
information on biotechnology-produced animals through official channels such as the court 
system and Access to Information (ATI) requests. CBAN’s coordinator described ATI requests 
as a barrier to information, a hurdle you have to cross (NGO-1). A member of the Green party 
mentioned the expense involved in going to court to obtain information: 
The general public does not have the money to do the studies, the Green Party don’t have 
the money to go to court to force them to release their studies and we don’t have lobby 
money to force our politicians to actually present both sides of the story. (GP-1) 
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A representative from the Council of Canadians said that the expense of an ATI request 
as the reason for not having submitted a request on the AquAdvantage® salmon (NGO-2). A 
reporter, in recognition that the only route to find information is through the ATI Act, expressed 
disappointment that interested parties had to use this cumbersome and time-consuming route to 
get information about projects such as the AquAdvantage™ salmon. The reporter also said that if 
the government is not providing information, using the ATI Act can work “like a fishing 
expedition”. The reporter also described ATI requests as “time delayed accountability”, referring 
to an experience in November 2011 when she received a response to an ATI request she had 
submitted in 2009 (JOUR). A Liberal MP referred to frustration with ATI requests in terms of 
the need to be both very specific in order to get the information you want and unconcerned about 
the cost (LMP-2). 
CBAN’s coordinator said that an ATI request doesn’t result in full disclosure (NGO-1). 
One professor who is a specialist in the study of Canada's environmental risk assessment of 
GMO didn’t mind the seeing blacked out information on ATI requests and said that in her 
experience there was enough information that wasn’t blacked out to see how regulatory 
approvals are conducted (ACAD-1). However she did describe an experience she had in the 
1990s a few weeks after getting an ATI package regarding GE crops: 
We got a letter from a well-known transnational agrichemical corporation saying if you 
ever release this information we will sue you, it was a really threatening letter...When we 
published our results we were very careful about what we could say – I don’t think we 
gave up on giving out the information but we just had to be very careful about how we 
used documents. We were joking that maybe someone made a mistake that someone sent 
us information by accident... Someone in the government must have said to them we have 
released this information to these two people and next thing you know Monsanto has my 
home address, it was pretty scary. At the time we were hearing about how Monsanto was 
going around with security guards taking samples from farmer’s fields to see if they had 
violated patents. (ACAD-1) 
 
The Risk of Biotechnology-produced animals not approved for Human Consumption 
Contaminating the Food Supply 
Concerns were raised by a few participants about the inability to assess the risk of 
biotechnology-produced animals unintentionally entering into Canada’s food supply. The former 
leader of the Green Party of PEI Labchuk and a representative from the Council of Canadians 
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both raised concern over the confidentiality surrounding research facilities including 
AquaBounty Technologies facilities in P.E.I. The NGO representative said that there was a huge 
potential for eggs to escape from AquaBounty’s research facility (NGO-2). Another NGO 
representative and an NDP MP both raised concern over the possibility of biotechnology-
produced animals escaping and breeding with their conventional counterparts (NGO-3; NDP-A). 
Labchuk stated “we have no idea what’s going on there” and questioned who would know if 
AquaBounty had an accident (GPPEI).  
The Federal Government’s Use of Ambiguous Language 
One participant highlighted difficulty in understanding the ambiguous language used by the 
Federal Government regarding genetically engineered food and biotechnology even for Members 
of Parliament who were attuned to such issues (OPP-2). A member of the Green Party’s shadow 
cabinet also found that the Standing Committee on Agriculture and Agri-Food’s Growing 
Forward 2 (2012) used key words like innovation that could mean anything (GP-1). An NDP 
MP pointed out that language is critical and is used to present a case of making people more 
assured that things are fine. The MP mentioned the ambiguity of terms such as novel food (OPP-
1). A Conservative MP said that biotechnology is a very broad umbrella issue that covers many 
different areas. The MP stated one of the challenges they had in the Standing Committee on 
Agriculture and Agri-Foods was that witnesses presenting to the Committee often narrowed their 
biotechnology discussions on genetically modified organisms (CMP).  
4.2.2. Inadequacy of the Current Policy and Regulatory Framework 
Sixteen participants said that the Federal Government’s lack of political will to ensure 
transparency has lead to inadequacies in the current policy and regulatory framework. A few 
participants brought up limitations caused by a market-driven regulatory system; limitations to 
updating regulations within the existing policy framework and; the unbalanced approach of the 
regulatory process between the right to know and the interest of the proponent. A few 
participants noted the absence of GE food regulations. A few participants noted inadequacies are 




A Market Driven Regulatory System  
Seven participants believed that the biotechnology industry is driving the Government’s agenda. 
A former NDP MP stated “We’ve just seen a complete move towards an absolute abandonment 
of the precautionary principle and the do-no-harm principle and a complete shift towards a 
market-driven market-regulated system” (NDP-J). The former MP said that the latest cutbacks to 
food inspections have left industry determining their own safety and the Federal Government 
without the adequate staff to do proactive investigations. She said “the industry has gotten 
stronger, the present Government ever being the puppets of big industry and not doing anything 
to cross large corporations” (NDP-J).  
A Green party shadow cabinet member stated the need for independent scientific studies 
to be done because industry was in control of Health Canada “in the application process and the 
industry themselves are supplying the science” (GP-1). The member said the issue is one of 
transparency and accountability and not capacity (GP-1). One professor who is a specialist in the 
study of Canada's environmental risk assessment of GMO said  
The argument is that Agriculture Canada is there to promote biotech products because 
they have invested so much of public funds into the research and the development of that 
industry that it is in their interest to make the regulatory system as minimalistic as 
possible and to have the least constraints on corporations. (ACAD-1) 
The Unbalanced Approach of the Regulatory Process  
Several participants (seven) identified a lack of balance in the regulatory process between the 
right to know and the interest of the proponent. A spokesman from a large Canadian food 
distributing company brought up the Government’s obligation to protect the commercial interest 
of the proponent (IND). A representative from the Council of Canadians said that the regulatory 
approach gave companies preferential treatment at the expense of openness (NGO-2). A 
participant stated that her fall-back position in the CBAC was that scientific discussions are not 
enough without considering ethical, social and equity issues and that in any case citizens have a 
right to know – even if the scientists consider there is no reason for concern (NGO-C).  
A spokesman from a large Canadian food distributing company said that it wasn’t a 
question of challenging the safety of food products; there were potential consequences, 
intentional and unintentional, to everyone in the supply chain and to consumers. The spokesman 
said that this was especially true with a new commodity in the absence of a unique traceability 
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and labeling system. The spokesman remained confident in the regulatory approval process. He 
added that a company’s existence was determined by the degree of consumer confidence in a 
product suggesting that if the Government opened its doors to broad consultations and the 
consideration of non-scientific facts, markets could be shut down by poorly informed consumers 
(IND). To address this problem, he said the process has to strike a balance between the interest 
of the proponent and encouraging innovation and providing transparency and making 
information available to the public. He referred to what happened to Canadian flax (which was 
banned in Europe as discussed in chapter 3) as an example of what can happen when a regulatory 
approval system protects the interest of the proponent, but offers no transparency or opportunity 
for other interested parties to comment. He questioned whether that same course of events would 
transpire as novel animal products are brought forward (IND).   
With regard to releasing information on applications a Conservative MP pointed out why 
that would be a problem from the perspective of a business, stating that  
From the competitor point of view – wouldn’t every business like to know that? If you 
were a car dealer, wouldn’t you love to know about Honda’s next model? Honda doesn’t 
want you to know until it comes to market – especially given its investment into it. 
(CMP) 
 
The spokesman from a large Canadian food distributing company said that it goes beyond the 
question of whether domestic consumers are confident and are being consulted because 
unapproved trans-border crossing, intentional and unintentional, is very important for the 
industry (IND). An NGO representative pointed out that the Enviropig™ was thought to be 
slated to be an export product to China and asked, “If it is something that we don’t want 
Canadians to eat or Canadians don’t want to eat, then why should we impose it upon our brothers 
and sisters in other countries” (NGO-3)? 
Limitations to Updating Regulations 
A few participants discussed limitations to the process of updating regulations. CBAN’s 
coordinator and an Environment Canada employee both said that regulators are boxed in by 
policy and restricted in the changes they could make and how transparent they could be. CBAN’s 
coordinator said that any regulations designed to address whether biotechnology-produced 
animals are safe to eat would have to be made within the existing policy framework for novel 
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foods. The coordinator said that the actual focus for change under the existing policy or existing 
regulations was narrow and that ethical and economic questions were considered to be irrelevant 
(NGO-1). A representative from the Council of Canadians said that after meeting with Health 
Canada “[Health Canada] does think that there should be some major changes but they can’t do 
that, it has to come through Parliament” (NGO-2). 
One professor who is a specialist in the study of Canada's environmental risk assessment 
of GMO does not express much confidence in the process: 
[T]he feeling is we’re just kind of making it up as we go along and we’re not really 
focusing on who is really being hurt by this and who is being affected by what is going 
on in terms of policy development or industrial development. It’s scary for a lot of people 
because we don’t know where it is going (ACAD-1).  
 
An Environment Canada employee said that because legislation often defines the role of 
departments (what they can do under an Act and what they cannot) and since the Act dictates 
what is in the regulations, including amendments to the regulations, changing the way something 
is regulated requires a change in the Act that governs that process. So, in order to critique 
regulatory issues around foods that have been produced through modern biotechnology 
effectively, one would have to critique the overall policy direction that led to that 
regulation.  Therefore, changes to the overall policy would be needed (arising from the 
population at large to effect a political change) to create the change in the legislation which, in 
turn, could change the approach in regulation (PS-1). A former member of both CBAC and 
CIELAP said that ten to fifteen years ago the Government was more open to having policy 
discussions, citing the CBAC as an example. The former member added that the policy changes 
that are still needed are the policy changes that CIELAP was calling for ten to fifteen years ago 
(NGO-C). 
CBAN’s coordinator said that it was obvious that reforming regulations is not going to 
address the problem of a lack of democracy around foods produced through biotechnology. She 
said that the actual perimeters of the scope of the policy have to be expanded and a total policy 
shift is required in order to reform the regulation of GE food (NGO-1). The coordinator believed 
that the policy and regulatory framework are very clear and that any of the changes CBAN 
would like to see would upend the policy and that is why regulatory changes that invite public 
discussion including small ones like disclosure will not happen. The coordinator stated the 
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Government is very clear that they don’t want discussion and that is why meaningful changes for 
transparency haven’t happened, why nothing has changed in the entire framework of novel foods 
and why the same barriers exist (NGO-1).  
The Absence of Genetically Engineered Food Regulations 
Three participants discussed the absence of regulations specific to GE foods and the use of the 
Novel Food regulations. A Federal Government official who works in the area of food and public 
health policy said that there are benefits to having a novelty regulation because risks could be 
introduced through conventional breeding (PS-2).  
Although it seems counterintuitive, the official noted that biotech products were the 
original focus when Division 28 of the Food and Drugs Act was set up in the 1990s (as discussed 
in Chapter 3). At the time, the big driver was biotechnology. The official said that the way 
Division 28 was written provided the flexibility to capture new technologies and utilize experts 
in various fields: “you are sure that the person looking at allergenicity knows something about 
the topic and about food in general” (PS-2). A food policy consultant said:  
Civil servants understand themselves to be experts at certain things and that certain things 
are their terrain and it is not for the public to be engaged in these kind of things…A lot of 
times that’s really what people believe who are working in these organizations and it’s 
not that they’re always completely misinformed on this. There are certain things they do 
have expertise on, but when their decision-making authority is rooted in the process that 
has never really had a public debate like GE, then it becomes highly problematic. 
(ACAD-2) 
 
The official said that the first approach had been to use existing regulations and not create a 
separate biotech regulation in order to capture biotech products within the specific contexts of 
food and environmental release. The official also said that in the 1990s, after seeing the 
complexity of the pre-market authorization process, they decided to use the pre-notification 
process for novel foods was used because using this approach meant they would avoid the very 
lengthy process of going through Canada Gazette I and II (PS-2). 
The official mentioned challenges concerning the breadth of the Novel Food Regulations 
and how long a food product should be considered novel. The official questioned once there is 
familiarity with something “is it still novel or run of the mill? Thirty years from now will GM 
foods be regulated as novel?” The participant said that as scientists gather information through 
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case-by-case assessment, there is a need to question whether the formal policy of the approach is 
sufficient, insufficient, or over kill (PS-2). 
The spokesman from a large Canadian food distributing company stated many scientists 
would say some of the techniques of traditional breeding used in plant production are more 
radical than GE in the sense of modifying the life form. He said that doesn’t seem to cause 
concern and questioned where the line should be drawn, and asked what type of technological 
innovation is so novel that society should demand traceability, labeling, and consultation (IND). 
The spokesman stated that parallel learning can be found between how the Government 
has or has not proactively set a framework for managing cloned animal and the government’s 
approach to novel foods. The spokesmen criticized both cases for lacking an overall risk 
assessment or policy framework. The spokesmen stated that Canada’s lack of an overall risk 
assessment or policy framework for cloned meat had resulted in the Government’s inability to 
distinguish, test or trace imported cloned meat. The spokesmen noted Health Canada had asked 
potential applicants to voluntarily withhold submitting an application until a risk assessment 
framework was in place. Currently Heath Canada has no legal basis to refuse a cloned meat 
application and would assess these food products under the Novel Food Regulations. Canadians 
would not know an application was put forth until it was approved (IND). The food company 
representative pointed out that technology to clone animals had been approved for use in the 
USA for human consumption which occurred after a lot of policy deliberation and after the 
industry had agreed on a system of identification and traceability of cloned animals. The 
spokesmen stated the possibility exists that milk and meat from cloned animals has been 
imported into Canada and the Federal Government has no process to distinguish it or test 
whether the imported meat is from a cloned animal. The spokesmen said that the risk of 
government inactivity could shake confidence and result in economic harm (IND). 
The spokesman said that a framework for biotechnology-produced animals should be 
established and public consultations undertaken before any applicant comes forward in order to 
provide an understanding about the basis upon which an individual application would be 
considered. The participant stated this has never happened for cloned animals. The participant 
said that over five years ago Health Canada stated they were going to do a general risk 
assessment to decide if a cloned animal should be considered novel or whether unique regulatory 
process should be in place. The participant stated that although Health Canada representatives 
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said it had been done and there had been inter-departmental committee talk about it, nothing has 
come out about it (IND).  
The Federal Government’s Slow Pace of Change with respect to updating Regulations 
Three participants discussed the Federal Government’s slow pace of change, worsened by staff  
cutbacks. With regards to updating the Guidelines, a Federal Government official who works in 
the area of food and health policy said that the work of regulators is prioritized based on funding, 
time, and resource issues (PS-2).  
An NDP MP elaborated on this point by noting that the Federal Government is a big 
machine and most of the time change is often incremental and doesn’t happen quickly (OPP-1). 
Adding to the situation, a reporter observed that biotechnology experts she’s interviewed 
suggest the government seems incapable of properly assessing cutting-edge products, both 
because of a lack of expertise and outdated regulations (JOUR). An NDP MP said that when the 
MP asked DFO for a status report they did not provide a lot and said that there wasn’t a lot going 
on. The MP believed them and that it was probably low on the priority list in terms of developing 
guidelines and regulations (OPP-1). 
4.2.3. Lack of Political Will to Ensure Transparency 
Related to the previous theme, the majority of participants in the study suggested the reason for a 
lack of publicly available information is that the Government doesn’t have the political will to 
ensure transparency. Many participants raised an issue as the lack of research being done by both 
the Federal Government and independent bodies. Moreover, when attempts have been made to 
hold the Government accountable, it’s been an issue of accountability without results and that 
there is a lack of democratic participation. Participants also said that the Government’s food 
safety initiatives have been superficial. A few participants also discussed the declining access to 
information from the Federal Government. They said that Federal Government initiatives to 
increase transparency do not address identified issues of transparency.  
A Lack of Government and Independent Research 
Ten participants also stated that transparency was difficult to achieve due to the limited amount 
of research being done by the Government and independent bodies. Former MP Wasylycia-Leis 
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said that things had become less transparent and that there had been no progress in terms of 
independent research (NDP-J). NDP MP Atamanenko said that the Government had not done 
any truly independent studies on the health effects of GE foods “there isn’t really an independent 
study done before we release GE organisms into the environment… A lot of the research is done 
by big companies and, upon researching them, you know their agenda” (NDP-A). 
A professor who is a specialist in the study of Canada's environmental risk assessment of 
GMO also stated no one wants to do a study against GE for fear of losing their lab or funding 
(ACAD-1). A member of the Green Party’s shadow cabinet pointed out that companies can say 
there is no scientific proof that GMOs have health risk because they can control the studies (GP-
1). The member echoed the need for real independent scientific testing:  
Companies are donating to the universities and they’re all friends so they can go to the 
university scientist, and even if he is trying to run an independent study, they can say, 
you really don’t want to do that study. Just like the MPs it’s all very tightly controlled 
(GP-1) 
Participants also discussed the limitations to the type of research that was being reviewed by the 
Government. Past MP and Health Critic Wasylycia-Leis said:  
During the whole period when I was raising these issues they always tried to suggest to 
us that research had been done and there was no evidence to suggest GE products were 
not safe beyond a reasonable doubt, and when you look below the surface, and this was 
fairly well critiqued by outside scientists, it was clear that they were trying to compare 
chemical makeup of the product, talk about chemical equivalence. They didn’t get at the 
root cause of long-term effects of GE food on human health and well-being (NDP-J). 
 
Wasylycia-Leis said that the current and previous Governments had put the onus of scientific 
health studies onto the industry itself “even though they [the industry] have a vested interested in 
one outcome” (NDP-J). She said that while the results are kept confidential when people have 
gone to court to force the studies to be made public, the studies are scientifically bizarre, “they 
messed with the science in order to try and get a particular outcome” (NDP-J). 
Two other participants also mentioned the lack of long-term testing by the Federal 
Government. A former member of CIELAP said that no data was being collected in the long 





A Lack of Democratic Participation 
 A number of participants (nine) stated that when they have held the Government accountable, 
it’s been an issue of accountability without results and that there is a lack of democratic 
participation. An NGO representative stated 
We can hold the government accountable but they don’t really care...We make them 
accountable, we call them to task... they just continue what they’re doing… We can hold 
them accountable using facts and figures and hard data but they’ll choose to ignore it 
(NGO-3) 
 
CBAN’s coordinator also commented that the issues go beyond whether the framework is 
transparent. She said that the Government is transparent about its bad regulatory policy and there 
is no democratic participation: 
the industry talks about transparency a lot. When faced with a series of critiques about 
GE they say okay we need to be more transparent. It’s a fall back agreement on behalf of 
the industry and Government… more transparency means consumers won’t be afraid etc, 
that’s the discourse of the industry side on transparency, just providing enough and 
although the framework is transparent it’s obvious reforming regulations is not enough 
and a policy shift is necessary. (NGO-1) 
 
She said she doesn’t see a window for the public to participate regarding GE food in a 
democratic way.  
There are consultations on reform or development of new regulations which are done 
with every process. Our fundamental criticism is that the whole framework for regulating 
GE foods is deliberately non-transparent... The system is expressly designed to exclude 
public participation, because often the government will agree, yes we do need to increase 
transparency. That’s not the issue that’s the symptom of a deeper problem. (NGO-1) 
 
A food company representative also pointed out that the timeframe and broader implications 
surrounding the Enviropig™ application were not being transparently debated (IND). 
Superficial Food Safety Initiatives 
According to five participants, food safety transparency initiatives focus on symptoms and not on 
root causes. A member of the Green Party asserted that food safety initiatives are completely 
meaningless without traceability in the processing system (GP-1). Regarding food safety 
initiatives a former MP and Health Critic observed 
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It’s a good camouflage isn’t it? It creates the illusion among the public that the food we 
eat is safe beyond a reasonable doubt when in fact nothing has changed below the 
surface...They’ll create the illusion that makes it hard for anyone to be a naysayer…It’s 
only gotten worse in terms of actual real meaningful research, independent research, and 
proactive investigations. (NDP-J) 
A Conservative MP maintained that the system is working and Canadians have confidence in the 
system and know that the food they buy is safe (CMP). The MP pointed out that there is a long 
process with many checks and balances before a product can be introduced into the food chain. 
The MP said that people will be opposed to the Enviropig™ but it is not on the market (CMP). 
The Declining Accessibility to Information from the Federal Government 
Four participants noted a declining amount of accessibility to information on the part of the 
Federal Government concerning biotechnology. A professor who is a specialist in the study of 
Canada's environmental risk assessment of GMO noticed that the Federal Government had taken 
down a lot of information about biotech policies, reports, and Canada’s biotech strategy from its 
websites after she had been monitoring them for a long time (ACAD-1). The professor stated 
“now they make you go through ten steps to get the report.” The professor continued 
There’s a real toughening up of the release of information by the Harper government in 
particular. Everybody says it feels that the Conservatives are not even talking to the 
media half the time – if you need information you can’t even talk to someone on the 
phone, they say send it in writing and you won’t get responses. They’ve really tightened 
the screw on information –it’s not a good day for democracy. Transparency is definitely 
not at its highest at the moment – not that it’s ever been very good but it’s getting worse. 
(ACAD-1) 
Federal Government Transparency Initiatives not Addressing Identified Core Issues  
Three participants commented that only superficial updates had been made to the regulatory 
framework and did not address identified issues of transparency. A food policy consultant said 
the modest increases in transparency are not about challenging the core of the system (ACAD-2). 
He noted that a lot of department statements were window dressing as the result of department 
obligations (i.e. a command from Treasury Board) (ACAD-2) 
CBAN’s coordinator and Past MP and Health Critic Wasylycia-Leis both talked about the 
Government’s unsatisfactory response to the Royal Society of Canada’s Expert Panel on the 
Future of Food Biotechnology recommendations. The coordinator said that the Government 
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made the mistake of asking an independent body to take a look at the future of biotechnology 
regulations as the RSC Expert Panel had established major critiques over the transparency of 
regulations (NGO-1). Wasylycia-Leis described the Federal Government Action Plans as being 
part of a clever strategy for the Federal Government to “wait it out, knowing that parties will 
change, that people will lose interest or the media will lose interest” (NDP-J). CBAN’s 
coordinator said some things in the Action Plans had been reversed or resulted in useless 
initiatives like the voluntary notice of submission project. She said that the Government had only 
made changes in response to industry pressure and its trade agenda and that the only change 
made regarding public pressure, the voluntary notice of submission project, was a hard fought 
win that resulted from all the questions of transparency. However, she added that it was set up by 
Croplife, remains voluntary, does not address what the public was asking for, and does not 
address biotechnology-produced animals (NGO-1). She also noted that there was still no access 
to how regulatory decisions get made or to the data in decision making behind regulatory 
approvals (NGO-1). 
4.2.4. Declining Avenues for Public Participation and Consultative Initiatives 
A majority of participants, including the majority of NGO representatives, said the lack of 
Federal Government transparency is manifested through reduced opportunities for public 
participation and consultative initiatives including participating in government consultations and 
the use of advisory bodies.  
Participating in Government Consultations 
Seven participants described different experiences with participating in Government 
consultations. Two NGO representatives said that they had informative and productive meetings 
with regulators to gain clarity on the process of regulating biotechnology-produced animals. One 
said they had an informative meeting with Environment Canada where the department went 
through the process of what they will do once it gets an application from AquaBounty (NGO-2). 
CBAN’s coordinator Sharratt said they had requested a meeting with regulators to gain clarity on 
the process of regulating the Enviropig™ and AquAdvantage® salmon. Sharratt said that 
although the meeting was productive CBAN’s preference would have been to provide advice on 
policy not regulations (NGO-1).   
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In contrast, Labchuk, the former leader of the Green Party of PEI and member of the 
NGO Earth Action P.E.I. felt that the Government representatives she had met with were not 
knowledgeable on the topic and/or were disinterested. In reference to a meeting with P.E.I. 
Premier Robert Ghiz Labchuk stated “he’s not really worried about it, he doesn’t really care, he 
doesn’t think it’s a problem. He told us ‘he is genetically engineered’ and is not going to be 
chasing down the Government” (GPPEI).
7
 Labchuk added “the Premier’s staff looked very 
uncomfortable standing around him when he said this” (GPPEI). 
A professor who is a specialist in the study of Canada's environmental risk assessment of 
GMO said the she didn’t believe that consultations meant that much. She said that for the 
consultation on the 1998 Strategy:  
They were supposedly asking the public what they thought about GE foods even though 
they’d been eating them unknowingly for years. They came and said ‘okay we’re going 
to have consultations about the future of GE foods in Canada, so here’s GE food, do you 
want this scenario or that scenario?’ There was no way in the whole consultation process 
to say we don’t want GE foods. They had come with two prepared scenarios. Most of the 
participants were essentially pro-GM so it was fine for them. It was so ridiculous that a 
bunch of us, Environmental-NGOs, activists, we just walked out. It was not a 
consultation it was not a debate. Everything was decided ahead of time, there was no 
democratic process to speak of. We were just there to make them look good because then 
they could say we consulted with ENGOs and civil society groups etc. (ACAD-1) 
 
The specialist said that attending a consultation  
doesn’t guarantee that you are going to get any more information or that you’re going to 
know what is actually going on – it is already going on underneath your nose...The 
problem is the Federal Government is not being an honest broker / partner because they 
don’t have a process for decision making that is inclusive. It’s between them and 
industry, what they call ‘stakeholders’. If you’re a random person you aren’t a 
stakeholder unless you’re organized some big consumer organization that is threatening 
to withhold your dollars, they are not going to even look at you. That’s the reality of the 
system. It’s really frustrating. You know that you’re right and they’re wrong. (ACAD-1) 
 
The specialist pointed out that Canada’s two biotechnology strategies (discussed in Chapter 3) 
were developed out of order. Implementation of the regulatory system was addressed before the 
GE strategy itself. She stated how the first one “was to implement the regulatory system and say 
we are consulting with Canadian society and stakeholders and we are developing this great 
regulatory framework – after the fact that it was already set up” (ACAD-1). She asserted that the 
                                                 
7
A representative from the Council of Canadians and a representative from NFU also attended the meeting (GPPEI) 
88 
 
focus of the second strategy, the National Biotechnology Strategy (1998) was “to have a societal 
debate around the acceptability of GE foods - and this is four years after GE foods were already 
in the environment and in the marketplace” (ACAD-1). The specialist noted that you should 
“first have a social debate about whether you want them and then you make the regulatory 
system but we did it the other way” (ACAD-1).  
A member of the opposition noted that there was public interest in the issue. One MP 
observed that when more than 300 people attended a forum on biotechnology in Guelph, people 
were in shock at the high attendance. The MP said that a lot of the people had had extreme 
misgivings about genetic modification (OPP-2). 
The Ability to Participate in Government Consultations  
Four participants discussed limitations surrounding their ability to participate in consultations, 
specifically having to find out if there was one; difficulties with the process, format, and cost for 
participation; and the limited focus. An NGO representative stated “It’s a highly complex issue 
so unless you’re following the issue really, really closely and are able to keep up with the 
language and understand the language and the process, it’s very intimidating” (NGO-3). The 
NGO representative said you had to know of the consultation and the time frame of the 
consultation. “You need a full-time staff person almost really to keep up with what’s going on” 
(NGO-3). As to the language used in online consultations the participant said, “many farmers 
don’t understand the language. It’s not that they’re stupid it’s just a very academic bureaucratic 
language and it’s very ambiguous” (NGO-3). The participant pointed out that a lot of 
consultations are held in Ottawa and that the funding that used to be provided for one or two 
representatives from each organization to attend the meetings is no longer provided. The 
participant added that when NFU did attend meetings regarding GE foods the majority of people 
were from industry and NFU would be marginalized as the nay-sayer. The participant said they 
attended consultations regarding GE food “at our own cost, our own peril and our own mental 
health…You really feel that it’s useless it’s very demoralizing. They’ve already decided and it’s 
getting to be increasingly like that and we basically stopped attending” (NGO-3).  
The ability to participate based on the focus of consultations was also raised. One food 
and health policy official stated that the Health Canada wanted feedback on the guidelines for 
biotechnology-produced animals but that the feedback had to relate to science (PS-2). CBAN’s 
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coordinator said that limiting the consultation’s focus to science-based risks meant limiting the 
expert participants invited to those who understood the science behind biotechnology:  
There is only a small group of people and organizations that have expertise in GM 
animals. The industry has a great advantage as they can maintain scientific expertise. 
Industry is the first place outside of Government that Government will go to to make 
changes to regulations. (NGO-1) 
The Use of Advisory Committees  
The limited mandate and term of the Canadian Biotechnology Advisory Committee (CBAC) was 
identified as an issue affecting transparency by two participants. A former member of the CBAC 
said there had been a lot of controversy even when the committee was set up over whether it was 
“just a greenwash”: 
There’s no means of holding that committee accountable because it’s been disbanded. It 
was replaced by a committee set  up under the auspices of Industry Canada, the Science 
and Technology Advisory Committee… there was no attempt to continue having a 
conversation with any civil society groups that did not see technology as the economic 
driver of the 21
st
 century and the job creator. (NGO-C) 
 
One MP observed that a number of people are keenly interested in getting the CBAC back 
together and stated intentions to press the issue in Ottawa (OPP-2). The MP also said that 
regulations are needed specifically with respect to the coexistence of GE and non-GE crops and 
food and for low-level presence and there should be a venue where stakeholders have an 
opportunity to talk and in some instances self-regulate. He said that he would prefer moving 
forward with both CBAC and the Science and Technology Advisory Committee (OPP-2).  
4.2.5. The Bias of the Government’s Agenda towards Biotechnology 
A strong theme emerged around the inadequacies of the current policy and regulatory 
framework. Eleven participants stated that these were the result the Government’s agenda that is 
biased in favour of biotechnology. Participants considered current and previous government’s at 
the Federal and provincial levels. The former leader of the Green Party of PEI said that P.E.I.’s 
provincial government is the main driver and has been and is aggressively pushing and 
promoting biotechnology. She pointed out that biotechnology has been mentioned in throne 
speeches under both the Conservatives and the Liberals (GPPEI).  
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A NDP MP said the Federal Government has had a pro-industry bias for at least 20 years 
(OPP-1). A Former NDP MP said that the biotechnology industry has dominated the scene with 
the Federal Government with both the Liberals and Conservatives parties choosing “to lay down 
and rollover whenever industry speaks” (NDP-J). An NGO representative said “We’re in a stage 
with our Government that it doesn’t matter what you say to whom, they’re blinkered. They’re 
going where they’re going and how we change them apart from getting rid of them, I don’t 
know” (NGO-C). Another NGO representative stated “I feel sad that the food is such an election 
issue and even the Liberals sit on their hands because they don’t want to piss off their industry 
buddies. They could have supported Bill C-474. I know Wayne Easter [Liberal MP in P.E.I] 
really well and he refused” (NGO-3). NDP MP Atamanenko said the industry is driving the 
agenda and the government has bought into the corporate agenda. With respect to his Bill C-474 
Atamanenko said:  
I was told basically by the Parliamentary Secretary and the Conservatives, the reason they 
don’t want any of the stuff being debated is because the biotech industry is basically 
telling them, look we spent all this money on research. You guys start interfering, you 
start debating the merits of this technology, we’re going to pull out our research. Simple 
as that. I would call it corporate blackmail. (NDP-A) 
 
A Green Party shadow cabinet member asserted that “they are changing bills and Parliament is 
doing things and they’re not telling the full story” (GP-1). The participant said that although the 
Government says it is driving things for a strong economy, she believes those to be meaningless 
words: 
How does this particular product bring me a strong economy? As a farmer and scientist 
I’ve been involved in politics, I pay attention to what’s being said and try to research it to 
be able to make sense of it. They are saying GM is going to help the economy and I know 
for a fact that it does not. The only piece of the economy that GM products are helping is 
the company’s bottom line. (GP-1) 
 
Past NDP MP and Health Critic Wasylycia-Leis, in reference to the Health Committee’s 
Standing Committee on Labeling (see chapter 3), commented that sometimes the Government 
will strategically let something go through that they don’t want knowing full well that it may run 
out of time, or Parliament will be prorogued, or an election will happen so the work will just die. 
Wasylycia-Leis had been the Health Critic from 1998 to 2003 and from 2007 to 2012. She said 
that the Standing Committee on Health “had not been great” for taking up the issue of labeling. 
“It goes back to why this tight control in this area?” She identified the predominance of industry 
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and the fact that the Liberals, the Government at that time, did not want to open the issue up as 
“they were well down the path of having devolved the system and had moved towards industry 
sponsored research and a risk management model that they had no intention of discussing. They 
had bought into the agenda” (NDP-J). 
A representative from the Council of Canadians concludes: 
Zero transparency – all there is is a push to get things on the market and it is being done 
for the benefit of industry…it’s almost a cookie-cutter approach… Just speed up the 
process to make it easier for industry to get their product on the market without people 
like us saying, well wait a minute, let’s unpack this and take a look at the costs and 
benefits. We would like to be more engaged and we would like it to be easier for us to be 
engaged. (NGO-3) 
 
A Liberal MP suggested that in the last budget there was an intentional defunding of 
alternative voices “whether it’s on environmental movement or other issues” (LMP-1). The 
representative from the Council of Canadian said  
It’s not just about the actual issue, about GE wheat or GE pigs. It’s also about 
transparency. This is another thing they’re doing behind closed doors for the benefit of 
industry without any respect or concern for the farmer or the consumer or the 
environment or the long term ramifications of their position (NGO-3). 
4.2.6. Disempowered Parliament 
The lack of Federal Government transparency is in part manifested through a disempowered 
Parliament including the limited ability of parliamentary proceedings to discuss and/or influence 
GE food policies according to eight participants. They brought up limitations to transparency 
surrounding a reduced oversight in parliamentary regulatory functions. Participants also raised 
limitations facing MPs, the use of committees, bills and motions, and having discussions ‘in-
camera’.   
Limitations Faced by Members of Parliament  
A few participants discussed limitations surrounding the ability of Members of Parliament (MPs) 
to shed light on issues of transparency. A Food policy consultant described the GE regulatory 
environment as:  
a deeply buried architecture that runs under the radar in part because the elected officials 
don’t have expertise to challenge it or the parliamentary procedures. For examples if 
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you’re a parliamentarian and you disagree with the way legislation or a policy initiative is 
unfolding what are you going to do about it? You don’t have an oversight capacity, staff 
to understand it, or the ability to follow it deep into the bowels of the bureaucratic 
process. (ACAD-2) 
One MP from the opposition said that people have enormous expectations of MPs and that MPs 
are not listened to and the press time they receive is based on the controversial nature of what 
they are discussing (OPP-2).  
Former NDP MP Wasylycia-Leis and a current NDP MP Atamanenko discussed how 
their interactions with the biotechnology lobby affected their ability as MPs. Wasylycia-Leis said 
“I can say for certain when I was raising these issues there was always a lobby of big food 
production companies and GE producers. I remember Monsanto being so pervasive and 
dominant in everything that was going on” (NDP-J). Atamanenko similarly observed:  
I was at a cocktail party and one of the executives of Croplife said ‘look we don’t even 
want your bill debated’. So here we are, a representative of this industry is telling an 
elected official that he does not have a right to have a full democratic debate on the topic 
as important as this. That is absolutely reprehensible. (NDP-A) 
Atamanenko added that before his bill to amend seed regulations, Bill C-474 (discussed 
in Chapter 3), was coming to a final vote (February 2011) the biotech industry had organized 
fifty meetings in December 2010 with Liberal and Conservative MPs to lobby against the bill 
and that there was a full-page ad in the Hills Times newspaper. With regards to the biotech 
industry he said “They are powerful. They are calling the shots” (NDP-A). A Liberal MP said 
that barriers MPs face have led to there being “no way for MPs to empower themselves” (LMP-
1). 
One participant, a food policy consultant, said that Parliament’s traditional function of 
overseeing Government had been reduced and had given rise to a regulatory apparatus that is 
lacking in transparency and accountability  
Now you have situations where agents of Parliament including the Auditor General or the 
Environmental Commissioner or the Privacy Commissioner have become effectively the 
opposition… The rules of Parliament have been so altered that the opposition parties 
don’t have the means or resources or the capacity or the rules to actually provide this 
oversight function which is supposed to be the main role of Parliament. These obviously 
are much bigger than the GE regulatory story but those things have happened to allow 




The consultant said that centralization of power in the PCO/PMO has also limited the role of 
MPs with respect to transparency (ACAD-2). 
Participants brought up the limited ability of bills and motions to make any changes. The 
food policy consultant said bills and motions regarding biotechnology food products “do not 
have any hope in passing in Parliament because the civil service is going to do everything it can 
through the Privy Council Office and Prime Minister’s Office as it [bills and motions] 
completely challenges the fundamental architecture they have deliberately constructed” (ACAD-
2). A Liberal MP added that “In general private members bills are tough to get through… once 
you make them political that just drives the divide down the middle of the house and often if they 
are criticizing the Government a fair bit, automatically the Government will vote against it 
(LMP-2)”. 
Limitations to the use of Parliamentary Committees 
A few participants raised the issue of how and whether biotechnology-produced animals are 
discussed in committees. An NDP MP brought up difficulties experienced by standing 
committees regarding capacity, the competitiveness to getting an issue in front of the committee, 
and the lack of pressing issues regarding GE fish (OPP-1). A food policy consultant said 
the only possible way to get parliamentary scrutiny is to convince House of Commons 
committee chair to hold hearing on it and call witnesses. The architecture of our so-called 
democracy fuels the capacity of Government when they want to bury these kind of 
decisions deep in regulatory architecture of the system and make it almost impossible to 
pull it out. (ACAD-2) 
NDP MP Atamanenko commented that there won’t be any controversial studies regarding 
biotechnology-produced animals in the Agricultural committee as the agenda is set by the 
Conservatives (NDP-A). After looking at Private Members Bill C-474 the Agriculture committee 
undertook a biotech study. The study had been interrupted by an election and as a Conservative 
MP stated, it wouldn’t be fair to new committee members to release a report summarizing 
information and proposing recommendations with respect to a study in which they did not 
participate (CMP). A summary of what the Committee had heard was appended to Growing 
Forward 2. Atamanenko said the summary report included in Growing Forward 2 was an 




Limitation to Proceedings going ‘In Camera’ 
Transparency and accountability under the current Government was difficult according to four 
participants, because controversial topics are discussed in-camera where there is no record. A 
Liberal MP stated that those in power want to control the message coming out and that 
increasingly light and fluffy issues are driven in-camera (LMP-2). A MP from the opposition 
said that the biggest barrier is that the Government suffers from ideological paranoia and that 
anytime anything that is contrary to their ideology comes up they go in camera. The MP stated 
“Canadians know that now - at least I’m hoping they do” (OPP-2). NDP MP Atamanenko stated 
he firmly believed that this Government didn’t want good healthy democratic debate in 
committee. He had tried to introduce a motion to put a moratorium on GE alfalfa which the 
Conservatives immediately moved to a meeting in camera “so that there would be nobody 
following the proceedings” (NDP-A).  
A Conservative MP provided an alternative perspective, saying that it was an unfounded 
accusation that committees go in camera too often. The MP said that the vast majority of 
committee work is done in public, is broadcast on CPAC, is sometimes televised, and the 
meetings’ minutes can be accessed by the public through the internet. The MP said that 
committees move in camera for two main reasons: to discuss committee business that has to do 
with the administration of the committee and to review and finalize the report it’s about to write, 
which is confidential until it is tabled in Parliament. The MP also said there are times when 
witnesses are called and where the committee does visits and those are not in camera (CMP). 
4.2.7. A Dramatic Decline in Civil Servant - Public Interaction and Communications Flow 
A dramatic decline in civil servant public interaction and communications was also noted by four 
participants. This included the muzzling of Federal Government scientists (NDP-J; NDP-A), 
resource cuts (NDP-J), and fear of repercussion. A reporter observed that decisions about when 
Federal Government scientists can talk to journalists appear to be made by political staff in 
ministers’ offices rather than communications specialists in the bureaucracy (JOUR). A Liberal 
MP said all departments fell into general secrecy about how they operate and the bureaucracy 





This chapter identified seven common themes that emerged from interviews with respect to the 
transparency and accountability of Federal decision-making processes, and institutions 
concerning biotechnology-produced animals. A majority of participants discussed the amount of 
information made publically available. Most participants pointed out inadequacies in the current 
policy and regulatory framework. Most interviewees also suggested that there is a lack of 
political will to ensure transparency. Just over half of interviewees hypothesized that this could 
be due to the Federal Government’s biased agenda towards biotechnology and that transparency 
appeared to be a growing problem due to declining avenues for public participation and reduced 
consultative initiatives. A few participants stated transparency appeared to be a growing problem 
due to a disempowered Parliament and a dramatic decline in public servant interactions and 
communications.  
Chapters 3 and 4 provided examples of limitations to transparency surrounding the 
regulation of GE crops. These issues still exist for biotechnology-produced animals as a similar 
regulatory framework is used. These limitations will be explored further in the next chapter. 
The next chapter provides an analysis of how the major themes from the interviews align 
with major themes from the literature. It discusses current issues with biotechnology-produced 
animals that highlight the diminishing transparency and accountability of the Canadian 






Chapter 5: An Analysis of Limitations to Federal Transparency with Respect 
to the Human Consumption of Biotechnology-produced animals 
5.1. Introduction 
Chapters 2 and 3 revealed the limitations to transparency in the Federal Government’s decision-
making processes and institutions involving the manufacture, importation and sale of a 
biotechnology-produced animal for human consumption through an extensive review of 
secondary literature. These limitations were further explored through primary interviews (as 
discussed in Chapter 4). This chapter analyzes those limitations to transparency both within and 
external to the regulatory process. It includes an analysis of (1) the confidential nature of the 
regulatory processes (2) the assessment of science-based risks (3) the risks and impacts not taken 
into account through the regulatory processes and (4) the ability of interested parties to review 
the regulatory processes. This chapter concludes with a discussion of external constraints on 
Canada’s regulatory system. 
5.2. Limitations to Federal Transparency Regarding Canada’s Regulatory Processes to 
Manufacture, Import and Sell a Biotechnology-Produced Animal for Human Consumption 
The two major steps in Canada’s regulatory process to approve a food product that is, or 
contains, material derived from a biotechnology-produced animal are pre-market notification 
under the New Substance Notification Regulations (Organisms); and Health Canada’s pre-market 
safety notification under the Novel Food Regulations. Limitations to transparency surrounding 
Canada’s regulatory processes to assess the human consumption of a biotechnology-produced 
animal arise from the confidential nature of the regulatory processes; the assessment of science-
based risks; the scope of science-based risks; and the ability of interested parties to review how 
decisions are made and to review and participate in shaping the regulatory processes. 
5.2.1. The Confidential Nature of the Regulatory Processes 
The Federal Government restricts and releases limited information on applications going through 
the regulatory processes. The reason given is that they contain confidential business information 
(CBI).  This affects transparency surrounding the manufacture, import and sale of a 
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biotechnology-produced animal for human consumption. Aside from CBI, as stated in the Royal 
Society of Canada’s Expert Panel Report on the Future of Food Biotechnology 
The amount of information the regulatory departments choose to disclose from the 
application and approval process is not set by any formal regulations. Rather, it is a 
policy judgment that seeks to balance the interests of industry against the desire for 
transparency in the regulatory process. (The Royal Society of Canada, 2001, p. 213) 
 
Chapter 3 and 4 discuss limitations to transparency surrounding foods that contain plants with 
novel traits (PNT aka GE plant). Table 5.1 compares Canada’s regulatory process regarding the 
human consumption of a biotechnology-produced animal to that of a food product that is or 
contains material from PNTs. It compares the confidentiality regarding the submission, 
assessment and final decision. It also includes voluntary initiatives regulatory departments have 
come up with to increase transparency through the regulatory processes.  
Table 5. 1. The Federal Regulatory Process regarding the Human Consumption of Biotechnology-Produced 
animals compared to Plants with Novel Traits (PNT) 
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Source: adapted from CFIA (2012e) 
* According to the Guidelines for the Notification and Testing of New Substances:(Organisms) “Under section 313 
of CEPA 1999, any person who provides information to the Government in support of a New Substances 
Notification may, at the same time, submit a written request that information be treated as confidential” 
(Government of Canada, 2010, p. 90). **Decisions regarding both the authorization for environmental release of 
PNTs and their use as livestock feed ingredients are also accessible from the Canadian Node of the Biosafety 
Clearing-House   
 
As noted in Table 5.1., departments and agencies with regulatory authority have undertaken 
voluntary initiatives to provide information on applications going through the notification 
processes. These consist of the CFIA and Health Canada’s Notice of Submission Project (as 
discussed in Chapters 3 and 4). A representative of Environment Canada added the department 
takes the time to make the assessment reports more readable and less technical and that, due to 
CBI, the applicant needs to approve what information gets included in the published report 
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before Environment Canada can post it. The representative also stated that the risk assessment 
summary may not be immediately posted on Environment Canada’s website and could, in some 
cases, take several years before being published (PS-1).  
The CFIA and Health Canada have a voluntary Notice of Submission initiative for food 
products from plants with novel traits (PNTs). One of the reasons the Notice of Submission was 
developed was “to support the commitment to achieve greater openness regarding product 
information made by the Government of Canada in its responses to the Royal Society of 
Canada's (RSC) Expert Panel Report” (CFIA, 2009a). According to Canadian Biotech Action 
Network’s (CBAN) coordinator, the voluntary system was set up by Croplife, a biotech trade 
association. The coordinator added  
The RSC report was looking to the future of regulations, well the future food are GM 
pigs and fish, and the Notice of Submission totally fails to address that, we’re right back 
where we were before Notice of Submission! CBAN tried to say at the time [it was being 
created] that it was a joke. (NGO-1) 
 
The initiative does not have a clear mechanism for considering incoming comments (Andree & 
Sharratt, 2004). It is also the only method set up by regulatory agencies for interested 
stakeholders to obtain information on applications going through the regulatory process. 
A Notice of Submission initiative has not been set up concerning applications to approve 
biotechnology-produced animals for manufacture, import or sale for human consumption. The 
initiative was set up between Health Canada, the CFIA, and Croplife and its members. Croplife 
represents companies involved in GM crop development. The institutions involved in animal 
biotechnology are not represented by Croplife. With regard to animal biotechnology a Federal 
Government official who works in the area of food and health policy said that the Government 
was only dealing with a few “companies, universities, things like that so they don’t have the 
same type of organizations like Croplife, umbrella organizations” (PS-2).  
Aside from the voluntary Notice of Submission Initiative and the posting of risk 
assessments information on applications is not released until after a decision has been made. It is 
unclear why information on applications that were retracted or not approved cannot be accessed 
by interested parties, other than concerns about a potential overload of information and to protect 
business interest. Having access would increase transparency and accountability in the regulatory 
process by permitting comparison of a negative decision to a positive one. As discussed in this 
chapter, it is difficult to find a listing of novel food submissions and decision documents to 
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figure out whether every application that has been submitted to Health Canada has been 
approved for human consumption and whether applications have been retracted.  
Health Canada posts decision documents on its website for novel food that have received 
approval through Health Canada’s pre-market safety assessment (Health Canada, 2012a). The 
length of time it takes for the decision documents to get posted online can limit transparency. 
The product could theoretically be on the market shelves before the decision document is posted. 
As of December 2012 the listing of Novel Food Decision on Health Canada’s website contained 
approximately 200 approved products. When the website was updated in October of 2012 the 
decision dates for the last two decision documents posted on Health Canada’s website were April 
27, 2011 and April 13, 2011. As of December 12, 2012, the website was last updated December 
7, 2012 (Health Canada, 2012a). The updated version of the website contained 16 additional 
approved products, with decision dates ranging from June 2011 to June 30, 2012. A decision 
document was not provided for any of these 16 additional approved products (Health Canada, 
2012a). This is the only method for a Canadian citizen to obtain information concerning the 
submission or approval of an application for a food product that contains biotechnology-
produced animals. Right to Know legislation can be used, but, as stated, the application itself is 
confidential and limitations to right to know legislation noted through the literature and through 
interviews might result in information not getting received until after a product is on the shelves. 
The amount of information provided in decision documents is also not an exact science. 
Some decisions documents give the notice of safety assessment and summarize Health Canada's 
safety assessment while others provide novel food information, consisting of a summary of the 
notification from the applicant and Health Canada’s evaluation (Health Canada. 2011d; Health 
Canada. 2010e). As novel foods cover a broad range of products, through the decision 
documents it is also not always clear whether the novel food product that was approved had been 
derived through modern biotechnology. Furthermore, not all of the products that receive 
approval will reach the market (CMP). There is nothing set up to show when a novel food that 
contains GE material has entered the market for the first time and no mandatory method like a 
labeling standard to indentify food products that are or contain GE material. 
Health Canada’s website states “To date, Health Canada has reviewed over 81 novel food 
submissions” (Health Canada, 2012d). Although this section of the website was updated in 2012, 
it did not update the number of novel food submissions. According to the Novel Food Decision 
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section on Health Canada’s website Novel Food submissions reviewed by Health Canada 
surpassed 81 in 2006 (Health Canada, 2012a). This leads one to question how many more novel 
food decisions have been made.  
Interestingly, a section on the CFIA website entitled Animals and Animal Products 
Derived Through Modern Biotechnology: Roles and Responsibilities of the Government of 
Canada states “No biotechnology-derived animals have been approved for release into the 
Canadian environment or for food. To date, the Government of Canada has not evaluated any 
requests for food use approval or environmental release of fish derived from biotechnology” 
(CFIA, 2012a). As of December 2012, this section on the website was last updated April 19
th
, 
2012. The website does not mention if a request had been submitted for any animal besides fish. 
The website also does not state that the University of Guelph received approval for the 
manufacture and import of the Enviropig™ as of November 26, 2009 (Environment Canada, 
2012).  
It is not mandatory for regulatory departments to release information during any of the 
regulatory processes listed in Table 5.1. The applicant approves the information that gets 
released through voluntary initiatives. Examining risk assessment documents, decision 
documents, or attempting to access information through right to know legislation or the court 
system are the only ways for an interested stakeholder to obtain information on the outcome of 
an application for a biotechnology-produced animal that has gone through one of the regulatory 
processes described in Table 5.1.  
An issue regarding the confidential nature of the application process concerns the lack of 
information the government releases, proprietary or otherwise. Opportunities exist under the 
regulatory framework that would allow regulatory departments to cater to the interest of 
applicants, the scientific community, or the public, as shown through the voluntary initiatives 
described above. A concern raised in the Royal Society of Canada’s Expert Panel report on the 
Future of Food Biotechnology (2001) was the need for a regulatory balance between building a 
relationship with the biotechnology industry and having an open regulatory process.  
The Expert Panel had questioned senior managers from Canadian regulatory departments about 
their 
handling of the issues of transparency and confidentiality in dealing with applicants for 
licensing of new biotechnology. Their responses uniformly stressed the importance of 
maintaining a favourable climate for the biotechnology industry to develop new products 
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and submit them for approval on the Canadian market. If the regulatory agencies do not 
respect industry interests in protecting the confidentiality of product information as well 
as data obtained from extensive health and environmental testing, industry in turn will be 
deterred from engaging in the regulatory approval process. (The Royal Society of 
Canada, 2001, p. 213) 
 
The Expert Panel Report stated that several managers “referred to the importance of maintaining 
a relationship of trust between industry and the regulators”. The managers had argued “Only in 
an atmosphere of trust… can Government and industry work together in the cooperative way 
necessary to generate the product and test data required for the protection of public safety” (The 
Royal Society of Canada, 2001, p. 213). The Expert Panel reported that the concern with 
industry development was understandable but highlights an aspect of the regulatory conflict: 
The conflict of interest involved in both promoting and regulating an industry or 
technology… is also a factor in the issue of maintaining the transparency, and therefore 
the scientific integrity, of the regulatory process. (The Royal Society of Canada, 2001, p. 
213, 214) 
 
The report also noted that  
 
In effect, the public interest in a regulatory system that is “science based” - that meets 
scientific standards of objectivity, a major aspect of which is full openness to scientific 
peer review - is significantly compromised when that openness is negotiated away by 
regulators in exchange for cordial and supportive relationships with the industries being 
regulated. (The Royal Society of Canada, 2001, p. 214) 
 
The need to protect proprietary information makes it important that there is trust in the system 
and that information is being provided on regulatory processes including the assessment of risks. 
5.2.2. The Assessment of Science-Based Risks 
The processes through which Federal regulatory bodies approve a biotechnology-produced 
animal for human consumption assess science-based risks. Balancing the interests of applicants 
with the ability for interested parties to review the scientific data used in assessments as well as 
how the data is assessed are important when considering transparency and accountability in a 
science-based regulatory framework. Transparency regarding the assessment of risks during the 
approval processes for biotechnology-produced animals for human consumption is limited by: 
(1) the ability for interested parties to obtain information on how applications will be assessed 
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for risks through regulatory processes and; (2) the independence, objectiveness, and quality of 
the science used in the assessments.  
The Assessment Process 
The degree of transparency regarding the manufacture, importation and sale of a biotechnology-
produced animal for human consumption is limited by the ability of the Federal Government’s 
regulatory bodies as well as third parties to review how and what risks are being assessed. For a 
food product from a biotechnology-produced animal to be approved for human consumption, as 
shown in Table 5.1., pre-market notifications must be made according to NSNR (Organisms) 
under CEPA 1999 as well as the Novel Food Regulation in the Food and Drugs Act. How a 
biotechnology-produced fish would be assessed is being developed, as are Health Canada’s 
proposed Environmental Assessment Regulations (EARs). 
New Substance Notification Regulations (Organisms) 
As of December 2012 the Enviropig™ is the only biotechnology-produced animal that has 
received approval for manufacture, import and sale through the NSNR (Organisms) under the 
Canadian Environmental Protection Act, 1999 (CEPA) 1999.  The NSNR examine whether the 
product is toxic under the criteria set out in section 64 of CEPA 1999.
8
 The NSNR risk 
assessment evaluation does not “include an assessment of the potential human exposure and 
health risks associated with the use of the notified organism in products derived from it in or as 
an item that falls under the purview of the Food and Drugs Act ” (Environment Canada, 2012). 
For PNTs, as shown in Table 5.1., approval for manufacture, import, sale and human 
consumption is done concurrently. The Enviropig™ application for manufacture, sale and import 
was submitted in January of 2009 and received approval in November (Environment Canada, 
2012). An application for human consumption was submitted in April 2009 and as far as the 
research can tell, a decision has not been reached (Mann, 2011). 
Through the NSNR (Organisms) the manufacture and import of the product can happen 
without the examination of potential risks to the food supply. This is worrisome as there is 
                                                 
8
 “In accordance with section 64 of the Canadian Environmental Protection Act, 1999 (CEPA 1999) a 
substance is toxic if it is entering or may enter the environment in a quantity or concentration or under conditions 
that (a) have or may have an immediate or long-term effect on the environment or its biological diversity; (b) 
constitute or may constitute a danger to the environment on which life depends; or (c) constitute or may constitute a 
danger in Canada to human life or health” (Canadian Environmental Protection Act, 1999). 
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potential for GE animals approved for manufacture and import to be unintentionally introduced 
into the food supply. The risk assessment summary for the NSNR concerning the Enviropig™ 
stated “[I]t is conceivable that the escape of transgenic pigs in those regions where wild boar 
populations exist may result in the introduction of the transgene into the feral wild boar gene 
pool with unknown consequences” (Environment Canada, 2012). 
The risk assessment summary concerning the Enviropig™ recommended a significant 
new activity (SNAc) provision “based on the uncertainties regarding possible environmental 
impacts of the notified organism in activities outside the scope of this assessment” (Environment 
Canada, 2012). Significant New Activity Notices were not designed specifically for 
contamination from biotechnology-produced animals. Canada does not have a unique system of 
traceability for GE animals. 
Federal Guidelines for the Safety Assessment of Novel Foods  
As of October 2012 Health Canada has not released a decision on the University of Guelph’s 
application for the human consumption of a biotechnology-produced animal, the Enviropig™. 
This notification is the only one Health Canada has confirmed it has received. How Health 
Canada would conduct its safety assessment is unknown as safety assessment criteria are still 
under development (Health Canada. Food Directorate Health Products and Food Branch, 2006). 
The Government of Canada’s January 2002 Progress Report regarding the “Action Plan of the 
Government of Canada in response to the Royal Society of Canada Expert Panel Report” stated 
Health Canada was in the process of drafting Guidelines for the Safety Assessment of Livestock 
Animals and Fish Derived from Biotechnology (Government of Canada, 2002a, p. 13). The 
Government’s December 2002 Progress Report stated they were working on developing and 
publishing Volume III on the safety assessment of foods derived from animals (Government of 
Canada, 2002b, p. 18). Information concerning updates to the guidelines regarding 
biotechnology-produced animals has not been released since 2006. 
A Federal Government official who works in the area of food and health policy said that 
the science-based guidelines are currently being worked on and could not say when they would 
be finished (PS-2). The official stated that theoretically, if Health Canada was doing parts of an 
assessment before having guidelines finalized, the department would be doing it under Codex 
Alimentarius guidelines. The official also said that guidelines being developed would not be that 
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different from Codex Alimentarius and to remember that guidelines documents are also living 
documents (PS-2). Although they do not have the force of law guidance documents are important 
as they “set out how a department, regulatory authority or other body applies laws and 
regulations under their jurisdiction. They provide transparency in decision-making and fill in 
details sometimes missing from the strict nature of legal language in laws or regulations” (Health 
Canada, 2010b). 
It can be surmised that until the safety assessment criteria for the human consumption of 
biotechnology-produced animals are developed and information is released on them, guidance 
information will not be made available to the general public regarding how biotechnology-
produced animals will be assessed for human consumption. The assessment process to approve a 
biotechnology-produced fish for manufacture, sale or import or for human consumption is also 
unknown. 
The Lack of Environmental Assessment Regulations (EARs) 
As stated in previous chapters, Health Canada was also given authority to make Environmental 
Assessment Regulations (EARs) to replace the NSNR with respect to new substances in products 
under the Food and Drugs Act. Health Canada website, under “Processing a Novel Food 
Notification/Submission in the Food Directorate”, last updated in 2006, states that “In some 
cases, an environmental assessment of novel foods is conducted under proposed Environmental 
Assessment Regulations” (Health Canada, 2006f). As of October 2012 Health Canada’s website, 
last updated in February 2011, states that it was anticipated the proposed EARs would be pre-
published for comment in the Canada Gazette, Part 1 in 2011 (Health Canada, 2011c).  
Summary 
According to the Federal Government’s Progress Reports concerning the Action Plan of the 
Government of Canada in response to the Royal Society of Canada Expert Panel (2001) all of 
the regulatory processes described in the above section were supposed to be completed by now. 
The last progress report released in 2005 included a section on genetically modified animals and 
on tasks that had yet to be completed regarding the regulation of food products from these 
animals (Government of Canada, 2005b). It is not known why the Government stopped 
producing reports, especially given there was no indication in the 2005 report that it was going to 
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be the final report. While following up with progress reports is not mandatory, it was a voluntary 
method for regulatory departments to inform interested stakeholders on the progress of 
recommendations made by the Royal Society of Canada’s Expert Panel on the Future of Food 
Biotechnology. 
 As discovered in the literature review and verified through interviews, an assessment of 
the decision-making structure is hard to conduct due to the lack of information being released by 
the Federal Government and the ability for members of the public to find pertinent information 
on the topic. Information released by the Government regarding the application process and 
assessment of risks has been inaccurate or is not up to date. The last updates and consultations 
for both Health Canada’s Guidelines for the Safety Assessment of Novel Foods as well as the 
Environmental Assessment Regulations took place in 2006. How data packages will be assessed 
for biotechnology-produced animals under EARs and under the current guidelines is unknown. It 
is also unknown how the concepts like substantial equivalence and novelty would apply to GE-
animals. Whether NSNR (Organisms) would still apply to biotechnology-produced animals after 
EARs are created is also unknown, as is whether the EARs would fall under the Food and Drugs 
Act or the Canadian Environmental Protection Act.  
It should be noted that it is challenging to keep websites up-to-date. It is also difficult for 
interested parties to obtain information on regulatory processes when Government websites 
provide contradictory information. Health Canada’s voluntary Interim Policy on Cloned Animals 
(2001) (as discussed in chapter 3) also provides an example of the regulatory process not being 
suitable for food products from animal biotechnology. Moreover, technology is speeding ahead 
of regulations. Things have become less transparent simply because nothing is set up specifically 
for biotechnology-produced animals. The development of biotech food products are outpacing 
updates to regulations. 
Concerns about the Independence, Objectiveness, and Quality of the Science  
As stated in Chapter 3, the processes through which Federal regulatory bodies assess foods 
produced through modern biotechnology (GE foods) are limited to the assessment of science-
based risks. The Royal Society of Canada’s Expert Panel Report on the Future of Food 
Biotechnology (2001) noted that “the claim that the assessment of biotechnology risks is ‘science 
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based’ is only as valid as the independence, objectivity and quality of the science employed” 
(Royal Society of Canada, 2001, p. 212). The Expert Report also stated  
This issue was raised as a concern by many of the parties who made submissions to the 
Expert Panel. It is generally framed in terms of public trust in the objectivity and 
disinterestedness of the scientists who develop, test and regulate biotechnology products. 
But it also concerns the process by which the underlying science used to assess GM 
products is made transparent to independent validation. (Royal Society of Canada, 2001, 
p.211)  
Conflicting Regulatory Roles 
The Royal Society Report recommended that “All the regulatory departments involved in the 
regulation of food biotechnology should seek to separate institutionally as much as possible the 
role of promoter from the role of regulator” (Royal Society of Canada, 2001, p. 212). As 
discussed in Chapter 3 and 4, the CFIA’s role to regulate GE crops and GE feeds has been 
critiqued (NDP-J; Royal Society Report 2001). Environment Canada, not the CFIA was given 
authority over the pre-market notification for manufacture, import and sale of biotechnology-
produced animals. Environment Canada was given the authority to regulate the products under 
the NSNR because no regulations were in place for biotechnology-produced animals, not 
specifically to avoid the CFIA’s noted conflict of interest. The CFIA still hold responsibility over 
biotechnology-produced animals, for example through the Food Rulings Committee described in 
Chapter 2.  
An Unconstrained Regulatory System for Genetically Engineered Animals 
Efforts to liberalize the regulatory processes for GE foods can impede transparency and 
accountability. Former MP Wasylycia-Leis said that the current and previous Federal 
Governments had put the onus of scientific health studies onto the industry itself “even though 
they have a vested interest in one outcome” (NDP-J). A professor who is a specialist in the study 
of Canada's environmental risk assessment of GMO said that GE seeds were given “extra points” 
to give them a boost in getting certified when they first entered the market.  
When GE crops were first coming on line, before crops could be approved the seeds had 
to be certified. Because GE seeds were new on the scene they were scored differently. 
They were given extra points than the regular conventional seeds to give them a boost 
into the marketplace. There are all these ways GE foods get promoted that fall under the 
radar because no one knows or understands how these things work unless you are an 
insider. It just happened that a friend of ours was doing work on seed certification and 
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was talking to a farmer who mentioned something about GE seeds getting certified 
through the same process but starting out higher on the points system. (ACAD-1) 
 
Attempts have also been made to streamline the regulatory approach to animal biotechnology 
such as CFIA’s Animal Biotechnology Focus Group Meeting held in March of 2004. Members 
of academia Lucy Sharratt (also coordinator of CBAN) and Peter Andree wrote that 
Given that no regulatory approach exists yet, an emphasis on streamlining is entirely 
inappropriate. This demonstrates the willingness of biotechnology regulators in Canada 
to look for business-friendly approaches before fully addressing public concerns. (Andree 
& Sharratt, 2004, p. 21) 
 
A professor who is a specialist in the study of Canada's environmental risk assessment of GMO 
said “They are trying to make it as streamlined, as easy as possible, for these products to be 
released into the environment and into the marketplace. They figure the return on the investment 
is worth the risk to the public and to consumers” (ACAD-1). 
It is unknown whether the onus of scientific health studies is placed on the industry 
regarding approving biotechnology-produced animals for human consumption (like GE crops, as 
discussed in chapter 4.3.2.) or whether the animals would be promoted through Federal 
Government processes that fall ‘under the radar’ to ease their introduction onto the market.  
Lack of information about the Federal Government’s Assessment of Risks  
  The last available information (2006) noted that Health Canada was still developing safety 
assessment criteria with respect to the approval process of a biotechnology-produced animal for 
human consumption (Health Canada. Food Directorate Health Products and Food Branch, 2006). 
Through previous examples of Health Canada’s assessment process we do know that the use of 
substantial equivalence, especially as seen in the approval of Smartstax™ maize (see chapter 3) 
does not look for novel risks created by evolving biotechnology processes. A professor who is a 
specialist in the study of Canada's environmental risk assessment of GMO referred to Professor 
Ann Clark’s work on some of the studies Health Canada was supposedly doing on feeding 
studies on GE crops to see if they were toxic or having toxic effects on animals. The specialist 
stated that professor had written the concept of “don’t look don’t find” was being utilized by the 
government. She elaborated   
What they do is very conventional nutritional studies and they don’t look at specific 
things that are connected to the process which is the way you integrate new genes into a 
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genome and looking for possible mutations and possible long-term effects etc. You can 
safely assume that things are not dangerous but in fact we know that that’s not the case. 
(ACAD-1) 
 
She connected these findings to GE animals: 
If you compared two animals to each other they will look the same, they will have the 
same characteristics essentially it becomes difficult to figure out what is different about 
them. It’s impossible to prove what isn’t there – it’s impossible to start studying 
something when you don’t really know what you’re looking for. (ACAD-1) 
 
The way the Federal Government examines data and assesses risks that are in the notification 
processes is a matter of some concern; sample size and the life span of an animal make testing 
biotechnology-produced animals difficult when compared to a genetically engineered crop. A 
professor who is a specialist in the study of Canada's environmental risk assessment of GMO 
said that there were a variety of issues with biotechnology-produced animals that don’t apply for 
GE crops “you’re dealing with a different level of genetic modification with much more complex 
genomes, much more unpredictable consequences” (ACAD-1). An NGO representative who had 
attended the United States of America’s Food and Drug Administration hearings on the 
AquAdvantage® salmon stated “the most glaring and obvious problem with the data that 
AquaBounty has sent to the Food and Drug Administration was that they were able to submit six 
salmon, all the others had die. They admit it in their own evidence” (NGO-2). It is unknown 
what Canadian regulatory departments would consider a large enough sample size to assess 
biotechnology-produced animals for human consumption and the length of time needed to 
conduct an assessment. The French group of Gilles-Eric Seralini has shed light that the Health 
Canada’s current assessment process is too short of a time period to properly assess for harmful 
effects on the consumption of GE maize (Seralini, et al., 2012). The appropriateness of time 
periods for assessment processes for biotechnology-produced animals is unknown. 
This is worrying as AquaBounty Technologies Inc issued a statement accusing the US 
government of unjustifiable delays in licensing its AquAdvantage® salmon. A representative of 
the company stated the approval is being impeded by reasons other than the science-based 
evaluation of the application (AquaBounty Technologies Inc, 2012b). If AquaBounty has 
submitted or was going to submit an application for human consumption to Canadian regulatory 
authorities there is potential for the company to pressure Health Canada to reach a decision. Also 
Health Canada has not reached a decision on the Enviropig™ application, submitted in April of 
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2009. As a result, the University of Guelph could start pressuring for action and approval if it 
hasn’t already. 
5.2.3. Limitations surrounding the Assessment of Risks / Risks and Impacts not taken into 
account through the Regulatory Processes 
It would be unrealistic to think that every risk, impact and concern that has been raised in the 
literature and interview should be taken into account during the regulatory processes for 
biotechnology-produced animals described in Table 5.1. One health policy government 
representative stated the assessment processes should remain science-based so that politics are 
not involved in safety regulations (PS-2). The degree of transparency and accountability in the 
science-based regulatory system for biotechnology-produced animals is affected by (1) potential 
science-based risks not being examined (2) risks that go beyond the science-based risks being 
assessed are not taken into account through other Government platforms / avenues and; (3) an 
inability to trace products in the food system. 
Participants and literature raised concern that science-based risks arising from the 
consumption of GE products outside of toxicity and allergenicity are not known and are not 
being looked for. For example, processes specifically designed to identify and assess risks from 
the manufacture, import and sale of biotechnology-produced animals for human consumption do 
not exist. The Federal Government has not undertaken long term health studies regarding GE 
foods. The ability to do long-term human health or scientific studies have been impeded by the 
fact that GE foods are not labeled, making it hard to find a sample population.  
The regulatory framework to approve a food product that is or contains material derived 
from a biotechnology-produced animal limits the risk assessment to science-based risks and does 
not examine social or economic risks, including the level of consumer acceptance and impact to 
export markets. The CFIA website under “Regulating Agricultural Biotechnology in Canada: An 
Overview” states   
The Canadian Food Inspection Agency and Health Canada regulate for safety and 
efficacy of these products, but are not responsible for evaluating need. The issue of 
whether or not these products are ‘necessary’ is left to the market place to determine. 




A similar regulatory framework is used for biotechnology-produced animals. The assumption 
that risks will be looked at or taken into account elsewhere leads to the potential for risks to be 
overlooked or remain unconsidered. For example the ability to ‘let the market decide’ is limited 
if consumers cannot identify what food products contain genetically engineered materials.  
Concern has also been raised over the lack of Canadian regulatory and traceability 
processes for food products from biotechnology-produced animals that receive approval in the 
international community. For example, scientists at the Department of Fisheries and Oceans 
raised concern that if the United States approves the AquAdvantage® salmon Canada doesn’t 
have a system of traceability set up (JOUR). A spokesman from large Canadian food distributing 
company also raised concern that there is no traceability system in place to determine whether a 
meat product comes from a cloned animal (IND). Traceability measures for research animals 
have also failed, as seen through the unintentional introduction of the Enviropig™ onto the 
market in 2002 (discussed in Chapter 3).  
5.2.4. Constrained Ability of Interested Parties to Review the Regulatory Process 
Safety testing, science-based regulation, and the scientific process itself, depend crucially 
on widespread trust in a body of scientists devoted to the public interest and professional 
integrity. If instead, the starting point of a scientific product assessment is an approval 
process rigged in favour of the applicant, backed up by systematic suppression of 
independent scientists working in the public interest, then there can never be an honest, 
rational or scientific debate. (Bardocz et al., 2002) 
 
There is a limited ability or inability for interested parties to review, participate in and influence 
the regulatory process surrounding the assessment of biotechnology-produced animals for human 
consumption through (1) peer review, (2) review through voluntary initiatives, right to know 
legislation and the court system, (3) review through the House of Commons and parliamentary 
committees and; (4) review of the policy framework. Influence is limited as evidenced by the use 
of the CBAC and RSC the focus of reviews and the lack of public debate. 
Lack of a Peer-review Process to assess scientific data  
The lack of a peer-review process regarding how biotechnology-produced animals are assessed 
for human consumption was raised in interviews and in literature. The New Democratic Party of 
Canada’s Dissenting Opinion attached to the Standing Committee on Agricultural and Agri-
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Foods Report Growing Forward 2 (2012) states the need for the creation of an independent body 
to peer-review relevant scientific data (Standing Committee on Agriculture and Agri-Foods, 
2012, p. 80). Health Canada’s proposed to have an external expert sit on the Food Rulings 
Committee (Government of Canada, 2001, p. 5). The need for another expert panel like the 
Royal Society of Canada’s Expert Panel on the Future of Food Biotechnology was raised by a 
spokesman from a large Canadian food distributing company (IND). None of these initiatives 
have been implemented.  
The ability for independent review of the regulatory process is especially important due 
to concerns over conflicting roles of regulatory departments (The Royal Society of Canada, 
2001). The CFIA website states that, “it is common in the sciences for data to be reviewed by 
scientists other than those who produced the data. This is done so that quality standards are 
followed and to allow for shared judgments of difficult issues - this co-operative approach also 
serves the goal of the reproducibility of regulatory decisions (CFIA, 2012f). 
If scientists in Health Canada, Environment Canada, or the CFIA are producing their own 
data through the assessment of data submitted by applicants, this arms length approach is 
presumably in place to ensure reliable information. If the departments are not producing their 
own data, it means that regulatory processes only rely on data being submitted by applicants, 
which is worrisome (as discussed in chapter 4). It is unknown whether Health Canada would 
produce its own data concerning biotechnology-produced animals.  
Review through voluntary initiatives, right to know legislation and the court system 
Access to information is limited with respect to the regulatory processes through voluntary 
initiatives (as discussed in chapter 5.2.1), right to know legislation and through the courts. For 
example the Auditor General’s Office has voluntarily put on its website an online catalogue to 
review petitions, but the information that can be released is limited (as discussed in chapter 2). 
As well, Canadian citizens who submit petitions must have knowledge about what they are 
looking for, which is a constraining factor, particularly with respect to biotechnology-produced 
animals since very little information gets released (as discussed in chapter 2). Literature and 
interviews have also revealed shortcomings in public access to information through right to 
know legislation, and the court system (i.e., particularly with respect to receiving responses in a 
timely and cost-efficient manner). Effective transparency also goes beyond the disclosure of 
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documents through Freedom of Information legislation and the Access to Information Act, as 
discussed in Chapter 1. As a result of the voluntary nature of initiatives, and a reliance on right to 
know legislation and courts, it is very difficult to hold decision-makers accountable. 
Limited Review through the House of Commons and Parliamentary Committees  
As of October 2012, Private Members Bill and motions regarding GE foods have not passed in 
the House of Commons and the House of Commons had not completed a broad review of the 
assessment of food products derived from biotechnology. The Standing Committee on 
Agriculture &Agri-Food’s study on the status of the Canadian biotechnology sector (2010-2011) 
was stopped it could release a full report (as discussed in Chapter 3). The Standing Committee 
on Health’s study Labeling of genetically modified foods and its impact on farmers (2001-2003) 
was stopped before the Committee could finish conducting research. Both Committees formed 
after a Private Member’s Bill was brought into the House of Commons. The Standing Committee 
on Health “agreed not to pursue the subject further” after hearing an update on the development 
of a voluntary labeling standard (Health Canada, 2006a). The AAFC’s Committee was stopped 
due to an election, which a Conservative MP stated as being a rare situation (CMP).  
Committee reports are divided by the responsibility and focus of the committee. For 
example the Standing Committee on Agriculture and Agri-Food study did not examine health 
and safety issues (NDP-A). The responsibility of critics in the House of Commons is also 
divided. Former MP Wasylycia-Leis said “when one person isn’t responsible for all you can 
dilute it a bit sometimes, you leave things to the other critic” (NDP-J).  
Review of the Policy Framework  
The division of responsibility for regulating biotechnology-produced animals for human 
consumption has limited the ability for review of the entire regulatory structure as well as the 
policy framework. This is especially true as approvals and updates happen in a fragmented 
manner. Participants identified an issue as the lack of reviews, advisory bodies, public debate or 
consultations on the broader policy framework for GE foods. The overarching policy direction is 





Narrow Focus of Reviews  
Public consultations and advisory bodies involved in the regulation of biotechnology have been 
criticized for being narrow in focus and for being “window dressing” as decisions had already 
been made surrounding the topics being discussed. Mitchell, a former member of the CBAC as 
well as members of the Royal Society of Canada’s (RSC) Expert Panel on the Future of Food 
Biotechnology stated they could only discuss a narrow range of issues (NGO-C; Royal Society 
of Canada, 2001). Mitchell said that the policy framework had already been decided and the 
CBAC could only provide advice on a narrow range of risks (i.e. little discussion of ethics) 
(NGO-C). In their report the RSC Expert Panel stated that discussions still had to take place 
beyond the scope of their paper (The Royal Society of Canada, 2001, p. x). These are examples 
of the narrow focus of past reviews. The Federal Government has not commissioned an external 
body to do a broad overarching critique on the chosen regulatory framework for the consumption 
of GE foods or biotechnology-produced animals. Whether it will is unknown. 
Lack of Public Debate and Participation 
There is no public consultation or review process for a research facility to become a commercial 
facility, for approval for the human consumption or manufacture, import and sale of a 
biotechnology-produced animal (as discussed in Chapter 5.2.1). Without public dialogue 
stakeholders do not have an opportunity to influence the outcome of applications and hold 
decision-makers responsible. A professor who is a specialist in the study of Canada's 
environmental risk assessment of GMO, an NGO representative and Lucy Sharratt, CBAN’s 
coordinator all voiced frustration with attending consultations regarding biotechnology (as 
discussed in Chapter 4 (ACAD-1; NGO-3; NGO-1)). 
When regulations are updated the consultation processes can be limited in scope (as 
discussed in Chapter 2). CBAN’s coordinator said that limiting the consultation’s focus to 
science-based risks means limiting the expert participants invited to those who understood the 
science behind biotechnology (NGO-1). These experts bring a focused interpretation of problems 
from which to base their policy-making decisions, an approach that does not take into account 
the ethical, social or political implication of the policies being considered which would allow for 
the involvement of a broader range of participants in the policy-making process. This approach 
prevents alternate perspectives and ideas from influencing Federal Government policy-making.  
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There is no public participation or consultations during the regulatory processes for 
biotechnology-produced animals described in Table 5.1 and it is minimal in the development of 
the regulatory framework for biotechnology-produced animals. For example a Federal 
Government official who works in the area of food and health policy stated that since guidelines 
are not a part of regulations, the consultation process for guidelines would consist of “one-step 
consultations” (PS-2). As well, the ability of the public to review potential risks to the food 
system depend on the information released concerning what is going on in research facilities. 
The ability to critique the process has been constrained because advisory bodies have 
been shut down (Health Canada’s Public Advisory Committee (PAC), have been replaced 
(CBAC), or are for selected stakeholders (e.g., the pork value chain roundtable). Consultations 
are also either fragmented for specific updates to regulations, or focus on broader issues than 
biotechnology, like food safety (as discussed in Chapters 3 and 4).  
There has never been a debate in Canada over the future of biotech animals for human 
consumption. Bureaucrats have had meetings with members of civil society but are restricted in 
the information they release and how they can responded to concerns or suggestions that are 
raised (NGO-2; NGO-1).  
CFIA’s website, under “safety assessment process for Novel Foods and Agricultural 
Products of Biotechnology” under the heading “what about social aspects” states 
The1993 Federal Regulatory Framework for Biotechnology requires departments and 
agencies to consider "the prosperity and well being of Canadians" in the development of 
regulations, including provisions for public input into the development of these 
regulations. As a result, social and economic impacts are considered when decisions to 
establish regulations are made; this includes an analysis of immediate and long-term 
impacts. (CFIA, 2012f) 
 
It does not appear that this has happened. The issues of making policies for the human 
consumption of food produced through biotechnology also emerged as a technical problem rather 
than a social question (as discussed in chapter 3). The need for public debate and consultation is 
evident as social and economic impacts from food products derived from biotechnology can 






5.3. External Restrictions to Transparency 
Factors that influence the development of regulatory processes for biotechnology-produced 
animals include: (1) how biotechnology-produced animals are portrayed (not just how they are 
being regulated), (2) the ability to “let the market decide” and; (3) the lack of a unique policy 
framework and division of regulatory responsibility. These issues impact the transparency and 
accountability of regulatory processes.  
5.3.1. Private-Sector Framing of Regulation 
Companies, research institutes, and developers have control over the information that gets 
released regarding the biotechnology-produced animals that are developed in their research 
facilities, including any notifications and applications they have submitted to relevant Federal 
Government departments concerning those animals. A professor who is a specialist in the study 
of Canada's environmental risk assessment of GMO said that if the majority of the animals in a 
research facility were mutated no one would know; the research facilities are confidential and 
Federal Government scientists and independent scientists are constrained in their ability to 
conduct additional tests to verify claims (ACAD-1).  
Other than the mandatory labeling requirements that apply to all food products, the 
regulatory processes for the manufacture, sale, import and human consumption of 
biotechnology-produced animals do not assess the validity of claims made by the notifier 
regarding the benefits of their product(s) (Environment Canada, 2012). Furthermore the ability 
for the public or independent bodies to test these claims is limited due to laws surrounding 
proprietary information, the lack of Federal Government resources, and the fact that research 
facilities have been and continue to be directed by the biotechnology industry (i.e. through 
university partnerships) (Royal Society of Canada, 2001, p. 215; GP-1). 
Government support in the public discussion of biotechnology  
In both literature and interviews in this study, it was evident that the Federal Government has 
been promoting the use of biotechnology (as discussed in Chapters 3 and 4). Government 
websites and publications package biotechnology-produced animals as a continuation of 
traditional methods that have a long history of safe use (Government of Canada, 2008b). This 
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arguably does not accurately reflect the advances that have been made. Research participants and 
literature also raised issues with deciphering Federal Government bodies’ uses of the terms 
novel, genetically engineered, biotechnology, genetically modified organisms, and genetic 
modification (Royal Society of Canada, 2001; NGO-3; GP-1: OPP-1; CMP). 
BioPortal: A biased government website 
The Government of Canada’s website “BioPortal’ was critiqued in interviews for being one-
sided (NGO-C). The website refers to sustainable development as “the ability of producers and 
manufacturers to satisfy product needs of today while preserving the ability to meet those needs 
in the future” (Government of Canada, 2011b). This is an industry-friendly view of the term 
when compared to more common definitions such as the Bruntland Commission’s which defines 
sustainable development as development that “meets the needs of the present without 
compromising the ability of future generations to meet their own needs” (United Nations. World 
Commission on Environment and Development, 1987).The sustainable development section of 
BioPortal also goes on to state that “Biotechnology and biotechnology-derived applications 
provide industries with tools to enhance the sustainability of products, thereby facilitating the 
attainment of sustainable development goals” (Government of Canada, 2011b). 
Through the 1995 amendments to the Auditor General Act federal departments and 
agencies have to prepare sustainable development strategies and update them every three years. 
By creating a definition of sustainable development, departments can state a sustainable 
development strategy is encouraging the use of modern biotechnology in the food system. The 
BioPortal website also goes on to state 
Even though biotechnology-derived applications may reduce manufacturing costs and 
improve profitability, there are many companies that rely instead upon traditional 
production methods, be it because they are unaware of biotechnology's industrial 
applications, or because they remain cautious of biotechnology use in 
industry…Biotechnology-derived applications are generally more environmentally 
friendly than existing industrial methods. (Government of Canada, 2011b) 
 
The site fails to mention the role of organic farming methods in sustainable development. The 
website also states “the proper handling and labeling of genetically modified foods promotes 
social responsibility in producers and ensures that consumers can make informed decisions when 
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purchasing such produce” (Government of Canada, 2011b).Whether proper labeling is being 
used is hard to judge as there hasn’t been a review of the labeling standard. 
Lack of Political will 
Increases to transparency with regard to how much and in what manner the Government releases 
information are directed by the will of the governing political body as well as the ability and 
willingness of bureaucrats to identify where transparency is lacking and where it can be 
increased. As stated in Chapters 3 and 4 department and agency initiatives to increase 
transparency concerning GE foods have gone beyond their mandates to foster transparency and 
accountability.  
Narrow Focus Regarding Food Safety 
Participants also said that any Government efforts that are being directed towards increasing 
food safety and food safety measures do not extend to the process of genetic engineering. In 
other words, no specific food safety rules have been created that apply directly to GE foods. As 
resources are being devoted to food safety, the AAFC have held consultations to allow a percent, 
0.1% or higher, of food to be contaminated with genetically modified (GM) foods that have not 
been approved by Health Canada for safe human consumption (AAFC, n.d.. p. 3; discussed in 
3.4.3). Health Canada’s regulatory assessment is also not set up to look for risks that could be 
introduced through the process of genetic engineering, as shown in the approval for Smartstax 
corn (discussed in chapter 3). Appendix A also reveals occasions that when GE foods are 
brought up in the House of Commons or media, the CFIA releases information on the confidence 
of or improvements to food safety. For example, in 2011 the same month NDP MP’s Fin 
Donnelly’s motion was tabled the CFIA announced they would strengthen food safety and 
transparency through a different method. 
5.3.2. A Limited Ability to “Let the Market Decide” 
The ability to “let the market decide” is based on explaining risks to consumers and having 
avenues for them to make decisions regarding whether they want to consume the products. How 
GE foods are framed, the lack of a public debate, the lack of a review of the effectiveness of the 
voluntary labeling standard, and the narrow scope of risks and impacts taken into consideration 
120 
 
before or after the food product is approved for human consumption impede the ability to “let the 
market decide”. One government representative said that food products should be assessed for 
safety risks, and that broader issues should be taken into account through other means (PS-2). 
Gauging consumers’ preference is limited if there is a lack of public information, review or 
debate and the only risks that are being identified by the Federal Government are science-based.  
Currently, the only way to avoid GE food products is through buying organic foods. The 
ability to buy organic food as an avenue to avoid GE foods is affected by the potential of low 
level presence (LLP) of GE material (discussed in chapter 4.2.1.) and the potential for 
unintentional contamination. Organic foods can also be more expensive, which can affect the 
ability of consumers to choose whether they want to consume GE foods. 
5.3.3. Lack of a Unique Regulatory Framework for Foods Derived Through Biotechnology 
Public discussions are not being held about the creation of a unique regulatory framework for 
food products of biotechnology that take into account unconsidered risks in the current 
regulatory framework.  
In the absence of a unique regulatory framework, transparency and accountability have 
become fragmented throughout the Federal Government departments and agencies and their 
various responsibilities and separate assessment processes. Furthermore, the current policy 
framework is not being reviewed for the ability to assess biotechnology-produced animals for 
human consumption. The division of responsibilities among Government departments and 
agencies also allows for conflicts of interest to exist in a way that is not obvious (i.e., the CFIA’s 
role as both promoter and regulator). 
5.4. Conclusion 
Limitations to transparency exist within and outside of the Federal Canada’s regulatory processes 
to manufacture, import and sell a biotechnology-produced animal for human consumption.  
These stem from the confidential nature of the regulatory processes, how and what risks are 
assessed during the assessment processes and the independence, objectiveness and quality of the 
science used in the assessment process, how the private sector frames the issue of GE food 
regulations, a limited ability to “let the market decide” and the lack of a unique regulatory 
framework designed for food derived through biotechnology resulting in a division of regulatory 
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responsibilities that lead to fragmented increases to transparency. The next chapter provides 
examples of existing and potential opportunities to increase transparency identified in interviews 






Chapter 6: Opportunities for fostering Transparency  
There is no better area to study in terms of lack of government transparency and 
accountability than these foods. (NDP-J) 
6.1. Introduction 
Despite the identified challenges, transparency could be fostered in Federal policies and 
regulations with respect to the human consumption of biotechnology-produced animals. Chapter 
two reviewed a number of mechanisms that could be used to increase transparency in the Federal 
Government if there was political will to do so. These approaches could be carried out through 
Federal Government institutions, non-government organizations (NGOs), private sector bodies, 
members of academia and the media. This chapter discusses additional avenues within and 
outside of government that could be used for fostering transparency based on primary interviews 
supplemented by the additional research of relevant literature.  
6.2. Opportunities for Civil Servants and Elected Officials to Foster Transparency 
Elected Federal Government representatives and public servants could use a number of avenues 
to enhance transparency including the release of Federal Government communiqués, information 
bulletins and reports. The public could be engaged through public consultations approaches or 
the establishment of expert panels. Members of parliament could use the House of Commons as 
a vehicle for increasing transparency, civil servants could take various initiatives and the ruling 
Federal Government itself could take a more active role in assessing and analysis the 
effectiveness of current regulations. All of this of course would require political will. 
Federal Government Information Releases 
Federal Government experts who are actively working on the biotechnology file could provide 
public reports about the state of affairs and challenges they are facing in a manner where 
trademarks and confidential information are not compromised (JOUR).  
The Federal Government could also issue a new Progress Report concerning its Action 
Plan of the Government of Canada in response to the Royal Society of Canada’s Expert Panel 
Report Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in 
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Canada (2001). The last progress report was published in 2005 and had action items and time 
lines concerning the creation of regulations for biotechnology-produced animals that, as of 
December 2012, still have not been reviewed. 
Suggested avenues that would increase transparency regarding the regulation of 
biotechnology-produced animals in the Royal Society’s Expert Panel Report on the Future of 
Food Biotechnology could be implemented (Standing Committee on Agriculture and Agri-
Foods, 2012, p. 80).  
Moreover, Federal Government department and agencies could review the information 
that it releases to the public outside of Access to Information (ATI) requests surrounding the 
regulatory processes to approve biotechnology-produced animals for human consumption. This 
includes information on the regulatory processes as well as individual applications. A professor 
who is a specialist in the study of Canada's environmental risk assessment of GMO said that a 
great deal of information concerning decision-making can be released on the assessment of an 
application without giving away confidential information (ACAD-1). The Federal Government 
could provide this information if it wished to do so.  
The Federal Government could also provide information to interested parties about all 
applications going through a pre-market notification process concerning a biotechnology-
produced animal including those applications that were retracted or not approved. This would 
improve public understanding of the regulatory processes and would increase transparency and 
accountability in the regulatory process by permitting comparison of a negative decision to a 
positive one. 
Federal Government releases could also include information that traced the production of 
biotechnology-produced animals that goes “right through the food system so the public is aware 
of what they’re eating” (GP-1). Such a system could reduce the potential of allowing unapproved 
food items to enter the market. Through a system of traceability a system could also be 
developed to compensate farmers in the event that livestock became contaminated with 
biotechnology-produced animals (NDP-A). A system of traceability could even extend to the 
creation of a mandatory labeling standard specific to food products that contain biotechnology-
produced animals. It should be noted that a process based labeling standard does exist in Canada 
for food products that have gone through irradiation. 
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Involvement of Non-state Actors in Consultation Processes and Third-Party Verification 
The Federal Government could also hold forums on the future of food biotechnology in Canada 
that could clarify the Federal Government’s agenda. There is a need for the Federal Government 
to consult with Canadians on its agenda and whether Canadians want to be part of unleashing the 
technology in the world (OPP-1). Providing the rationale for updating regulations to interested 
parties ‘at the ground level’ could address concerns that the function of updates is to allow the 
biotechnology industry to short cut the regulations (as seen with GE seed certifications, 
discussed in Chapter 5.2.2). 
A Federal Government official who works in the area of food and health policy stated 
that the changing lay of the land regarding interest groups would make it hard for the 
Government to keep up with demand with regard to risk communication, especially as GE foods 
are being assessed on a case-by-case basis (PS-2). A food policy consultant said that the risk 
communication side often receives more attention by the Federal Government than consideration 
of the kinds of risks that might be deemed legitimate, and what mechanisms could be used to 
assess them (ACAD-2).The consultant maintained that the Canadian regulatory system asks a 
very limited set of questions regarding what kinds of risks are legitimate and what mechanisms 
are used to assess risk (ACAD-2). Consultations regarding biotechnology-produced animals 
could take place concerning both risk assessment and those risks that are taken into account in 
the regulatory processes. The consultant also suggested that the Federal Government could 
undertake a regulatory reconfiguration or regulatory pluralism approach “where the Government 
actively facilitates the interaction of non-state actors involved in designing and executing 
programs and policies” (ACAD-2).
9
 
Public advisory or expert panels could be set up to review the current policy framework 
for the adequacy of its ability to assess new biotechnology products. It could also be critiqued to 
assess for past success in regulating biotechnology food products, including GE flax and cloned 
meat. The Federal Government could consult with interested stakeholders regarding current 
transparency initiatives with respect to regulatory processes, including the notice of submission 
project, decision documents, and the voluntary labeling standard. The Federal Government could 
also assess how unique regulations and policies for GE foods could be developed. 
                                                 
9
This topic is discussed in the 2012 book Rod MacRae co-edited with Elisabeth Abergel entitled Food 
System: Advocacy and Opportunity for Civil Society. 
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The current framework could be critiqued through an Advisory Committee with a broader 
membership and mandate than that of the Canadian Biotechnology Advisory Committee 
(CBAC) which would allow it to explore ethical and social issues surrounding biotechnology-
produced animals for human consumption.  
The Federal Government could also commission another Expert Panel with a focus on 
biotechnology-produced animals. The resulting report could be compared to the Royal Society of 
Canada’s Expert Panel Report on the Future of Food Biotechnology (2001). In addition, the 
Federal Government could also invest in independent scientific research and set up a system of 
third-party verification. 
The CFIA’s website states “Confidential business information is considered valuable to 
the companies that provide it for assessments, and the Government is required by law to assure 
that such information is not given to unauthorized recipients” (CFIA, 2012g). Companies and 
regulators, however, could agree on a third party, external and independent to the Federal 
Government and industry, to conduct an independent scientific review of the data submitted to 
Health Canada or Environment Canada concerning biotechnology-produced animals. 
Confidentiality agreements could be used to make this happen.  
An independent review could examine company claims about their products. A Green 
Party member said “If these products are really as good as the companies say they need to prove 
that to the public. If a company is going to make a claim that they are producing a drought 
tolerant crop, well let’s do some real science about this before they can make that claim” (GP-1). 
Potential Role of Ministers and Members of Parliament 
Former leader of the Green Party of PEI Labchuk saw the potential from increased awareness of 
widespread public interest in the issue among candidates and sitting Federal and provincial 
politicians who could make it an election issue (GPPEI). They could campaign to increase 
transparency and accountability in regulations and policies for the human consumption of 
biotechnology-produced animals through private member bills, question periods, motions, and 





Public Servants as Communication Providers 
Public servants could “push from the bottom up”. Public Servants interviewed by the researcher 
provided examples of where they had fostered transparency regarding GE animals and 
biotechnology, including posting a risk assessment summary for the Enviropig online (as 
discussed in chapter 4.2.1). Committees and departments have also taken the initiative to hold 
meetings to inform people about what is going on and to explain legislation (OPP-2; PS-1). 
6.3. Opportunities for Interested Stakeholders outside of Federal Government to engage in 
and/or assess Policy and Decision-Making Processes 
It’s up to citizens if this is going to be stopped, there has to be a groundswell against it 
(NGO-2) 
 
 In this thesis, primary and secondary research uncovered many possible opportunities for 
interested stakeholders outside of Federal Government to engage in and/or assess policy and 
decision-making processes in order to foster transparency and accountability in Federal policies 
and regulations with respect to the human consumption of biotechnology-produced animals. A 
number of activist strategies were suggested including making the question of biotechnology-
produced food one that mattered in an election, to pressure politics. 
An NGO representative said that food must become an election issue and be part of the 
candidates’ platforms. The representative said all members of Parliament should have an 
understanding and a position on food:  
We need to make them accountable we need to make it an election issue. We need them 
to be scared that this is one of the things that is going to cost them the next election. That 
can only happen if we have a groundswell of people out there who are pushing back and 
saying no. It’s not just about the actual issue about GE wheat or GE pigs. It’s also about 
transparency. (NGO-3) 
 
Interested parties could also pay closer attention to what is going on in the House of Commons 
and publicly support Private Member’s Bills and Motions that promote transparency and 
accountability regarding policies and regulations for biotechnology-produced animals.  
An MP from the opposition said that consumers need to demand the transparency they 
feel is necessary (OPP-2). A Liberal MP said that unless the court or the court of public opinion 
(media and what people are saying on the street) demands it the Federal Government will not be 
forthcoming. The MP said that when Canadians demand answers “the Government feels the 
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pressure coming from the public, but if the public doesn’t do that then the Government goes, 
maybe we can sweep it under the carpet” (LMP-2). A participant said “It’s as much your 
responsibility as it is mine. It is each of our responsibilities in whatever capacity that we are 
operating in at the time to get the word out and inform people” (OPP-2). A professor who is a 
specialist in the study of Canada's environmental risk assessment of GMO described pushing for 
labeling as the “tip of the iceberg” but a way to get people to rally around the issue (ACAD-1).  
Public pressure could enhance the potential for interested parties to have an impact and a 
greater role in policy. CBAN’s coordinator believes that there is a role for CBAN to play in 
policy, not because Federal Government is open to it, but because it is necessary and that public 
pressure could support that role (NGO-1). Public pressure that is focused on challenging the core 
of the system and expanding the perimeter of the scope of the policy could increase transparency 
and accountability in decision-making for biotechnology-produced animals.  
One food policy consultant suggested regulatory changes might happen through applying 
constant pressure on the civil service to reveal that “the system and the people in it are 
incompetent and a political liability” (ACAD-2).The consultant suggested instead of going after 
the politicians, you go after the civil servants in a way that makes the politicians uncomfortable 
because they feel they have an incompetent civil service structure underneath them (ACAD-2). 
Interested stakeholders could also lend support to public servants who find themselves in the role 
of “whistle blowers” when it comes to this topic area.  
A former executive director of the Canadian Institute for Environmental Law and Policy 
(CIELAP) argues that citizens should write to MPs, or to newspapers, and to educate the public. 
The former director also said that CIELAP had been successful in producing a citizens’ guide to 
biotechnology and distributing it into schools (NGO-C). An MP said that if you want the 
Canadian public to understand what is going on you have to start writing letters to the editor 
about political matters. The MP thinks 10% of what he writes gets published (OPP-2).  
The issue of biotechnology-produced animals provides a powerful draw for a variety of 
interested stakeholders who could join forces and share resources to push for increased 
transparency and accountability in regulations and policies. Campaigns could include farmers, 
academics, NGOs, food groups, school groups, hunger organizations, consumer groups, MPs, 
and industry representatives. A professor who is a specialist in the study of Canada's 
environmental risk assessment of GMO said that it’s really important to have your ear in the 
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farming community especially in those communities where these crops or animals are being 
developed (ACAD-1). An NGO representative said that the NFU sits on the CBAN steering 
committee and that NGOs have greater clout when they echo each other. She said “we’re also 
members of Food Secure Canada and Food Secure Canada also mirrors our position.” She said 
that it’s necessary to work with a national food organization such as Food Secure Canada, so that 
it’s more than just the farmers’ saying no “through pushing back at that level it’s going to 
become an election issue” (NGO-3). A food policy consultant provided an example of a 
successful public campaign with multiple stakeholders groups that had stopped Bovine Growth 
Hormone from being approved in Canada (ACAD-2). 
Interested parties could also reach out to researchers and advocates internationally. An 
NGO representative connected with researchers and advocates in the United States and joined 
them on a four-day speaking tour through the Maritimes that discussed biotechnology-produced 
fish that he described as successful (NGO-2).  
  Members of the interested public could also reach out to industry groups and businesses 
that are involved with biotechnology-produced animals. An NGO representative notes that they 
had met with Ontario Pork and posed the question “why do this?” (NGO-3)  A food policy 
consultant said  
Sometimes we tend to think the business side is a bit monolithic on the stuff, that they are 
lined up with the state on how things should unfold but in fact in the agricultural system 
there are many different actors. The system is so complex you get all kinds of different 
opinions depending on who you’re talking to. (ACAD-2) 
 
Grassroots campaigns are also effective in raising awareness about the need for increased 
transparency and accountability in regulations and policies for biotechnology-produced animals. 
Interested parties could start a grassroots campaign to talk about the issues related to 
biotechnology-produced animals, including those that are and those that are not being assessed 
through Federal Government regulations and policies. An NGO representative said that a 
grassroots approach is needed 
We can hold [the Federal Government] accountable using facts and figures and hard data 
but they’ll choose to ignore it and that’s the frustrating part. We need to change our 
strategy to grassroots organizations... it used to be that we go straight to the top and lobby 




A professor who is a specialist in the study of Canada's environmental risk assessment of GMO 
noted that there are additional issues such as ethical, animal welfare, and animal rights issues in 
terms of GE animals that are slightly different from issues concerned with GE crops. She said “a 
different kind of ethical issues related to animal engineering affect people in a different way” 
(ACAD-1). She recognized that the public could rally around the issues but pointed out that the 
problem with that is the public doesn’t know the issues (ACAD-1). An NGO representative also 
said we’re the ones who need to unpack it and let people know what’s going on (NGO-3).
 
Interested parties could also work to create an alternative regulatory system and national 
food policy (as is done through People’s Food Policy and the Conference Board of Canada). A 
food policy consultant said that the creation of a national food policy “is not going to come from 
inside the Government, it will come from the outside. We are going to have to work out all the 
details” (ACAD-2) and he said that there are “way more details than we’ve done right now 
which is the weakness of social movements. We do not have the capacity or the willingness to do 
the real tough slogging work which is to go deep into the system and to propose concurrently all 
the things that need to be changed” (ACAD-2). 
Opportunities for Industry Transparency and Corporate Citizenship 
The researchers and producers of biotechnology-produced animals could find it in their own 
enlightened self-interest to provide more information concerning their product(s) than the 
information provided by the Federal Government. A public dialogue can be created through a 
trusted independent third party discussing the benefits and risks of these products.  
Opportunities at the Municipal Level 
Decisions regarding GMOs can also be made at the municipal level. On May 29
th
 2012, the 
Council of Richmond City, British Columbia unanimously confirmed a decision to make the city 
a GE Free Zone. The city also agreed to send letters to all levels of government “requesting 
strengthened management of genetically modified plants, and including the introduction of 
mandatory labeling requirements, more transparent assessment procedures and enhanced 
communication with the public” (CBAN, 2012c). Other GE free zones in British Columbia 
include Powell River, Kaslo, Nelson, New Denver, and Rossland. 
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6.4.  Additional Possible Approaches 
Participants described many avenues to obtain information both within and outside of the Federal 
Government that could be used to shed light on Federal decision-making processes. Some of 
these have been described in previous chapters. Five that stood out were: looking at information 
that is fed into the decision-making; examining administrative structures; following funding; 
paying attention to what is going on in the international community; and obtaining information 
that is being released by Civil Servants. 
Research the Information that Influences Decision-Making Regarding Animals Derived 
through Modern Biotechnology (Channels that flow into Cabinet) 
A Liberal MP suggested looking into what information was fed into the decision-making process 
instead of just looking at the final decision. The MP said that the process around decision-
making is very broad as it is usually done around the Cabinet table. The MP said that opening 
access to some of the channels that flow into the decision-making process, like departmental 
analysis and advice prior to decision-making, would allow better insight into why the decision 
was made. As the MP stated it provides insight into whether the department or the ministers 
listened to the advice of the Civil Servants and whether the advice of the Civil Servants is totally 
off the mark (LMP-2). 
Examine Administrative Structures 
The Federal Government Employee Directory found on the Federal Government of Canada 
website could be used as a source to see how departments are split and to determine the 
hierarchy of departments (NGO-1). Knowledge of how resources are allocated in Federal 
Government institutions and departments could also provide some insight into the ability of 
decision makers to complete their tasks. 
Follow Funding 
Another suggestion was that it was possible to “follow the money” from the sources to the 
recipients to find out what is being funded and what work on biotechnology-produced animals is 
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being done by whom. A professor who is a specialist in the study of Canada's environmental risk 
assessment of GMO said that although access to information is more difficult in the corporate 
world, sometimes company websites include information on current research. The scientist said 
that even though detailed information may not be available “it’s one little hint as to where you 
need to be digging.” She also suggested university collaborations as a potential source of 
information for what is being funded and what may be coming down the pipe line (ACAD-1). 
It’s just as important to look at funding cuts as a potential source for information on the direction 
Federal Government is taking regarding policy making. A Liberal MP said that the last budget 
included an intentional defunding of alternative voices, including those of the environmental 
movement (LMP-1). 
Participate / Pay Attention to decisions being made in the International Community 
Paying attention to what is going on in the international community can shed light on what 
applications will be submitted to Health Canada and Environment Canada concerning 
biotechnology-produced animals. An NGO representative who  attended the United States of 
America’s Food and Drug Administration hearings on the AquAdvantage™ salmon (as 
discussed in chapter 5.2.2) (NGO-2) learned that the AquAdvantage® salmon application was 
based on growing the fish eggs in Canada in a commercial facility for which the company, 
AquaBounty Technologies, had not received approval. Monitoring the direction Canada’s trading 
partners are taking and actions the Federal Government is taking in the international community 
with respect to biotechnology-produced animals can also lead to valuable insights into issues of 
accountability concerning Federal Government policies. 
Obtain information that is being released by Civil Servants 
Despite the paucity of information on many issues, there are Federal Government outlets for 
information on GE Animals that could be accessed by the public such as the posting of 
summaries of risk assessments on Environment Canada’s website or on Novel Food on Health 
Canada’s website. An Environment Canada employee stated that although it could be a bit dry, 
all the information was laid out in legislation and in regulations and Environment Canada would 
make attempts to try and explain it to any interested parties (PS-1).An NDP MP said that 
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committees do good work but that the Canadian public has little idea about the number of studies 
and amount of information within these studies. He said that that reports are accessible but 
acknowledged that they can be challenging to go through (OPP-1). 
6.5. Why the Federal lack of Transparency around GMO Food Regulations? 
This research project has shown that there is a lack of transparency around GMO food 
regulations, something for which the current Government has been critiqued on multiple 
occasions (Berthiaume, 2012; Smith, 2012; LMP-1; NGO-3; NGO-C: ACAD-1). This thesis has 
also noted a lack of transparency behind GE food regulations and policies under previous 
governments. The political will to increase transparency regarding GMO regulations has not 
been present under previous governments and it does not appear that the current government has 
the political will to review issues of transparency that have arisen concerning GE foods, or to 
increase transparency (Wasylycia-Leis, 2001; Royal Society of Canada, 2001; Andree, 2006 p. 1; 
Andree & Sharratt 2004, p. 20; Schmidt, 2011c; NDP-J; NDP-A; GPPEI; NGO-1; NGO-3; 
NGO-C; ACAD-1; ACAD-2; JOUR). It is troublesome, but not surprising, that this trend for 
GMO food regulations continues under the current government.  
Federal policies and regulations are based on the premise that GMOs are as safe as their 
natural counterparts. For example Health Canada uses the concept of substantial equivalence as a 
guide in the safety assessment of novel foods (Health Canada, 2006d). Federal policies and 
regulations view the process of using modern biotechnology techniques as not introducing new 
health and safety risks to the food system (Health Canada, 2006d; CBAN, 2012a). GMO food 
regulations also only assess science-based risks. Based on these assumptions there is no reason 
for the Government to hold consultations or discussions for GMO food regulations regarding 
risks that are not science-based, or as new biotechnology-produced food products, like 
biotechnology-produced animals, are being assessed for entry into the Canadian food system. 
Health Canada’s website does states that studies to address long term health effects may be a 
valid approach “should developments in the technology result in modifications that provide 
significantly different nutrient combinations or other novel food characteristics not previously 
encountered in the food supply” (Health Canada, 2006d). The regulatory process is designed to 
address new risks, when appropriate, that arise from the use of biotechnology.  
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Roles and responsibilities for GMO regulations are also spread across Federal 
Departments and Agencies. Transparency issues can arise from the ability of the public to stay 
informed on the roles of each department and agency and when regulations are being updated.  
It also may be challenging for the Federal Government to provide information to and hold 
discussions with a participatory public on a complex subject like GMO regulations. This is 
especially true as the focus of GMO regulations are limited to assessing science-based risks and 
do not take into consideration socio-economic, economic or ecological risks (ACAD-2; GEPEI). 
Those that can provide advice or join in consultations surrounding GMO regulations are limited 
to experts that understand the science behind biotechnology (NGO-1).The lack of transparency 
around risks that are not science-based exists in GMO regulations as the responsibility to assess 
these risks remain outside of GMO regulations. 
A lack of information being released by the Government to a participatory public can 
lead to the creation of what members of the public consider ineffective policies. This is 
especially true in the case of GE foods as the policy framework has been critiqued for having 
been designed without a public debate (ACAC-2). As regulations and guidelines are 
continuously being updated and created it also might be challenging for regulatory bodies to 
keep the public informed. An example of this would be keeping websites and links to documents 
up-to-date. 
The government also cannot release confidential business information submitting during 
the assessment process to approve biotechnology-produced animals for human consumption or 
environmental release (CFIA, 2012g; Royal Society of Canada, 2001 p. 213; Government of 
Canada, 2010 p. 90: Patterson, 2010; IND; NGO-1;; NGO-1; JOUR). The release of confidential 
patented company information could also negatively affect competitiveness. The Government 
also has an interest in accommodating business interests in a sector that is extremely capital 
intensive concerning product development (Royal Society of Canada, 2001; IND).  
For this research project, the researcher also faced difficulties in presenting the Federal 
Government’s side of the argument due to the very lack of transparency that appears to have 
prevailed throughout the current government’s mandate. This made it difficult to get in contact 
with people who were willing to speak about the issue, would agree to be interviewed and 




Mechanisms are available for overcoming limitations to transparency laid out in the previous 
chapters surrounding the human consumption of biotechnology-produced animals. Some of the 
opportunities raised by participants also have the potential to foster food democracy. The Federal 
Government can still maintain confidentiality of businesses’ proprietary information while 
opening up a dialogue with interested parties. Avenues for change for civil servants and elected 
officials exist through the Federal Government’s release of information; the involvement of non-
state actors through consultation processes and third-party verification; through ministers and 
members of parliament and through public servants being communication providers. Interested 
stakeholders outside of the Federal Government can lobby by making it an election issue, 
participating in grassroots campaigns, and for industry to foster transparency and corporate 
citizenship. Avenues also exist for citizens to act proactively through researching information 
that influences decision-making, examining administrative structures, following funding, paying 
attention to the international community, and through obtaining information that is being 
released by civil servants.  
This might have to be the case if change is to happen in the immediate future for as 
discussed in Chapter 4, there is little indication that the government is motivated to foster 
transparency. At the time of writing, the current government has indicated that it is moving in the 
opposite direction. A Liberal MP believes that the current government (as of 2012) is possibly 
the least transparent government in the history of Canada (LMP-1). The MP said that 
information is power and in regards to the Conservatives, “are all about power and will only 
share information after virtually putting a proverbial parliamentary gun to their head” (LMP-1). 
An NGO representative stated “we need bad press for the government, to unpack the stuff and 
give them bad press because they’re just doing all these things behind closed doors” (NGO-3). 
Former CBAC and CIELAP member Mitchell stated “We’re in a stage with our Government that 
it doesn’t matter what you say to whom, they’re blinkered. They’re going where they’re going 
and how we change them apart from getting rid of them, I don’t know” (NGO-C). A professor 
who is a specialist in the study of Canada's environmental risk assessment of GMO stated 
“They’ve really tightened the screw on information – it’s not a good day for democracy. 
Transparency is definitely not at its highest at the moment – not that it’s ever been very good but 





Chapter 7 Summary, Conclusions and Recommendations 
7.1. Summary 
This research paper examines the transparency of the Federal Government’s decision-making 
processes and institutions with respect to the human consumption of biotechnology-produced 
animals. It identifies current issues in order to assess and analyze the transparency of the Federal 
Government’s decision-making processes and institutions as well as challenges and opportunities 
for increasing transparency before regulations are finalized. It provides a timely study for, at time 
of writing, the Federal Government is currently deciding whether and how biotechnology-
produced animals are to be approved for human consumption. At this time, the Federal 
Government was also assessing a notification to approve a biotechnology-produced animal, the 
Enviropig™ for human consumption. Government decisions regarding the human consumption 
of biotechnology-produced animals in the following years have the potential to revolutionize 
food systems on the national and international level. 
A historical analysis reveals an enduring lack of transparency and accountability 
regarding the Federal Government’s decision-making processes and institutions for foods 
derived through modern biotechnology which has continued to the present day throughout both 
Conservative and Liberal governing mandates. These limitations are still present for the 
regulation of biotechnology-produced animals. Current issues with biotechnology-produced 
animals outline the decreasing transparency and accountability of the Federal Government with 
regards to GMO regulations. This research project concludes that there is little indication that the 
Federal Government is motivated to foster transparency. 
7.2. Discoveries 
Seven themes concerning the transparency and accountability of federal decision-making 
processes and institutions with respect to biotechnology-produced animals were identified 
through interviews with key stakeholders. A majority of participants discussed the lack of 
publically-available information. Most participants pointed out inadequacies in the current policy 
and regulatory framework and suggested that there is a lack of political will to ensure 
transparency. Just over half of interviewees hypothesized that this could be due to the Federal 
Government’s biased agenda towards biotechnology and that transparency appeared to be a 
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growing problem due to declining avenues for public participation and reduced consultative 
initiatives. A few stated that transparency appeared to be a growing problem due to a 
disempowered Parliament and a decline in public servant interactions and communications flow. 
Through an interpretive qualitative analysis of primary and secondary data these themes 
were compared with limitations to transparency found in the literature. The research project 
identified limitations that stem from the confidential nature of the regulatory processes, how and 
what risks are assessed during the assessment processes and the independence, objectiveness and 
quality of the science used in the assessment processes. Limitations also stem from the private-
sector framing of regulations, the ability to “let the market decide” and the lack of a unique 
policy framework and division of regulatory responsibility. 
The research project identified existing and potential opportunities to increase 
transparency. The Federal Government can maintain private sector competitive interests while 
still opening up a dialogue with interested parties. This can be fostered through the 
Government’s release of information, the involvement of non-state actors in consultative 
processes and the use of a third party, like the Royal Society of Canada, to verify Government 
data and to review the policy direction for GMO food regulations. Ministers and Members of 
Parliament could also campaign to increase transparency and accountability in regulations and 
policies. Public servants could also re-examine their role as communication providers.  
Opportunities for increasing transparency regarding the research topic also exist for 
interested stakeholders outside of the Federal Government. These stakeholders could focus on 
making the subject an election issue and through participating in grassroots campaigns at all 
levels including the municipal level and the international community. Stakeholders who are 
researching and producing biotechnology-produced animals also have the opportunity to foster 
transparency and corporate citizenship, especially though opening a public dialogue through a 
trusted third party to discuss the benefits and risks of consuming biotechnology-produced 
animals. They can also research the information that influences government decision-making; 
administrative structures; funding; information released by civil servants, the media and 
members of academia; and pay close attention to what the Canadian Government is doing in the 
International community. Such knowledge is a crucial first step to the identification of the 
important pressure points for change. 
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The researcher found that attempts by the Federal Government to increase transparency 
through the use of Acts and food safety initiatives have little impact on a policy process that is 
based on confidentiality. Food safety initiatives have not been extended to examine any new 
risks to consuming food products that can be introduced by the process of using modern 
biotechnology to create biotechnology-produced animals. Federal attempts such as Acts to foster 
sustainable development in departments are limited by the definition of sustainable development 
used by individual departments. 
There is a lack of citizen engagement and consultation in the creation of the regulatory 
process for biotechnology-produced animals. Working groups and advisory bodies exist 
concerning food safety but the transparency and accountability of the research topic is more than 
an issue of the Federal Government setting up advisory bodies to obtain advice from select 
stakeholders. The majority of the population, even with these bodies, still does not have access to 
information regarding the decision-making process and what is going on and are not being 
consulted.  
7.3. Recommendations 
Without a solid understanding of public perception and acceptance of these animals into 
the food system, it is difficult to tell how much transparency is needed or wanted in the 
regulatory process. Polls and surveys have identified that there is low public acceptance in both 
Canada’s regulatory process for biotechnology-produced animals as well as the introduction of 
biotechnology-produced animals into the food system. The researcher found that there is no 
indication public confidence will be increased with the introduction of more biotech products. 
This is especially true given that the Federal Government is not conducting long term studies and 
the independent studies have raised issues of confidence concerning the regulatory system. 
Products that fall under GMO food regulations are also becoming arguably more complex with 
expanding risk bases. Public engagement and consultation is needed before moving forward with 
these technologies. For example, there is a need for public consultation and engagement to 
determine if and how potential broader impacts beyond science-based risks of approving these 




On that note, Canadians have to work for transparency if they want it. Interested 
stakeholders can connect and seek out the transparency and accountability they think is 
necessary in decision-making for biotechnology-produced animals. While it is not feasible for 
the Federal Government to “spoon feed” the information to the public, the information should be 
made available for those who are seeking it. This goes beyond making information available 
through right to know legislation or voluntary initiatives. It is understandable that confidentiality 
is needed, but it is also clear that there is a need to be transparent about how regulatory bodies 
are ensuring the protection of the food system. Moreover, if the government objective is to 
promote commercial interests, a regulatory process can also negatively affect business if there is 
no trust or accountability in the process or product that is being or has been reviewed. 
Transparency is centered on information that is released by the Government regarding 
GMO food regulations and applications. There is a lack of information regarding the human 
consumption of biotechnology-produced animals being proactively released by the Federal 
Government on what it is working on, on regulatory processes, on issues it has to face, and on 
applications that have been submitted or are going through the regulatory process. The 
information that gets released by the government is fractured and is intermittent. Regulatory 
departments have been working on regulations and policies to assess biotechnology-produced 
animals for human consumption for over a decade. How a biotechnology-produced animal would 
be assessed for human consumption is unknown as regulations are currently being updated. As 
discussed in this paper, regulations are being updated in a piece-meal approach, and the approval 
of biotechnology-produced animals for specific commercial purposes does not happen 
concurrently. There is a need for the Government to release information concerning how it will 
regulate the human consumption of biotechnology-produced animals, as well as GMO food 
regulations in general. 
The information that is released by the Federal Government is limited by the confidential 
nature of the regulatory processes. Interested parties must rely on information provided by 
voluntary initiatives undertaken by departments, or by the applicant. For example information 
that has been provided by the University of Guelph regarding the Enviropig™ application for 
human consumption was provided on a voluntary basis by the University. The Federal 
Government has nothing set up to provide information on applications that it has received or is 
working on concerning the human consumption of biotechnology-produced animals.  
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It should not be considered acceptable to leave it up to employees of Federal departments 
to go outside of their mandates to fill in transparency voids of the overall policy structure, or for 
the applicant to bear the brunt of questions concerning its application. In the case of 
biotechnology-produced animals transparency is even more elusive because even the limited 
transparency initiatives that have been set up for Plants with Novel Traits do not apply to 
biotechnology-produced animals. Transparency initiatives need to be set up for biotechnology-
produced animals to at least be equivalent to the information being released regarding PNTs. At 
the very least, transparency surrounding GMO regulations and applications can be increased 
through the Federal Government updating websites, checking for accuracy and biases, and fixing 
broken links to relevant documents. The researcher would like to acknowledge her use of web 
archival sites, like Wayback Machine, to obtain information that had been taken down from 
Government websites.  
Breaking down the barriers identified in Chapters 4 and 5 and fostering the opportunities 
discussed in Chapter 6 can aid in incorporating food democracy into Canada’s food system and 
in increasing democratic participation. 
The timeline given in Appendix A can aid in creating a living document that records the 
history of decision making surrounding GMO food regulations. It can also be utilized to aid in 
comparing when GE foods have been brought up in the media or through the House of Commons 
to Federal Government responses (i.e. through food safety initiatives). 
Federal government approaches to transparency, even when applying the very limited 
formal institutional notion is a long way from being realized, particularly with respect to 
genetically engineered foods. This is a concern given that the definition, understanding, and 
implementation of transparency need to be expanded in the context of food democracy. In fact, it 
can be argued that since 2006 with the election of the Conservative government, there has been a 
loss of capacity to ensure transparency. As discussed in this thesis, that loss has included 
concerns about a decreasing ability for private and public actors to gather information from 
governing bodies, conduct research on genetically modified organisms, and participate in 
consultative initiatives. Concerns about the loss of capacity can be seen in issues raised in this 
research paper including the inability of stakeholders to effectively utilize the Access to 
Information Act, the lack of publically accessible information since 2006 on how regulations are 
being updated to incorporate the human consumption of animals produced through 
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biotechnology, the lack of a public review of the regulatory, policy framework, identified issues 
concerning transparency, a paucity of information posted on government websites specifically 
with respect to decision documents, and the apparently limited amount of  research being 
completed by the government, especially in the area of long-term testing and traceability. This 
apparent loss of capacity adversely affects the ability of Canadian citizens and residents to have 
any input into issues the most directly affect them—namely how their food is regulated and 
handled. As such, they have limited means to ensure the safety of their food system. This 
identified loss of capacity and the formal institutional notion of transparency raise issues of 
public democracy and governance with respect to many issues including the potential human 
consumption of animals produced through biotechnology. The latter is a timely concern, for this 
issue needs to be addressed before animals produced through biotechnology are approved and 
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Appendix A: A Timeline of Events Regarding Genetically Engineered Foods  
Events that take place within the same month might not be in chronological order. When 
specific dates are given they are provided in brackets (i.e. (Aug 5)). The events where only the 
year was given are listed directly under the heading for that year.  
Events that are highlighted are not directly discussed in the body of this research paper.  
~ Mid 1980s ~ 
Mid 1980s Increasing amounts of products derived through rDNA techniques are nearing the 
stage of commercialization. 
Mid 1980s Regulatory authority over biotechnology products is given to existing departments 
that held authority over the same products made from traditional techniques 
(Moore 2000, p. 96). 
~ 1983 ~ 
1983 Release of Canada’s National Biotechnology Strategy (NBS). 
Establishment of Canada’s National Biotechnology Advisory Committee (NBAC). 
~ 1987 ~ 
1987 Regulatory departments agree to build on existing legislation and internationally 
developed guidelines, to regulate the product and not the process of genetic 
engineering, and to use risk based assessments (Kneen, 1999 p. 135). 
~ 1992 ~ 
Aug. 1992 
 
(Aug 5) Health Canada releases Information Letter (IL) No. 806 to interested 
parties. The letter describes Health Canada’s proposed approach to assess the 
safety of novel foods and was released so interested parties could comment on the 
proposed approach. This Information Letter was the Canadian government’s first 
public step in the development of safety regulations for novel foods (Health 
Canada, 2000). 
~ 1993 ~ 
Jan. 1993 
 
The Government announces a new Federal Regulatory Framework for the 
regulation of biotechnology products. A key principle was to continue using 
existing laws and regulatory departments to ensure that “the benefits of 
biotechnology products and processes are realized in a way that protects health, 
safety, and the environment” (Health Canada, 2012d). 
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Nov. 1993 Agriculture Canada, Health Canada, Environment Canada and Industry and 
Science Canada conduct the consultation workshop Regulating Agricultural 
Products of Biotechnology. The need for further public consultations is evident 
(Moore 2000, p. 197).  
~ 1994 ~ 
1994 A poll commissioned by Industry Canada shows that up to 95% of Canadian 
consumers want labels on GE Foods (Council of Canadians, 1999).  
Sept.1994 Health Canada’s Health Protection Branch release Guidelines for the Safety 
Assessment of Novel Foods, Volume II: Genetically Modified Microorganisms and 
Plants to assist developers in their product safety assessments. It was up to the 
developer to determine whether review by Health Canada was advisable (Moore 
2000, p. 146). The guidelines refer to GE food as novel foods, and GE plants as 
Plants with Novel Traits (PNTs) (Food Directorate Health Protection Branch, 
1994).  
Nov. 1994 A multi-stakeholder Technical Workshop on the Labeling of Novel Foods Derived 
Through Genetic Engineering is held to produce consensus on general principles 
and was attended by approximately 60 participants. The workshop serves as the 
basis for the development of Canada’s regulations for GE foods (Moore, 2000; 
Kneen, 2000).   
~ 1995 ~ 
Aug. 1995 Health Canada proposes the establishment of a new division in the Food and Drug 
Regulation in the Canadian Gazette I “that will define the concept of a novel food 
and provide for notification prior to the sale or advertising the sale of such food 
products” (Health Canada, 1995 p. 2987). Thirty five responses were received that 
commented on the proposed amendments (Health Canada, 1995). Of responses, 
“28 were on behalf of industry or industry associations, 2 were from agencies of 
one foreign government, 2 from individual citizens, 1 from a labour organization, 1 
from an environmental interest group and 1 from a consumers group”  (Regulations 
Amending the Food and Drug Regulations, 1999). Health Canada published the 
revised version of its proposed new regulations in September 1998. 
Health Canada’s Regulatory Impact Analysis Statement considered two options: 
the premarket approval similar to that required for food additives; and the proposed 
pre-market notification option. The pre-market approval approach “was viewed as 
introducing unnecessary impediments to the marketing of novel foods without 
providing a corresponding increase in the level of consumer protection” (p. 2989). 
The Regulatory Impact Analysis Statement states that regulatory principles it 
described were supported by responses to consultations that had taken place and 
that the issue of labeling GE foods remained to be resolved (p. 2989). The 
consultations listed in the  Regulatory Impact Analysis Statement included 
Information Letter No. 806 (1992), the publication of the Guidelines for the Safety 
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Assessment of Novel Foods and a public workshop the department co-sponsored 
with Agriculture and Agri-Foods Canada and the Department of the Environment 
concerning the regulation of agricultural products of biotechnology. 
Dec. 1995 The AAFC release its Communiqué: labeling of novel foods derived through 
genetic engineering. The Communiqué complied comments that had been made 
during the 1994 consultations. The Communiqué stated that participants of the 
Technical Workshop had reached a consensus that labels on foods that have been 
genetically engineered must identify potential health and/or safety risks for 
individuals, and/or significant compositional or nutritional changes (Food 
Inspection Directorate, 1995). 
~ 1996 ~ 
1996 The CFIA approves the “CDC Triffid” GM flax for environmental release. This 
flax lead to Europe closing its door on Canadian flax in 2009 (CBAN, 2012b). 
Health Canada’s Health Protection Branch publishes a revised version of its 
proposed new regulations for the safety assessment of novel foods under the Food 
and Drugs Act. 
May 1996 The Standing Committee of the Environment discusses the regulatory framework 
for biotechnology. The topic was discussed over the course of the nine public 
hearings in May and June of 1996. 
Nov.1996  The Standing Committee on Environment and Sustainable Development came out 
with the report Biotechnology Regulation in Canada: A Matter of Public 
Confidence. The report states that Fisheries and Oceans Canada's regulations for 
GE fish are being drafted (Commissioner of the Environment and Sustainable 
Development, 2004b). 
~ 1997 ~ 
Apr. 1997 Establishment of the Canadian Food Inspection Agency (CFIA).  The CFIA is 
given authority over novel feeds and genetically modified crop plants (Health 
Canada, 2012d). 
Agriculture and Agri-Foods Canada issue the Information Letter Communiqué: 
labeling of novel foods derived through genetic engineering. The Letter presents 
guidelines which form the basis for Canada’s labeling policy in regards to GE 
foods. The Information Letter summarizes comments that were made concerning 
the guidelines that were developed through the 1994 Technical Workshop on the 
Labeling of Novel Foods Derived Through Genetic Engineering Workshop. It also 
summarizes comments that were made on the AAFCs 1995 communiqué (Moore, 
2000, p.  155, 197). 
The Department of Fisheries and Oceans Canada state in an internal memo that it is 
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“committed to having the regulations in place that year” (Commissioner of the 
Environment and Sustainable Development, 2004b). 
~ 1998 ~ 
1998 Health Canada approves the “CDC Triffid” GM flax for human consumption. This 
flax lead to Europe closing its door on Canadian flax in 2009 flax (CBAN, 2012b). 
(1998-1999) “Industry Canada's BRAVO Web site (as of 17 May 2004) states that 
GE fish regulations are expected to come into effect during 1998–99” 
(Commissioner of the Environment and Sustainable Development, 2004b). 
May 1998 The House of Commons Committee on Agricultural report Capturing the 
Advantage: Agriculture biotechnology in the new millennium (Canada. Standing 
Committee on Agriculture and Agri-Food, 1998). 
Aug. 1998 The renewed Canadian Biotechnology Strategy (CBS) is released to replace the 
1983 National Biotechnology Strategy. No changes were made to the regulatory 
framework or principles. An emphasis was placed on strengthening 
interdepartmental coordination as well as public awareness and participation 
(Moore 2000, p. 117). 
The Canadian Biotech Advisory Council (CBAC) were created through the CBS to 
“provide expert advice to the Federal Government on ethical, social, regulatory, 
economic, scientific, environmental and health aspects of biotechnology” (Health 
Canada, 2006d). The CBAC was given a wider mandate than the NBAC (1983), 
which it replaced.  
Sept. 1998 Health Canada’s Health Protection Branch publishes a revised version of its 
proposed new regulations for the safety assessment of novel foods under the Food 
and Drugs Act in the Canadian Gazette I with a comment period of 60 days through 
which nine comments were received. 
Nov. 1998 (Nov 2-3) Multi-stakeholder consultation on "Regulating Livestock Animals and 
Fish Derived from Biotechnology". The consultations are sponsored and supported 
by Health Canada, the CFIA, AAFC, and the Department of Fisheries and Oceans. 
~ 1999 ~ 
Apr. 1999 Agricultural Minster Lyle Vanclief holds a closed door Roundtable in 
Communications and Agricultural Biotechnology with representatives of the 
biotech industry regarding the future of the biotechnology industry. 
June 1999 A Prairie Research Associates poll shows 92% of Manitobans want labeling (77% 
of those polled believed GE foods were unsafe or were unsure of their safety) 
(Council of Canadians, 2011). 
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Sept. 1999 The Canadian General Standards Board (CGSB) and the Canadian Council of 
Grocery Distributers (CCGD) establish a multi-stakeholder committee to undertake 
the development of a voluntary labeling standard for foods derived from 
biotechnology. 
Oct. 1999  An insert considered to critics as being pro-biotech appears in Canadian Living 
Magazine entitled What Am I Eating? Consumers, Producers and Genetically 
Modified Foods. The insert was sponsored by the CFIA (CFIA, 2000, p. 241). In a 
reference to the October 1999 insert, the Royal Society of Canada’s Expert Panel 
on the Future of Food Biotechnology reported “CFIA has engaged in active media 
campaigns promoting agricultural biotechnology, and seeking to allay public fears 
about risks associated with GM foods” (Royal Society of Canada, 2001, p. 212). 
(Oct 27) Health Canada publishes its final version of its Novel Food Regulations in 
the Canada Gazette.  
Nov. 1999 An eight page pro-biotech supplement entitled A Growing Appetite for Information 
is featured in Canadian Living Magazine. The insert was funded by the CFIA. The 
insert did not acknowledge its connection with the CFIA. Bradford Duplisea from 
the Canadian Health Coalition discovered that the publications had been financed 
and edited by the CFIA through Access to Information requests. Duplisea 
questioned “Why didn't the CFIA just do these in-house... Why did they go through 
such elaborate measures to put these items out as if the CFIA is not associated with 
them?" (Steward, 2001).  
Nov. 1999  (Nov 27) CIELAP release their report The Regulation of Agricultural 
Biotechnology in Canada. The report criticized the contradictory role of Canada’s 
regulatory approach and was a comprehensive inventory of the gaps within the 
Canadian biotechnology regulatory frame. 
Dec. 1999 A Montreal Gazette poll of 966 Montrealers found almost unanimous support for a 
mandatory GE food label. Over 50% of the respondents thought that GE foods 
should be banned (Abley, 2000). 
Establishment of the Royal Society of Canada’s Expert Panel on the Future of 
Food Biotechnology at the request of Health Canada, the CFIA and Environment 
Canada. 




Fisheries and Oceans Canada’s senior management commit to Environment 
Canada that regulations for GE fish will be in force in the fall of 2002 
(Commissioner of the Environment and Sustainable Development, 2004b). 
Jan. 2000 GE Alert, a group of scientists and academics, release the report Food Safety of 
GM Crops in Canada: Toxicity and Allergenicity. Findings reveal that testing of 
the toxicity and allergenicity of GE crops by Health Canada had not been 
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conducted on 70% of the 42 GE crops Health Canada approved (McKenzie, 2002, 
p. 170). Dr E. Ann Clark, a Professor at the University of Guelph and member of 
GE Alert said that “Allergenicity was not assessed through lab or feeding trial 
measurements on any of the 42 GE crops. All conclusions of safety regarding 
toxicity and from allergenic responses were based entirely on inferences and 
assumptions” (Council of Canadians, 2000). 
Mar. 2000 The CFIA publishes its controversial Food Safety and You pamphlet seen as being 
biased by those who questioned the regulatory regime and standard’s project. The 
pamphlet is mailed to Canadian households. The CFIA did state that the 
publication cost $2.53 million (23 cents x 11 million copies) (Kneen, 2000). 
Apr. 2000 Canadian researcher Brewster Kneen, a member of the consultation workshop held 
in November of 1993, raises concern about transparency of the formation of 
Canada’s regulatory process. Kneen utilizes the April 2000 edition of his 
newsletter, “The Ram’s Horn”, to outline his participation in the 1993 and 1994 
public consultation workshops (Kneen,, 2000). Contrary to what was written in 
Agriculture and Agri-Food Canada’s (AAFC) Communiqué: labeling of novel 
foods derived through genetic engineering (1995) and a 1997 information letter of 
the same name, Kneen said that neither of the public consultations had reached a 
consensus on the topic of GE food labeling(Kneen, 2000). Kneen outlined multiple 
occasions where his involvement in the 1993 and 1994 consultations had been used 
by “industry flacks” to legitimize the consultative process. Kneen was referenced 
in a fall 1999 conference at McMaster University by Mary Lou Garr of AGCare, a 
February 2000 meeting in Saskatoon by Dale Adolph of the Canola Council, and a 
March meeting in British Columbia by CFIA’s Stephen Yarrow (Kneen, 2000). 
May 2000 Fisheries and Oceans Canada states in its response to Petition No. 23, that it is 
developing regulations for GE fish (Commissioner of the Environment and 
Sustainable Development, 2004b). 
May 2000 Petition No: 23 Federal laws, regulations, and policies on genetically modified 
organisms (GMOs) is filed under the Auditor General Act against the Federal 
Government for failing to protect public health and the environment in regulating 
genetically modified organisms. 
~ 2001 ~ 
2001 Health Canada releases a decision document that approves Monsanto’s GM corn 
NK603 for human consumption. This corn was used in a 2012 peer-reviewed study 
by the French group of Gilles-Eric Seralini that described harmful effects on rats 
fed on diets containing GE maize (Seralini, et al., 2012).  
The CFIA deregisters the “CDC Triffid” GM flax, making it illegal to sell the seeds 
(CBAN, 2012b). This was done at the request of the Flax Council of Canada and 
Saskatchewan Flax Development Commission over concerns about losing the 
European market (CBAN, 2012b). This flax lead to Europe closing its door on 
167 
 
Canadian flax in 2009 flax (CBAN, 2012b). 
Feb. 2001 The Royal Society of Canada’s (RSC) Expert Panel on Biotechnology release their 
report Elements of Precaution: Recommendations for the Regulation of Food 
Biotechnology in Canada The Expert Panel uses the report to raise alarm about the 
ethics and safety of the use of GE crops and the potential risks posed to human 
health, biodiversity and the environment 
Dr. Brian Ellis (then Associate Director of University of British Columbia's 
Biotechnology Laboratory, joint head of the Royal Society of Canada Scientific 
Panel on Food Biotechnology, and Co-Chair of the Expert Report) states on the 
CBC radio program Quirks & Quarks the “issue is not with methodology itself but 
the secrecy that surrounds it” (McDonald, 2001). 
The Canadian Government responses to the RSC report through an Action Plan. 
(Feb 28) MP Charles Caccia (Liberal - Davenport Ontario), introduces private 
members bill, Bill C-287 to amend the Food and Drugs Act and make mandatory 
labeling standard for GE foods containing more than 1% GE ingredients and carry 
out studies on the long-term effects of GE foods on human health. 
Apr. 2001 The Release of the Canadian General Standard Board (CGSB) Committee’s 
Regulation of Genetically Modified Food Consultation Document. Fifty Canadian 
NGOs declined to participate in the CGSB consultations. The document was used 
to solicit input from Canadians for the CGSB workshops on the Voluntary labeling 
standard (Council of Canadians, 2002). 
Sixty-one “civil society” groups sent letters to the Prime Minister’s Office 
boycotting CBAC and describing it as being fundamentally flawed (Glover et al, 
2003). 
May 2001 Wasylycia-Leis, NDP MP for Winnipeg North Centre and a member of the Health 
Committee, introduced Bill C-310 for the mandatory labeling of GE foods into the 
House of Commons.  
A Pollara & Earnscliffe Research and Communications poll for the Globe and Mail 
shows that 94% of Canadians believed the government should order companies to 
label GM foods (MacKinnon, 2001).  
May 2001 Debate on Bill C-287 was initiated by MP Charles Caccia in the House of 
Commons. 
 (May 18) The CFIA sends a letter to several members of Parliament including 
Allan Rock, Lyle Vancleif, Brian Tobin, Minister of Industry, Pierre Pettigrew, 
Minister of International Trade, and Charles Caccia, expressing the view that the 
bill C-287 was unworkable (CFIA, 2001b).  
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June 2001 (June 6) Debate on Bill C-287 is initiated by MP Charles Caccia in the House of 
Commons. 
Aug. 2001   (Aug 22) CBAN releases Improving the regulation of genetically modified foods 
and other novel foods in Canada: interim report to the Government of Canada 
Biotechnology Ministerial Coordinating Committee.  
Sept. 2001 The Minister of Health announces that substances in products regulated under the 
Food and Drugs Act would be subject to the New Substance Notification 
Requirements (NSNR) under CEPA 1999. 
Health Canada publishes a Notice of Intent in Canada Gazette Part I to inform the 
public of the department’s intention to undertake the development of appropriate 
Environmental Assessment Regulations (EARs) for new substances in products 
regulated under the Food and Drugs Act(Health Canada, 2010b). The EARs “will 
differ from existing requirements with respect to when companies are required to 
submit data and the type of data companies are required to submit” (Health 
Canada, 2011c). When finished the EARs would be published in the Canadian 
Gazette and would undergo a comment period before appearing in the Canadian 
Gazette 2.The objective of the new EARs is to ensure that those substances are 
evaluated for their potential risks to the Canadian environment and human health 
through environmental exposure (Health Canada, 2011c). 
Establishment of the Environmental Impact Initiative (EII) Division of Health 
Canada following the publication of a Notice of Intent in the Canada Gazette Part 
I. 
(Sept 1 – Oct 30) Opportunity to comment on Health Canada’s Notice of Intent to 
undertake the development of EARs for new substances in products regulated 
under the Food and Drugs Act. 
(Sept 24) Wasylycia-Leis, NDP MP for Winnipeg North Centre and a member of 
the Health Committee, writes a policy briefing entitled “Government’s Biotech 
Strategy Supports Biotech Corporations” that appears in The Hills’ September 24
th
, 
2001 issue. She stated that voluntary standards were irrelevant to a public that 
consistently registers more than ninety percent support for a mandatory label 
(Waylycia-Leis, 2001). She refers to an open letter that had come from a “broad 
coalition of more than 200 consumer, environmental, and farm producer groups 
concerned for the future of Canada’s $6 billion per year overseas wheat sales.” She 
states that the Government had chosen not to act on any of the Royal Society of 
Canada’s suggestions declaring that it would prefer to wait until the CBAC and 
CCGD had finished their reports (Waylycia-Leis, 2001). 
Oct. 2001 (Oct 12) A letter is sent to the Chair of the Standing Committee on Health that 
spoke out against Bill C-287 and suggested the Committee hold hearings about the 
best options for meeting consumers’ information needs with respect to genetically 
modified foods. The letter was signed by the Ministers of Heath (Allan Rock), 
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Agriculture (Lyle Vanclief), Industry (Brian Tobin) and International Trade (Pierre 
Pettigrew) (Freeman, 2001).  The use of the Standing Committee was described in 
the media as an attempt at a stalling technique as well as a way to take focus away 
from Bill C-287. 
(Oct 17) When Liberal MPs showed up to the House of Commons to vote on Bill 
C-287 they found a pamphlet entitled, “vote against bill C-287 and support 
Canada’s agri-food business” on each of their desks (Freeman, 2001).  
(Oct 17) Bill C-287 is defeated 129 to 91 in the House of Commons. Health 
Minister Allan Rock, the only senior Cabinet Minister on record as supporting 
mandatory labeling, avoided the vote out of cabinet solidarity (CBC, 2001).  
(Oct 23) The Standing Committee on Health releases a statement that they have 
adopted the proposal to study the issue of GE food labeling. 
Nov. 2001 The Federal Government responds to Royal Society Paper through an Action Plan 
Greenpeace submits Petition 38A on Genetically Engineered Fish to request 
“information about Federal Government policy concerning the rearing of 
genetically engineered (GE) fish. Greenpeace maintains that all GE fish should be 
raised in secure, land-based facilities as the risks associated with rearing GE fish in 
open net pens in oceans and lakes are too high” (Office of the Auditor General of 
Canada, 2001). 
“A senior management briefing note states that the Minister of Fisheries and 
Oceans committed to developing the regulations by the fall of 2002.” 
(Commissioner of the Environment and Sustainable Development, 2004b). 
~ 2002 ~ 
2002 The University of Guelph send eleven Enviropig™ piglets to a rendering plant 
where they were unintentionally turned into animal feed. Egg farmers, turkey 
farmers, and broiler chicken producers in Ontario were sold 675 tons of 
contaminated poultry feed (Strass, 2002). The animals were supposed to have been 
destroyed as biological waste. The bodies of these piglets were being “stored in a 
refrigerator at the University's Ridgetown research station with bodies of animals 
meant to be sent to the renderers and were accidently taken away with them” 
(Strass, 2002). 
A Pew Global Attitudes Project survey reports that 37% of Canadians viewed 
scientifically altered fruits and vegetables as good, whereas 63% thought these 
products were bad (Martin and Grey, 2010).  
The Public Advisory Committee (PAC) forms to advice Health Canada's Health 




Lucy Sharratt from CBAN writes the report Regulating Genetic Engineering... for 
Profit through the Polaris Institute 
Jan. 2002 The Canadian government release a Progress Report in response to the Royal 
Society of Canada Expert Panel Report Progress Reports 
Jan. 2002 CIELAP submitted to the CBAC Comments on the Interim Report “Improving the 
Regulation of Genetically Modified Foods and Other Novel Foods in Canada” 
(Jan 18) Greenpeace submits Petition 44 Post approval monitoring of genetically 
modified organisms (GMOs) 
Jan - Apr, 
2002 
The Standing Committee on Health study is initiated in January of 2002.Four 
public hearings are held between January and Apr, 2002 During the hearings 
Greenpeace Canada and the Canadian Health Coalition (CHC) release documents 
that suggested “the Federal Government has spent $3.3 million in to promote the 
safety of GE Foods" (Greenpeace, 2002; Wilson, 2002). Officials challenged the 
numbers and stated they were not promoting biotechnology. During the same 
hearing Wasylycia-Leis, NDP MP for Winnipeg North Centre and a member of the 
Health Committee, asked “aren’t you running the risk of being seen as the 
mouthpiece of the biotech industry?” (Wilson, 2002) Suzanne Trembley, a Bloc 
Quebecois MP also raised that issue (Wilson, 2002). The Royal Society’s Expert 
Panel on the Future of Food Biotechnology co-chairs Brian Ellis and Conrad Brunk 
also used the hearings to reiterate the Expert Panel’s recommendations. During the 
hearings CBACs Co-Chair Peter Phillips stated mandatory labeling could cause a 
North American Free Trade Agreement trade war: “It would undoubtedly 
complicate our relations with our major trading partner, the United States, and 
complicate the access of our market into their market and vice- versa” (Stewart, 
2002). 
Mar. 2002 The Canadian Institute for Environmental Law and Policy (CIELAP) releases its 
Citizens Guide to Biotechnology. CIELAP stated its guide was “not a traditionally 
balanced approach, but we take it because the critical perspective provided here is 
largely absent from the information provided to citizens by the federal government 
and the biotechnology industry.” (CIELAP, 2002, p.2). 
Apr. 2002 Health Canada and Environment Canada sign an MOU regarding the NSNR, giving 
Health Canada responsibility over the NSNR assessments for products in the Food 
and Drugs Act. 
The HPFB release a Technical Discussion Report in response to the Royal Society 
of Canada Expert Panel Report. 
 Fisheries and Oceans Canada states in its response to Petition No. 38A that it is 
developing regulations for GE fish. (Commissioner of the Environment and 
Sustainable Development, 2004b). 
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May 2002 The Canadian government release a Progress Report in response to the Royal 
Society of Canada Expert Panel Report Progress Reports 
May 2002 Canadian researcher Devlin Kuyek publishes The Real Board of Directors: The 
Construction of Biotechnology Policy in Canada, 1980-2002 
June 2002 The Standing Committee on Health completes its study Labeling of genetically 
modified foods and its impact on farmers (Canada. Standing Committee on 
Agriculture and Agri-Foods, 2002). 
Aug. 2002 Health Canada releases a draft of its Guidelines for the Safety Assessment of Novel 
Foods derived from Plants and Microorganisms  
(Aug 26) The CBAC released its final report entitled Improving the Regulation of 
Genetically Modified Foods and Other Novel Foods in Canada. The CBAC 
promoted it as a “comprehensive and balanced report which identifies opportunities 
for improvement of the Government regulatory approach for products derived 
through biotechnology” (Health Canada, 2006d). CIELAP Executive Director 
Anne Mitchell, one of the twenty- committee members was “strongly in favour of 
proceeding directly to mandatory labeling” and had noted “a majority of 
respondents to our Interim Report urged a mandatory system” (CBAC, 2002, p. xi).  
Nadège Adam, campaigner for the Council of Canadians, stated  
CBAC's credibility is and will always be an issue given its membership 
composition...The vast majority of the committee members have either ties or 
notable sympathies towards the biotech industry. It comes as no surprise that the 
basic concerns of Canadians are not reflected in this report. (Council of Canadians, 
2002) 
The CBAC reports that Fisheries and Oceans Canada is currently developing 
regulations for GE fish (Commissioner of the Environment and Sustainable 
Development, 2004b). 
Aug. 2002 The U.S. National Academy of Sciences releases its report Animal Biotechnology: 
Science based Concerns. 
Dec. 2002 The Canadian government release a Progress Report in response to the Royal 
Society of Canada Expert Panel Report Progress Reports 
Oct. 2002 (Oct 31) The Federal Government’s  response to the Standing Committee on 
Health’s study entitled “Labeling of genetically modified foods and its impact on 





~ 2003 ~ 
Jan. 2003 Health Canada release an Issues Identification Paper to serve as a basis for 
discussion with stakeholders to identify the issues being addressed by the 
Government of Canada and to set out the goals and objectives for the 
Environmental Assessment Regulations (Health Canada, 2011b). 
Mar.  - 
May 2003  
(March – May) The Standing Committee on Health study Labeling of genetically 
modified foods and its impact on farmers is resumed with participation from Health 
Canada. The Committee agrees not to pursue its study further after hearing an 
update from the chair of the CGSB on the development of a voluntary labeling 
standard (Health Canada, 2006c). 
Apr, 2003 CIELAP release Involving the Public in the Canadian Biotechnology Policy 
Process (CIELAP, 2003). 
Fisheries and Oceans states in an internal audit document that the target date for the 
regulations for GE fish is 2005 (Commissioner of the Environment and Sustainable 
Development, 2004b) 
June 2003 The Canadian government release a Progress Report in response to the Royal 
Society of Canada Expert Panel Report Progress Reports 
July 2003 The release of Health Canada’s Final Issue Identification Paper regarding the 
creation of the EARs.  
The release of Health Canada’s revised Guidelines for the Safety Assessment of 
Novel Foods. Public online consultations regarding the revised Guidelines for the 
Safety Assessment of Novel Foods are held from July 15
th
 to September 30
th
 2003 
(Health Canada, 2006g). 
July 2003 Greenpeace submits Petition No. 84: Effects of GE crops on soil health; Petition 
No. 85: GE crops and products: trade concerns and other international matters 
and petition No. 88: GE wheat and the future of Canadian agriculture. 
Sept. 2003 (Sept 8) CGSB announce they have reached an agreement on a voluntary labeling 
standard for GE foods.  
 (Sept 24) Health Canada’s Food Directorate publishes its Interim Policy on Foods 
from Cloned Animals. The interim policy considers foods produced from livestock 
developed using the technique of somatic cell nuclear transfer (SCNT) to be 
captured under the definition of “novel food” and therefore subject to Novel Food 
Regulations. Developers of cloned animals are requested to “withhold novel food 
notifications until requirements are determined and further guidance is available” 




Greenpeace submits Petition 38B - Follow-up petition on genetically engineered 
fish 
Greenpeace submits Petition  No. 94: biotechnology and “pharming” crops  
Oct. 2003 The Consumers Association of Canada’s national poll on the labeling of genetically 
modified foods found 88% of Canadians wanted mandatory labeling on GE food 
products source (Canada Newswire, 2003). 
The Notice of Submission Pilot project begins. Novel foods going through the 
approval process would now be listed on Health Canada’s website and made 
available for public comment. 
Nov. 2003 (Nov 8) William Leiss, Chair of the Royal Society of Canada and co-chair of the 
Expert Panel on the Future of Food Biotechnology, reiterates the Expert Panel’s 
findings in his paper The Case for Mandatory Labeling of Genetically-Modified 
Foods (2003). The paper discussed the self-defeating approach of making a 
voluntary labeling standard (Leiss, 2003, p. 17). 
Dec. 2003 The Canadian government releases a Progress Report in response to the Royal 
Society of Canada Expert Panel Report Progress Reports. 
~ 2004 ~ 
2004 The CFIA and Health Canada launch a project “to post on the CFIA website 
‘notices of submission’ to describe the product and the data they receive from 
certain product developers who have requested safety assessments of plants with 
novel traits (PNTs) for unconfined release and safety assessments of novel feeds 
and novel foods derived from PNTs” (CFIA, 2009a). According to the CFIA’s 
website, the purpose of the project is: 
- to give the public an opportunity to provide input on scientific matters 
relevant to the safety assessment of each submission 
- to increase transparency of the regulatory process 
- to increase confidence in the regulatory system with respect to PNTs, and 
novel feeds and novel foods derived from PNTs 
- to support the commitment to achieve greater openness regarding product 
information made by the Government of Canada in its responses to the 
Royal Society of Canada's (RSC) Expert Panel Report titled, Elements of 
Precaution: Recommendations for the Regulation of Food Biotechnology in 
Canada, as well as those identified in the Canadian Biotechnology 
Advisory Committee (CBAC) report, called Improving the Regulation of 





The project is based on members of CropLife Canada volunteering to write the 
notices of submissions that would accompany their submissions to the CFIA and 
Health Canada “to demonstrate their support and understanding of the public desire 
for more transparency in the regulatory system” (CFIA, 2009a). According to 
CFIA’s website “Scientific questions or information will be forwarded to CFIA and 
Health Canada evaluators for consideration in the assessment. Non-scientific input 
will be evaluated and appropriate ways of addressing it will be explored” (CFIA, 
2009a).  
Experimental GM pharma-pigs from the Quebec company TGN Biotech are 
accidentally turned into chicken feed instead of being incinerated. (Sharratt, 2010). 
The Public Advisory Committee of the Health Products and Food Branch is closed.  
Jan, 2004 Fisheries and Oceans Canada states in its response to petition No. 28B that it is 
developing regulations for GE fish (Commissioner of the Environment and 
Sustainable Development, 2004b). 
Mar. 2004 CFIA’s Animal Biotechnology Focus Group Meeting is held. It is presented as an 
effort to “streamline” the regulatory approach to animal biotechnology (Andrée and 
Sharratt, 2004, p. 21). 
Apr.  2004 (Apr 14) The enactment of Canada’s Voluntary Labeling Standard for Genetically 
Engineered foods. Proponents of the food biotechnology industry dominated the 
voting committee.
10
 The unbalanced nature of the voting committee went against 
CGSB policies for balanced representation.
11
 
Apr. 2004 Citizen Anna Kirkpatrick submits Petition No. 108: Human, social and 
environmental impacts of genetic engineering:  
May 2004 The Departments of Fisheries and Oceans Canada (DFO), Environment Canada 
(EC) and Health Canada (HC) sign a Memorandum of Understanding respecting 
the implementation of the NSNR (Organisms) for certain aquatic living organisms.  
June 2004 “Fisheries and Oceans Canada states that it cannot give a timeline for completing 
the regulations [for GE fish]” (Commissioner of the Environment and Sustainable 
Development, 2004b). 
Aug. 2004 The Canadian government release a Progress Report in response to the Royal 
Society of Canada Expert Panel Report Progress Reports 
 
                                                 
10
 This information was made available by ATI requests completed by Bradford Duplisea of the Canadian 
Health Coalition (CHC). 
11
 The CGSB has a section on “Balanced Representation” in their CGSB Policy Manual for the 
Development and Maintenance of Standards (1994). 
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The Submission of Petition 125 – Federal regulation of genetically modified 
organisms 
Oct. 2004 Dr. Peter Andrée and Lucy Sharratt Coordinator CBAN, release a 53-page report 
that tracked what the Government had and had not done to implement the RSC 
Panel’s recommendations and stressed the fact that there had not been a public 
debate (Andrée and Sharratt, 2004).  They also noted that requesting to keep 
animals out of the food system was clearly insufficient due to the contamination of 
research animals in the food supply (Andrée and Sharratt, 2004, p. 21). 
(Oct 29) CFIA publishes the revised Assessment Criteria for Determining 
Environmental Safety of Plants with Novel Traits. 
Oct. 2004 (Oct 30) The Minister of the Environment publishes in the Canada Gazette, Part I, 
the proposed New Substance Notification Regulations (Organisms).  
~ 2005 ~ 
2005 CFIA employees write the journal article Regulatory considerations for 
biotechnology derived animals in Canada. The article stated “The need to ensure 
the biosafety of genetically engineered animals is one of the most critical 
challenges that the agricultural biotechnology industry and regulatory agencies 
face” (Kochhar, Adlakha-Hutcheon, & Evans, 2005, p. 117). 
Feb. 2005 The Canadian Government responses to the RSC report through an Action Plan 
June 2005 The last Action Plan of the Government of Canada in response to the Royal Society 
of Canada Expert Panel Report Progress Reports was issued.   
Health Canada releases Options Analysis Paper (OAP) - An Environmental 
Assessment Regime for New Substances in Products Regulated under the Food and 
Drugs Act This paper was released to obtain feedback on the legislative authority 
under which the Environmental Assessment Regulations should be placed(Health 
Canada, 2011a).  
 (June – Sept 30) The period of time for stakeholder feedback in regards to the 
Health Canada’s Options Analysis Paper (OAP) - An Environmental Assessment 
Regime for New Substances in Products Regulated under the Food & Drugs Act 
July 2005 (July 8) Greenpeace submits Petition 152 – Full access to information used for 
decisions on genetically modified organisms 
Sept. 2005 (Sept 21) The New Substance Notification Regulations (Organisms) is published in 




~ 2006 ~ 
2006 A survey by Decima Research concludes that 58 percent of Canadians believed that 
biotech animals will make life worse over the next twenty years, 54 percent held 
the same view of biotech fish, and 50 percent believe their future will be negatively 
impacted by biotech food (Martin and Grey, 2010). 
In An Analysis of Efforts to Improve Genetically Modified Food Regulation in 
Canada which appeared in the Journal Science and Public Policy (2006) the author 
Dr. Peter Andrée concludes that, “while some efforts have indeed been made, the 
Government of Canada continues to fall far short of meeting the RSC Panel’s 
expectations in key areas, including food safety, environmental assessment, peer 
review, transparency, and monitoring and surveillance” (Andrée, 2006, p. 1). 
The Enactment of the Federal Accountability Act. The Act acknowledges the need 
to integrate environmental, economic, and social factors in the making of all 
decisions by government. 
The Enactment of the Federal Sustainable Development Act. 
Feb. 2006 Health Canada releases its Options Analysis Paper Feedback Analysis Report to 
provide “an analysis and summary of the comments from stakeholders on the 
regulatory options, the critical issues and their components, and other issues of 
concern” (Health Canada, 2006e, p. 4). 
Mar.  2006 (Mar 13) Health Canada releases an Environmental Impact Initiatives Discussion 
Document for the March 29 and 30 2006 Stakeholder Consultations on The 
Development of Environmental Assessment Regulations for New Substances 
Contained in Products Regulated under the Food & Drugs Act 
June 2006 Health Canada releases its updated Guidelines for the Safety Assessment of Novel 
Foods “to reflect the advancement of methods and knowledge regarding product 
review” (Health Canada, 2012d). The 2006 Guidelines for the Safety Assessment of 
Novel Foods (Volumes I and II) stated that the section for Novel Foods Derived 
from Animals is “Under Development” (Health Canada. Food Directorate. Health 
Products and Food Branch, 2006) “Manufacturers or importers of novel foods 
derived from animal sources should consult with the Food Directorate to discuss 
what information is appropriate to the evaluation of the safety of a particular 
product” (Health Canada. Food Directorate. Health Products and Food Branch, 
2006). 
Sept. 2006 The CBAC released the report Toward a Canadian action agenda for 
biotechnology: a report from the Canadian Biotechnology Advisory Committee.  
~ 2007 ~ 
Mar. 2007 (Mar 26-28) The Environmental Assessment Working Group (EAWG) holds a 
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meeting in Ottawa 
May 2007 The CBAC’s mandate concludes with the release of the Government of Canada's 
Science and technology Strategy. 
Oct. 2007 (Oct 18-19) The Environmental Assessment Working Group (EAWG) holds a 
meeting in Ottawa 
Dec. 2007 Announcement of the Food and Consumer Safety Action Plan. The 2008 Budget 
invested $113 million over two years in the Food and Consumer Safety Action Plan 
(Prime Minister of Canada, 2007). 
~ 2008 ~ 
2008 Limitations regarding the ability of regulatory bodies to regulate biotechnology-
produced fish used for research are raised in the Auditor General’s Office’s 2008 
audit report (Commissioner of the Environment and Sustainable Development, 
2008). 
A survey by BIOTECanada, a biotech industry group, states 79 percent of 
Canadians agree that “biotechnology” would bring benefits to agriculture (Martin 
and Grey, 2010). 
Jan. 2008 Technical consultations are held for the Food and Consumer Safety Action Plan 
(Treasury Board of Canada Secretariat, 2012). 
Feb. 2008 (Feb 12) The Environmental Assessment Working Group (EAWG) holds a meeting 
in Ottawa via teleconference. 
Mar. 2008 The launch of the Food and Drugs Act Liaison Office. 
Apr. 2008 (Apr 8) The Prime Minister announces tougher food and product safety legislation 
to protect Canadian consumers (Prime Minister of Canada, 2008).  
Apr. 2008 Gilles-André Perron Bloc Québécois MP for Rivière-des-Mille-Îles proposes 
Private Member’s Bill C-517 to establish a new definition of genetically modified 
(GM) food and to require the mandatory labeling of Genetically Modified food.  
May 2008 (May 7) Bill C-517, which would have given consumers the right to know if the 
food sold in Canada contains genetically engineered (GE) ingredients, was defeated 
in the House of Commons by a vote of 101 to 156 after its second reading 
(Greenpeace, 2008). 
June 2008  (Jun 7-8) Release of the Environmental Assessment Working Group report 
Scientific and Regulatory Considerations (SARC) documents pending for National 
Health Products (NHPs) and Novel Foods and Additives. 
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July 2008 The Federal, provincial and territorial (FPT) governments announced the signing of 
a five-year agreement on agriculture called Growing Forward, a strategic 
framework encompassing the policies and programs put in place to support the 
Canadian agriculture and agri-food sector. Growing Forward replaced Canada’s 
original agriculture policy, the Agricultural Policy Framework (APF). Growing 
Forward concludes on March 31, 2013 and its successor, Growing Forward 2, will 
take effect April 1
st
 2013 (Standing Committee on Agriculture and Agri-Food, 
2012, p. 1). 
Aug. 2008 A Listeriosis outbreak centered on meat products produced by Maple Leaf Foods 
resulted in the death of 22 Canadians. 
~ 2009 ~ 
2009 Genetically Modified (GM) flax contamination found in Canadian flax exports to 
Europe lead to the European market closing its doors to Canadian flax (CBAN, 
2012b). This was done at the request of the Flax Council of Canada and 
Saskatchewan Flax Development Commission which were concerned about losing 
the European market (CBAN, 2012b). Approximately 60% of Canada’s yearly flax 
exports went to Europe (CBAN, 2012b). 
Jan. 2009 Appointment of Sheila Weatherill, Independent Investigator, to conduct an 
investigation into the August 2008 Listeriosis outbreak that centered on meat 
products produced by Maple Leaf Foods. 
Jan. 2009 The University of Guelph submits paperwork for the reproduction and exportation 
of Enviropig™ via a “Significant New Activity Notice”. 
Apr. 2009 The University of Guelph submits an application to Health Canada to approve its 
genetically engineered Enviropig™ for human consumption. No mandatory 
deadline for a decision was given (Mann, 2011). 
May 2009 Internal DFO media lines are prepared in case of journalists' questions about 
AquaBounty. The media lines state that the Canadian regulations "currently 
provide an effective regulatory framework for protecting the environment from 
potential risks of GE fish” (Schmidt, 2011c). 
June 2009 (Jun 30) Canada’s Organic Products Regulations are set in place. The regulations 
“require mandatory certification to the revised National Organic Standard for 
agricultural products represented as organic in international and inter-provincial 
trade, or that bear the federal organic agricultural product legend (or federal logo)” 
(CFIA, 2001c). 
Approval of a biotech maize named Smartstax™ for release in Canada by the 
CFIA. The maize has eight different gene coding for several pest resistant and 
herbicide tolerant traits. As each GM trait had been individually approved in earlier 
crops by Health Canada, Health Canada did not classify the GE SmartStax™ as a 
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“novel food”. The GE maize was approved for release by the CFIA, without 
approval from Health Canada. The GE maize was approved for environmental 
release by the Canadian Food Inspection Agency without an environmental risk 
assessment (CBAN, 2012a). 
July 2009 (July 20) Sheila Weatherill, Independent Investigator, submitted her report to the 
Minister of Agriculture and Agri-Food that investigated the August 2008 
Listeriosis outbreak that centered on meat products produced by Maple Leaf Foods 
Nov. 2009 MP Alex Atamanenko, who at the time was the MP for BC Southern Interior and 
the NDP Agriculture Critic, introduces Private Member’s Bill C-474 to “amend the 
Seed regulations to require an analysis of potential harm to export markets be 
conducted before the sale of any new genetically engineered seed is permitted” 
(Bill C-474, 2009). The bill was “a response to the fact that the introduction of 
certain genetically engineered(GE) organisms can put Canada’s export markets at 
risk but that current regulation does not consider this question of potential negative 
economic impacts” (CBAN, n.d.). In an interview for this research project 
Atamanenko stated that the Bill had attracted a lot of attention because thousands 
of people sent him e-mails and letters of support and sent letters to the Government 
(NDP-A). 
~ 2010 ~ 
2010 Approval, for the first time in Canada, of a GE Animal, the Enviropig™ developed 
at the University of Guelph, for reproduction and exportation under New Substance 
Notification Regulations (Organisms). 
Feb. 2010 Significant New Activity Notice provisions for the Enviropig™ are published in 
the Canada Gazette, Part I. 
Agriculture Canada commission a telephone survey “after Government officials 
hosted a series of meetings with AquaBounty Technologies Inc., as part of pre-
notification consultations with the company concerning the human consumption of 
the animals” (Schmidt, 2011a). A telephone survey of 812 Canadians between Jan. 
31 and February 11 is conducted by Harris/Decima. “Results are considered 
accurate to within 3.4 per cent, 19 times out of 20” (Schmidt, 2011a).  
Mar. 2010  The National Farmers Union of Ontario passed a Resolution that they “oppose the 
commercial production of the Enviropig™ in Canada and request that Ontario Pork 
and OMAFRA withdraw support for the Enviropig™ and the University of Guelph 
shut down the project immediately” (NFU Ontario, 2010, p.1). 
Apr. 2010 A majority of MPs vote in favour that Bill C-474 to amend the Seed Act be read a 
second time and referred to the Standing Committee on Agriculture and Agri-Food. 
May 2010 CBAN launch a Stop the Enviropig™ campaign that includes a petition, letters to 
be sent to MPs, articles, policy briefings, debates, and speaking tours. Lucy 
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Sharratt from CBAN said that “Enviropig™ was allowed to happen because there 
has never been a democratic debate in Canada about genetic engineering and there 
is no public overview of the direction of public research” (Sharratt, 2010). 
Aug. 2010 A draft of the media lines prepared by the CFIA state: "The GE salmon are bred in 
contained, land-based systems and are reproductively sterile females, eliminating 
the threat of interbreeding amongst them or with native populations” (Schmidt, 
2011c). 
Aug. 2010 The Guidelines for the Notification and Testing of New Substances: Organisms were 
published pursuant to the NSNR (Organisms) under CEPA, 1999. According to the 
guidelines any request to develop biotechnology-produced fish for commercial purposes 
would be subject to the NSNR under CEPA, 1999 (Government of Canada, 2010). 
Sept. 2010 The Canadian Institute of Environmental Law and Policy (CIELAP) file Petition 
No. 305: Accountability for Labeling of Genetically Modified Organisms. 
The U.S. Food and Drug Administration hold public hearings regarding the 
AquAdvantage® salmon. Documents are release revealing that AquaBounty plans 
to produce all its GM salmon eggs in Prince Edward Island (PEI) and ship the eggs 
to Panama for grow-out and processing. The company was not asking for approval 
to grow the fish in the U.S.A (CBAN, n.d.2; Patterson 2011). Lucy Sharratt, 
CBAN’s coordinator stated  
AquaBounty has so far avoided a full environmental review by splitting its 
proposal between the U.S., Canada and Panama... Canada’s decision on GM 
salmon eggs is critical to the future of Atlantic salmon around the world, but 
Environment Canada remains silent on the risks and any review they might be 
conducting. Meanwhile, AquaBounty has assumed it will get approval to produce 
its GM salmon eggs in PEI (CBAN, n.d.2). 
A joint motion to start a new study on biotechnology to be completed by the 
Standing Committee on Agriculture & Agri-food was introduced by Liberals and 
Conservatives to have the Standing Committee on Agriculture and Agri-Food 
conduct a study on the status of the Canadian biotechnology sector (Canada. 
Standing Common on Agriculture and Agri-Food, 2010). 
Ruth Salmon states in a CBC interview on behalf of CBAN and the Canadian 
Aquatic Industry Alliance said that "the Canadian aquaculture industry does not 
support the commercial production of transgenic fish for human consumption” 
(Sharratt 2010b). 
The Food Regulatory Advisory Committee hold their inaugural meeting 
Oct. 2010 CBAN and Beyond Factory Farming release a 7 page report on the Enviropig 





(Oct 7) CBAN’s coordinator Lucy Sharratt and Sean McGivern, then Regional 
Coordinator of the National Farmers Union Ontario debate Rich Moccia VP 
Research, University of Guelph and Dr. Cecil Forsberg, the creator of the 
Enviropig™. The topic of the debate was "Enviropig: Helpful or Harmful?" The 
event is organized by University of Guelph students and hosted by the Critical 
Knowledge Collective at the University of Guelph (Giacomini, 2011, p. 12). 
Nov. 2010 (Nov11- 28) The CFIA conduct a survey on food safety. 
(Nov 16) The P.E.I. Coalition for a GMO Free Province, an NGO, send a letter to 
P.E.I. Premier Robert Ghiz requesting that that the Premier take action for PEI 
residents, and insist that Environment Canada disclose if they are already assessing 
GE salmon eggs for production on PEI. (Broderick, Labchuk & Boyd, 2010). 
(Nov 18) Agriculture Minister Gerry Ritz announced that the Government of 
Canada has taken a step to strengthen Canada’s food safety system by appointing 
seven advisors to the Ministerial Advisory Board (MAB) of the CFIA. 
Dec. 2010 The biotech industry hold fifty meetings in December 2010 with Liberal and 
Conservative MPs to lobby against bill C-474 (NDP-A). 
(Dec 1)  The New Democratic Party used an obscure rule to secure an extended 
debate in the House of Commons of up to five hours on Bill C-474 for early in 
2011. 
(Dec 6) The Food Regulatory Advisory Committee hold a meeting  
(Dec – Mar 2011) The House of Commons Agriculture Committee holds 10 public 
hearings on Bill C-474. A theme that had been addressed during the hearings was 
the need for greater transparency.  
Some witnesses stressed the need for transparency in regulatory decisions so that 
everyone has confidence in the system. They stated that regulatory authorities 
examine all new scientific data, but that information is not in the public domain. 
Neither the public nor independent scientists have access to the scientific data the 
government evaluates. For now, regulatory authorities are required by law to keep 
confidential any information produced by a commercial venture. The witnesses 
talked about the need to come up with ways of making scientific data accessible. 
Peers could review scientific protocols and replicate experiments, and that would 
improve the regulatory process. (Canada, 2012, p. 51) 
Sixty-three fisheries and oceans conservation, environmental and social justice 
groups released a joint statement in December 2010 opposing GM fish (Donnelly, 
2011).  
Dec. 2010  (Dec 8) Agriculture Minister Gerry Ritz launches a roundtable “focused on giving 
consumers an additional opportunity to raise concerns and discuss ways to further 
improve Canada's food safety system. This new forum is another way the 
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Government of Canada is improving transparency, consultations and 
communications with Canadians, as recommended by the 2008 report of the 
independent investigator, Sheila Weatherill (CFIA, 2010b) 
CBAN give a briefing to the House of Commons Standing Committee on 
Agriculture and Agri-Food Genetically Engineered Organisms: The Need to 
Consider Potential Economic Harm Prior to Commercial Release 
~ 2011 ~ 
2011 The Federal Government hold consultations on Low Level Presence, “the 
unintended presence, at low levels, of a genetically modified (GM) crop that is 
authorized for commercial use or sale in one or more countries, but is not yet 
authorized in an importing country” (AAFC, n.d. p. 3). 
2011 A commitment of $100 million over five years is made to invest in inspector 
training, tools and technology, and science capacity concerning food safety (CFIA, 
2011a). 
Jan. 2011 A meeting takes place between a coalition of opponents to AquaBounty plans 
(including the Council of Canadians, P.E.I. Health Coalition, the CBAN and Earth 
Action PEI), P.E.I. Premier Robert Ghiz and P.E.I. Provincial Environment 
Minister Richard Brown. The group asked Ghiz to address “growing opposition to 
AquaBounty's development of GMO salmon in P.E.I” (CBC News, 2011). 
Feb. 2011 Bill C-474 was debated and voted on in the House of Commons while many 
Agriculture Committee members were on the road. The bill was defeated in its 
third reading, the farthest a Private Members Bill on genetic engineering has gone 
in the Parliamentary process (CBAN, 2012b). 
Feb. 2011 (Feb 9) Over 150 people participate in the “Pig Rally: Stop U of G’s Enviropig™” 
sponsored by the OPIRG Guelph (Ontario Public Interest Research Group) student 
group as well as the Ecological Farmers of Ontario, the National Farmers Union 
Ontario, The Big Carrot NaturalMarket in Toronto, CBAN, and The Council of 
Canadians Guelph Chapter (CBAN, 2011c). 
(Feb 23) Journalist Sarah Schmidt writes an article GE salmon could harm our fish 
stocks: scientists discussing an ATI request she did re DFO scientists.  
Mar. 2011 Fin Donnelly NDP MP and Fisheries and Oceans Critic tabled motion M-648 in the 
House of Commons “asking for transparency and more study before genetically 
modified (GM) Atlantic salmon are approved for human consumption.” 
M-648 —— Mr. Donnelly  — That, in the opinion of the House, the Government 
should immediately: (a) provide greater regulatory clarity by identifying which 
Government departments are responsible for the regulation of genetically modified 
salmon and other transgenic aquatic organisms; (b) prevent the introduction into 
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the Canadian food system of genetically modified salmon destined for human 
consumption until further scientific studies are concluded by the relevant 
departments to determine the impact of genetically modified salmon on human 
health and on the health of marine species, ecosystems and habitats; and (c) direct 
the departments responsible for the regulation of genetically modified salmon to 
establish a practice of notifying the Canadian public of all requests and approvals 
and of any information and findings regarding genetically modified salmon and 
salmon eggs. (CBAN, 2011a) 
(Mar 2) Liberal Agriculture Critic Wayne Easter put forth a  Motion for a 
Moratorium on GE Alfalfa  
The House of Commons Agriculture Committee held 10 public hearings on Bill C-
474 between December 2010 and March 2011. 
Mar. 2011  (Mar 16) Agriculture Minister Gerry Ritz announces that the CFIA will begin to 
publish information about its compliance and enforcement activities being taken to 
protect the safety of the Canadian food, animal and plant supply... ...This will give 
our inspectors another tool in the toolbox to shine the light of transparency on 
repeat offenders and companies that try and import unsafe food” (CFIA, 2011b). 
May 2011 The House of Commons Agriculture Committee study on biotechnology comes to 
an end with the May 2, 2011 election of the 41
st
 Parliament. A full report with 
recommendations was not completed but a summary of results was included in the 
Standing Committee on Agriculture and Agri-Food report Growing Forward 2 
(2012). 
June 2011 (June 23) The first reading of NDP MP Alex Atamanenko’s Bill C-257 to amend 
the food and Drugs Act for the mandatory labeling of genetically modified foods 
(Bill C-257, 2011). 
June 2011 (June 1-2) The Food Regulatory Advisory Committee holds a meeting.  Members 
decide to rename the Committee the Food Expert Advisory Committee (FEAC) to 
better reflect its mandate. 
July 2011  (July 5) Voluntary labeling guidelines for GE foods were issued by the Codex 
Alimentarius Commission. 
July 2011  (July 20) The release of the CFIA Public Opinion Research Final Report Food 
Safety: Canadians’ Awareness, Attitudes and Behaviours. 
Sept. 2011 CFIA’s release a press release Food Safety Confidence in Canada on the Rise 
stating “Canadians remain confident in Canada’s food safety system, according to 
results from a recent survey conducted by Leger Marketing in the spring of 2011. 
Sixty-eight per cent of Canadians gave the system a favourable confidence 
rating.  That is up from 65 per cent in 2010 and 60 per cent in 2008” (CFIA, 
2011a).The press release quotes Agriculture Minister Gerry Ritz as stating “The 
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Canadian food safety system works well and the majority of Canadians 
acknowledge that. They have confidence in Canadian standards, regulations and 
processes” (CFIA, 2011a). 
Sept. 2011 (Sept 20) Advocacy Day takes place in Ottawa “to raise awareness of the 
biotechnology industry and to foster ongoing support of public policy within 
multiple levels of government” (PEI BioAlliance, 2011) 
Oct. 2011  (Oct 4) Journalist Sarah Schmidt article Canadian Skeptical of government’s 
ability to regulate GM animals  
(Oct 17) Journalist Sarah Schmidt article GE fish may pose risk to wild stock: 
documents. Schmidt states that Environment Canada had admitted the department 
“isn’t sure it can fully protect wild fish stocks if it approves the commercialization 
of the hatchery for genetically engineered salmon eggs” (Schmidt 2011b).  
Schmidt reports that according to the internal records  
Environment Canada concluded that the narrower oversight option - while ‘easily 
enforceable by inspecting shipments at the port of export’ in Canada – ‘falls short’ 
of meeting Canada's legal obligations under CEPA ‘because it does not fully 
consider potential effects within Canada’. (Schmidt 2011b). 
Journalist Sarah Schmidt also releases articles stating internal records obtained 
through the ATI Act revealed senior scientists specializing in biotechnology and 
aquaculture from the Department of Fisheries and Oceans “are concerned about 
‘limited’ and possibly ‘constrained’ regulatory powers around the approvals for GE 
fish (Schmidt, 2011c). 
Schmidt also releases articles comparing DFOs internal media line from May 2009 
with CFIA’s from August 2010. Internal DFO media lines that were prepared in 
May 2009 in case of journalists' questions about AquaBounty stated that the 
Canadian regulations "currently provide an effective regulatory framework for 
protecting the environment from potential risks of GE fish” (Schmidt, 2011). A 
draft of the media lines prepared by the CFIA in August of 2010, stated: "The GE 
salmon are bred in contained, land-based systems and are reproductively sterile 
females, eliminating the threat of interbreeding amongst them or with native 
populations” (Schmidt, 2011c). Schmidt’s article identified concerns from a DFO 
scientist over the changes to the media lines.   
A representative from the Council of Canadians gives a presentation on the topic of 
the AquAdvantage® salmon to the House of Commons Agricultural Committee in 
a lot of questions were received that zeroed in on GE Salmon. The representative 
was one of a few presenters (NGO-2). 
(Oct 24 – 27) A 4-city speaking tour took place against the pending approval of 
GM fish. Featured speakers include Eric Hoffman, Biotechnology Policy 
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Campaigner, Friends of the Earth U.S., Washington DC, Jaydee Hanson, Senior 
Policy Analyst, Center for Food Safety, Washington DC, Lucy Sharratt, 
Coordinator, Canadian Biotechnology Action Network, Ottawa and Leo Broderick, 
Vice Chair, Council of Canadians, PEI (Patterson, 2011) 
Nov. 2011 (Nov 1) Agriculture Canada organizes stakeholder consultations on “Low Level 
Presence” to allow a percent, 0.1% or higher, of food to be contaminated with 
genetically modified (GM) foods that have not been approved by Health Canada 
for safe human consumption. A Comment period was held until November 25 
(AAFC, n.d.; Schmidt, 2012).  
~ 2012 ~ 
2012 The Agriculture Committee’s releases its Growing Forward 2 report. Growing 
Forward 2 will replace Growing Forward on April 1
st
 2013 (Standing Committee 
on Agriculture and Agri-Foods, 2012). 
In a Dissention opinion attached to Growing Forward 2 the NDP party 
recommended  
That the government undertake a comprehensive review of the regulations 
governing GE seeds, fish and animals with a view to: 
- Implementing the Royal Society of Canada’s 58 recommendations 
- Introducing transparency in the scientific reviews and approval processes 
- Creating a mechanism to consider market implications in the approval 
process  
- Creating a separate category of regulations to govern GE seeds, fish and 
animals 
- That an independent body be created to peer-review relevant scientific data 
- Impose an immediate moratorium on GE food/ animals/fish, alfalfa and 
wheat until such time as a regulatory review has been conducted and 
modernized rules brought into effect. (Standing Committee on Agriculture 
and Agri-Foods, 2012, p. 80) 
Enviropig™ were slaughtered and their semen frozen. The initiative was 
undertaken by the University of Guelph due to a lack of funding for their research 
(Leung, 2012). 
The French group of Gilles-Eric Seralini conduct a peer-reviewed study that 
describes harmful effects on rats fed on diets containing GE maize. (Seralini, et al., 
2012). This study was the first biotechnology-produced animal feeding trial that 
had been conducted over the lifetime of laboratory rats (two years) to test 
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Monsanto’s GM corn NK603 and their herbicide Roundup, approved in Canada in 
2001. 
Sept. 2012 The Federal Government’s “draft plan for managing the low-level presence of 
GMOs in food and feed products” is to be submitted to the World Trade 
Organization in September (Schmidt, 2012).  The research for this paper has been 
unable to find information on whether this happened. 
Oct. 2012.  (Oct 25) The release of “Health Canada and Canadian Food Inspection Agency 
statement on the Séralini et al. (2012) publication on a 2-year rodent feeding study 
with glyphosate formulations and GM maize NK603” (Health Canada, 2012f). 
Nov. 2012 Canada’s voluntary labeling standard for GE foods has not undergone review. 
The Europe Market is still closed to Canadian flax.  
Information has not been released concerning any requests made by AquaBounty 
Technologies Inc to approve its AquAdvantage® salmon for human consumption. 
It was anticipated that the proposed Environmental Assessment Regulations would 
be pre-published for comment in the Canada Gazette, Part I in 2011. The EARs 
have not been completed. 
Information has not been released whether Health Canada has made a decision on 






Appendix B: Selected Consultations 
Health Canada’s Environmental Assessment Regulations 
Between September 1
st
 and October 30
th
 2001 Health Canada held a comment period on 
the Notice of Intent it had published regarding the Environmental Assessment Regulations 
(EARs). In January 2003 the department released an Issue Identification Paper to serve as a basis 
for discussion with stakeholders to identify the issues being addressed by the Government of 
Canada and to set out the goals and objectives for the EARs’ options (Health Canada, 2011a). 
This paper was followed by a Final Issue Identification Paper (July 2003) and an Options 
Analysis Paper (OAP) - An Environmental Assessment Regime for New Substances in Products 
Regulated under the Food & Drugs Act (June 2005). The Options Analysis Paper was to obtain 
feedback on the legislative authority under which the EARs should be placed (Health Canada, 
2011a). Between June and September 2005 stakeholders were given the opportunity to provide 
feedback on the Option Analysis Paper. In February 2006 the Options Analysis Paper Feedback 
Analysis Report was released to provide “an analysis and summary of the comments from 
stakeholders on the regulatory options, the critical issues and their components, and other issues 
of concern” (Health Canada, 2006e, p. 4). A month later, in March 2006, Health Canada released 
a Discussion Document for Stakeholder Consultation held March 29 - 30, 2006 on The 
Development of Environmental Assessment Regulations for New Substances Contained in 
Products Regulated under the Food & Drugs Act 
 
Guidelines for the Safety Assessment of Novel Foods 
The Guidelines for the Safety Assessment of Novel Foods (Volumes I and II) have 
undergone review on multiple occasions. A draft version of the Guidelines for the Safety 
Assessment of Novel Foods derived from Plants and Microorganisms was released in August 
2002 and a revised version was published in July 2003. Public online consultations regarding the 
Guidelines were held from July 15
th
 to September 30
th
 2003 (Health Canada, 2006g). 
 
Labeling Genetically Engineered Foods  
CFIA’s website states that a set of guidelines were developed based on three major 
consultations on the labeling of novel foods derived from genetic engineering that had taken 
188 
 
place since 1993 (CFIA, 2012d). The guidelines “reflect a general consensus to: require 
mandatory labeling if there is a health or safety concern, i.e., from allergens or a significant 
nutrient or compositional change (these decisions will be made by Health Canada), in order to 
inform consumers of the allergen or change” and to permit voluntary negative and positive 
labeling “on the condition that the claim is not misleading or deceptive and the claim itself is 




Appendix C: Selected Polls 
A 1994 poll commissioned by Industry Canada showed that up to 95% of Canadian consumers 
wanted labels on GE Foods (Council of Canadians, 1999).  
In June of 1999 a Prairie Research Associates poll released showed 92% of Manitobans want 
labeling (77% of those polled believed GE foods were unsafe or were unsure of their safety) 
(Council of Canadians, 2011). 
In December of 1999 a Montreal Gazette poll of 966 Montrealers found almost unanimous 
support for a mandatory GE food label. Over 50% of the respondents thought that GE foods 
should be banned (Abley 2000). 
In May of 2001 a poll conducted by Pollara & Earnscliffe Research and Communications for the 
Globe and Mail shows that 94% of Canadians believed the government should order companies 
to label GM foods (MacKinnon, 2001). 
In 2002 a Pew Global Attitudes Project survey reported that 37% of Canadians viewed 
scientifically altered fruits and vegetables as good, whereas 63% thought these products were 
bad (Martin and Grey, 2010).  
In October of 2003 The Consumers Association of Canada’s national poll on the labeling of 
genetically modified foods found 88% of Canadians wanted mandatory labeling on GE food 
products (Canada Newswire, 2003) 
A 2006 A survey done by Decima Research concludes that 58%  of Canadians believed that 
biotech animals will make life worse over the next twenty years, 54 percent held the same view 
of biotech fish, and 50 percent believe their future will be negatively impacted by biotech food 
(Martin and Grey, 2010). 
A 2008 survey by BIOTECanada, a biotech industry group, stated 79% of Canadians agreed that 





Appendix D: Interview Questions 
Office of the Auditor General 
1. Would the Commissioner of the Environment and Sustainable Development be involved 
with concerns over how transparent the decision-making process of the Federal 
Government is with respect to the human consumption of animals produced through 
biotechnology? 
 
2. If yes, has the Commissioner of the Environment and Sustainable Development brought 
to attention any issues concerning the transparency of the decision-making process of the 
Federal Government?  
 
3. Is information available concerning decisions your departments has made or is making 
with regards to novel foods derived from animals? 
 
Members of the Official Opposition Party 
1. Does your party hold any concerns over how transparent the decision-making process of 
the Federal Government is?  
a) If yes - Has the opposition utilized methods (motion days, question periods etc) to 
shed light on these concerns?  
b) If yes - What methods were utilized? 
c) Were the efforts successful? 
d) Is your party planning on utilizing methods?  
 
2. Does the opposition party hold any concerns over how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of animals 
produced through biotechnology? 
a) If yes - Has the opposition utilized methods (motion days, question periods etc) to 
shed light on these concerns?  
b) If yes - What methods were utilized? 
c) Were the efforts successful? 
 
3. Is there anything else you would like to say regarding the topic of transparency in the 
Federal Government, or policy making surrounding the human consumption of 
genetically engineered animals? 
 
4. Is information available concerning decisions your departments has made or is making 





Representative from the Novel Foods Section Food Directorate, Health Products 
and Food Branch, Health Canada 
Transparency Initiatives  
 
1. What transparency initiatives have been or are being utilized regarding the development 
of the safety assessment criteria for novel foods derived from animals?  
 
2. How successful have these initiatives been? 
 
3. Are any other initiatives being considered to increase transparency throughout the 
decision-making process? 
 
Obtaining Information on progress that has been made 
 
4. The most up-to-date information that I can find regarding the pre-market safety 
assessment of novel foods are the 2006 guidelines. These guidelines state that “Safety 
assessment criteria for novel foods derived from animals are under development”. Is 
information available on progress that has been made since 2006?  
 
5. How is the Food Directorate keeping the public informed regarding decisions that have 
been made or are being made with regards to novel foods derived from animals? 
 
6. Is information available concerning decisions your departments has made or is making 
with regards to novel foods derived from animals? 
 
7. Are any other departments providing information to the public regarding the development 
of safety assessment criteria for novel foods derived from animals? 
 
8. The 2006 guidelines also state that “Manufacturers or importers of novel foods derived 
from animal sources should consult with the Food Directorate to discuss what 
information is appropriate to the evaluation of the safety of a particular product.” Is it 
possible to access the information the food directorate is providing applicants?  
 
After decisions have been made 
 
9. When the safety assessment criteria for novel foods derived from animals are finalized, 




10. What stakeholders have been invited to participate in deciding safety-assessment criteria 
for novel foods derived from animals, and what are their roles? What point(s) in decision-







11. Do you know if Health Canada will postpone making a decision on approving the 





12. Is there anything else you’d like to add about the development of the safety assessment 
criteria for novel foods from animals? 
 
13. Is there anyone else you think I should talk to? 
 
Representatives from Health Canada’s Environmental Impact Initiative (EII) 
within the Health Products and Food Branch (HPFB) 
Transparency Initiatives  
 
1. What transparency initiatives have been or are being utilized regarding the development 
of the EARs?  
 
2. How successful have these initiatives been? 
 
3. Are any other initiatives being considered to increase transparency throughout the 
decision-making process? 
 
Obtaining Information on progress that has been made 
 
4.  The last document I could find regarding the development of the EARs was a discussion 




 2006.  Is 
any information available in regards to these Consultations? Is information available on 
progress that has been made since 2006?  
 
5. Is information available concerning decisions your departments has made or is making 
with regards to novel foods derived from animals? 
 
6. How is the public being informed regarding decisions that have been made or are being 
made with regards to the development of the EARs? 
 
7. Are any other departments providing information to the public with regards to the 








After decisions have been made 
 
8. It was anticipated that the proposed Environmental Assessment Regulations would be 
pre-published for comment in the Canada Gazette, Part I in 2011. When do you think 
they would be released? Is there an up-dated timeline for the EARs? 
 




10. What stakeholders have been invited to participate in decision making for the EARs, and 
what is there role? What point in decision-making are they involved with? 
 
Information on the EARs 
 
11. Will there be a separate section in the EARs for novel foods? 
 
12. Will these regulations make the decision-making process regarding the human 
consumption of food derived through modern biotechnology more or less transparent 
than the process under the NSNR? (i.e. when companies have to submit data and the type 




13. Environment Canada was in charge of the NSNR for the Enviropig. Does Environment 
Canada have a role regarding the EARs for novel foods? 
 
14. If no, what happens if a food product containing biotechnology-produced animals gets 
approved before the EARs are implemented? if the Enviropig is approved for human 
consumption under the NSNR, would it have to be approved under the EARs once they 
are finalized? 
 
15. Do you know if Health Canada will postpone making a decision on approving the 
Enviropig™ for human consumption until the EARs are finalized? 
 
Last thoughts  
 
16. Is there anything else you’d like to add about the development of the EARs in regards to 
novel foods from animals? 
 







Representatives from Health Canada 
Transparency Initiatives  
 
1. What transparency initiatives have been or are being utilized regarding the development 
of regulations for novel foods derived from animals?  
 
2. How successful have these initiatives been? 
 
3. Are any other initiatives being considered to increase transparency throughout the 
decision-making process? 
 
4. Is information available concerning decisions your departments has made or is making 




5. Has Health Canada put out an Action Plan in response to the Royal Society’s Export 
Panel Report “Elements of Precaution: Recommendations for the Regulation of Food 
Biotechnology in Canada” since June 2005?  
 
6. Will Health Canada be updating its FAQs on biotechnology which was last updated in 
2006? If yes, when might this done? 
 
Enviropig application  
 
7. What information is available to the public regarding the application submitted by the 
University of Guelph for the Enviropig™? How is that information being made 
available? 
 
8. What information is available to the public concerning the process the application is 
going through? 
 
9. What stage of the process is the Enviropig application going through? 
 
10. What sections of Health Canada is responsible for making decisions concerning this 
application? 
 
11. Are there any other federal departments or agencies that have responsibilities over the 
application? 
 
12. EARs are being created and the safety assessment of Novel foods is under development 
concerning novel foods derived from animals. Are applications for novel foods derived 






After decisions have been made 
 
13. How will the public be informed when a decision regarding the application has been 
made? 
 
Public Advisory Committee 
 
14. The Public Advisory Committee of the Health Products and Food Branch has been closed 
since 2004. Why was it closed? Is there another initiative that took over the role of the 
PAC? 
 
15. Is there anyone in particular I should speak to about the PACs activities? 
 
Last thoughts  
 
16. Is there anything else you’d like to add? 
 
17. Is there anyone else you think I should talk to? 
 
Interview Questions for Non-Government Organizations 
Canadian Biotechnology Action Network (CBAN) 
1. Why did the CBAN become interested in the human consumption of biotechnology-produced 
animals in Canada? 
 
2. What does the CBAN know about the decisions the Canadian government has made or is 
currently making concerning the human consumption of animals produced through 
biotechnology?  
 
3. How did the CBAN come across this information? 
 
Participation – Environment Assessment Regulations (EARs) and Human Safety Assessments  
 
4. The government is currently updating its EARs and Pre-safety notification requirements. Has 
the CBAN participated in any activities concerning the development of Health Canada’s 
Environmental Assessment Regulations for new substances contained in products regulated 
under the FDA? 
 










6. Have you or your organization attempted to obtain information on decisions the government 
is making or has made regarding the human consumption of animals produced through 
biotechnology? 
 
7. Has the CBAN perceived or come across barriers to obtaining information about the 
decisions the Canadian government has made or is currently making concerning the human 
consumption of animals produced through biotechnology?  
 
8. Has the CBAN been able to access all the information it wanted regarding this topic?  
 
9. Is there any information the CBAN has been unable to obtain concerning decisions the 
Canadian government has made or is currently making concerning the human consumption 
of animals produced through biotechnology?  
 
10. Was the CBAN denied access to any information it was trying to obtain regarding this topic? 
If yes, was the CBAN given reasons why it was denied access to the information? 
 
11. Is the CBAN taking or considering taking additional measures to gain access to the 
information they were unable to obtain? (For example ATI Act)   
 
12. What challenges has CBANs faced in its attempts to obtain information concerning this 
topic? 
 
13. Following up on that question, has the CBAN attempted to obtain information regarding the 
University of Guelph’s application to Health Canada for the Enviropig™?  If so, what has 




14. Have you or the CBAN been given any opportunities to participate in or to influence the 
decision-making (i.e. policy-making) processes of the Federal Government regarding the 
human consumption of biotechnology-produced animals? 
 
15. Have you or the CBAN participated in or attempted to participate in the policy process, either 
directly or indirectly?  
 
16. Have you or the CBAN perceived or come across barriers to participating in a meaningful 
way? 
 
17. Do you/your organization feel that you could effectively participate in the decision-making 
process? Are there any institutional or political barriers that would prevent this or do you feel 







18. Does the CBAN think the government is making decisions in a transparent manner? 
 
19. How transparent would you say the process is in terms of the public’s ability to hold the 
government accountable? 
 
20. You have a long history with studying GE food regulation in Canada. In October 2004 you 
wrote a paper with Peter Andree entitled Genetically Modified Organisms and precaution: Is 
the Canadian Government Implementing the Royal Society of Canada's Recommendations?". 
Is there anything you would like to say to elaborate on your findings? Do you know if the 
government has released an action plan since 2005? 
 
21. You stated “Enviropig™ was allowed to happen because there has never been a democratic 
debate in Canada about genetic engineering.” Do you think transparency is increasing or 
decreasing regarding GE food policy in Canada? 
 
22. How do you think transparency in decision-making at the federal level regarding this topic 
could be increased? 
 
23. In regards to ATI documents that were released concerning the AquAdvantage® salmon, you 
stated “This could be a case of good scientists inside departments constrained by 
regulations.” What are your thoughts on the ability of institutions that are set up to hold the 
government accountable for decisions being made? (i.e. using the ATI Act to obtain 
information). 
 
24. Can you identify, or have you come across any barriers to transparency that you have not 
mentioned? (regarding access to information, participating in decision-making, etc) 
 
25. Is there anything else you would like to add regarding how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 
26. Is there anyone else you think I would benefit from talking to?  
 
The Council of Canadians 
1. What activities have the Council of Canadians undertaken with regards to the human 
consumption of animals produced through biotechnology? 
 
2. Is the council currently involved in any activities? 
 
3. have you or your organization attempted to obtain information on decisions the government 





4. Repeat of previous questions asked to representatives from NGOs (transparency questions, 
etc). The questions would stay the same but the names of participants would change. 
 
The Canadian Aquatic Industry Alliance 
Questions regarding information gathering 
 
1. In a September 2010 interview you stated that "The Canadian aquaculture industry does not 
support the commercial production of transgenic fish for human consumption.” Why did the 
CAIA feel the need to speak out about the human consumption of transgenic fish? 
 
2. What does the CAIA know about the decisions the Canadian government has made or is 
currently making concerning the human consumption of animals produced through 
biotechnology?  
 
3. How did the CAIA come across this information? 
 
4. Has the CAIA attempted to obtain additional information regarding how transgenic fish 
would be approved for human consumption? 
 
5. How successful was the CAIA in gather information regarding decisions the Federal 
Government has made or is currently making concerning the human consumption of 
transgenic fish?  
 
6. Has the CAIA perceived or come across barriers to obtaining information?  
 
7. Is the CAIA taking or considering taking additional measures to gain access to the 
information they were unable to obtain? (For example ATI Act)   
 
8. What challenges has the CAIA faced in its attempts to obtain information concerning this 
topic? 
 
Questions regarding Decision-making process 
 
9. Have you or the CAIA been given any opportunities to participate in or to influence the 
decision-making (i.e. policy-making) processes of the Federal Government regarding the 
human consumption of biotechnology-produced animals? 
 
10. Have you or the CAIA participated in or attempted to participate in the policy process, either 
directly or indirectly?  
 





12. Do you/your organization feel that you could realistically affect the decision-making 
process? Are there any institutional or political barriers that would prevent this or do you feel 
that the process is inclusive? 
 
Transparency Questions  
 
13. Do you think the government is making decisions in a transparent manner? 
 
14. How transparent would you say the process is in terms of the public’s ability to hold the 
government accountable? 
 
15. How do you think transparency in decision-making at the federal level regarding this topic 
could be increased? 
 
16. What are your thoughts on the ATI documents released by PostMedia? 
 
17. Can you identify, or have you come across any barriers to transparency? (regarding access to 
information, participating in decision-making, etc) 
 
18. What are your thoughts on the ability of institutions that are set up to hold the government 
accountable for decisions being made? *ask this if they utilized institutions 
 
19. Is there anything else you would like to add regarding how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 
20. Is there anyone else you think I would benefit from talking to? 
 
The National Farmers Union 
1. You’ve spoken out a great deal regarding the Enviropig on behalf of the National Farmers 
Union. Why is the NFU so interested in the Enviropig? 
 
2. Has the NFU attempted to obtain information regarding the University of Guelph’s 
application to Health Canada for the human consumption of the Enviropig™? 
 
Questions regarding Decision-making process 
 
3. Have the NFU been given any opportunities to participate in or to influence the decision-
making (i.e. policy-making) processes of the Federal Government regarding the human 
consumption of biotechnology-produced animals? 
 
4. Have you or the NFU participated in or attempted to participate in the policy process, either 




5. Have you or the NFU perceived or come across barriers to participating in a meaningful 
way? 
 
6. Do you/your organization feel that you could effectively participate in the decision-making 
process? Are there any institutional or political barriers that would prevent this or do you feel 
that the process is inclusive? 
 




8. Do you think the government is making decisions in a transparent manner? 
 
9. How transparent would you say the process is in terms of the public’s ability to hold the 
government accountable? 
 
10. How do you think transparency in decision-making at the federal level regarding this topic 
could be increased? 
 
11. Is there anything else you would like to add regarding how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 
12. Is there anyone else you think I would benefit from talking to? 
 
Interview Questions for Representatives from the Royal Society of Canada 
 
1. The Royal Society’s expert panel report entitled “Elements of Precaution: Recommendations 
on the Future of Food Biotechnology (2001),” included a lot of recommendations concerning 
the regulation of food products from transgenic animals. It also included a lot of 
recommendations concerning transparency. The Canadian government released a lot of 
reports in response to the expert panel. Are you familiar with these recommendations? 
 
2. Are you familiar with the government’s responses? 
 
3. Do you know someone who would be better suited to ask about the response from the 
government? 
 
4. What are your thoughts regarding the responses from the Canadian government? 
 





6. The last response the government made with regards to the Royal Society’s report was 
completed in June 2005. Do you know if there has been an Action Plan issued by the 
government since 2005? 
 
7. Do you think there is a reason that the government stopped publishing reports on what it’s 
doing? 
 
Questions regarding Decision-making process 
 
8. Since the initial report, has the Royal Society been given any opportunities to participate in 
or to influence the decision-making (i.e. policy-making) processes of the Federal 
Government regarding the human consumption of biotechnology-produced animals? 
 
9. Have the Royal Society participated in or attempted to participate in the policy process, 
either directly or indirectly?  
 
10. Have the Royal Society perceived or come across barriers to participating in a meaningful 
way? 
 
11. Do you/your organization feel that you could effectively participate in the decision-making 
process? Are there any institutional or political barriers that would prevent this or do you feel 




12. Do you think the government is making decisions in a transparent manner? 
 
13. How transparent would you say the process is in terms of the public’s ability to hold the 
government accountable? 
 
14. Do you think transparency is increasing or decreasing regarding GE food policy in Canada? 
 
15. How do you think transparency in decision-making at the federal level regarding this topic 
could be increased? 
 
16. Can you identify, or have you come across any barriers to transparency that you have not 
mentioned? (regarding access to information, participating in decision-making, etc) 
 
17. Is there anything else you would like to add regarding how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 






Expert Panel on Ocean Climate Change and Marine Biodiversity November 26, 2009 – 2012 
 
19. Will the report the Royal Society is working on entitled “Ocean Climate Change and Marine 
Biodiversity” take into account GE Fish? How? 
 
Interview Questions for Journalists from Postmedia 
 
1. In February of 2011 Sarah Schmidt wrote an article that talked of an ATI request that was 
made by Postmedia regarding meetings and subsequent discussions between AquaBounty 
and scientists in DFO. What information did Postmedia hope to obtain through its ATI 
request? 
 
2. Why did Postmedia attempt to obtain this information? 
 
3. Was Postmedia able to access all the information it wanted regarding this topic? 
 
4. Do you know what reasons, if any, were given for sections of the documents obtained 
through the ATI Act being blocked out? 
 
5. Did you try to gain access to the information they were unable to obtain through the ATI 
Act? If yes, what avenues did you utilize/attempt to use to obtain information? 
 
6. What are your thoughts regarding your efforts to obtain this information? 
 
7. Would it be possible for me to obtain a copy of the ATI request? (I will ask this before we set 
up an interview). 
 
8. What are your thoughts on how the concerns scientists raised were treated? 
 
9. Do you think the government is making decisions in a transparent manner? 
 
10. How do you think transparency in decision-making at the federal level could be increased? 
 
11. How transparent is the ATI process in terms of the public’s ability to hold the government 
accountable? 
 
12. What are your thoughts on the ability of institutions that are set up to hold the government 
accountable for decisions being made? *ask this if they utilized institutions 
 
13. Is there anything else you would like to add regarding how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 




Interview Questions for academia (Specialist in biotechnologies and public policy) 
 
Questions regarding Decision-making process 
 
1. You have spoken out against Health Canada’s ability to assess GE animals. Do you think 
concerned stakeholders will have the opportunity to question Health Canada’s ability to 
assess whether GE Animals should be approved for human consumption? 
 
2. Have you been given any opportunities to participate in or to influence the decision-making 
(i.e. policy-making) processes of the Federal Government regarding the human consumption 
of biotechnology-produced animals? 
 
3. Have you attempted or are you going to attempt to participate in the decision-making 
process regarding how biotechnology-produced animals would be assessed for human 
consumption? 
 
4. Have you perceived or come across barriers to participating in a meaningful way? 
 




6. What are your thoughts on the ability of institutions that are set up to hold the 
government accountable for decisions being made? 
 
7. Do you think the government is making decisions in a transparent manner? 
 
8. How transparent would you say the process is in terms of the public’s ability to hold the 
government accountable? 
 
9. How do you think transparency in decision-making at the federal level could be 
increased? 
 
10. Is there anything else you would like to add regarding how transparent the decision-
making process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 
11. Is there anyone else you think I would benefit from talking to? 
 
Interview Questions for Canadian Researchers 
 
1. In the past you have been very vocal when the government was making decisions concerning  
GE food. Are you involved, or planning on getting involved in the decision-making process 




2. Why or why not? 
 
3. Have you participated in any activities concerning the development of Health Canada’s 
Environmental Assessment Regulations for new substances contained in products regulated 
under the FDA? 
 
4. Have you participated in any activities concerning the safety assessment of novel foods? 
 
5. What do you think about the information the Federal Government is providing to the public 
on its decision-making process regarding the human consumption of animals produced 
through biotechnology? 
 
Questions regarding Decision-making process 
 
6. Have you been given any opportunities to participate in or to influence the decision-making 
(i.e. policy-making) processes of the Federal Government regarding the human consumption 
of biotechnology-produced animals? 
 
7. Have you participated in or attempted to participate in the policy process, either directly or 
indirectly?  
 
8. Have you perceived or come across barriers to participating in a meaningful way? 
 
9. Do you feel that you could effectively participate in the decision-making process? Are there 
any institutional or political barriers that would prevent this or do you feel that the process is 
inclusive? 
 
Transparency Questions  
 
10. Do you think the government is making decisions in a transparent manner? 
 
11. How transparent would you say the process is in terms of the public’s ability to hold the 
government accountable? 
 
12. How transparent is the process in terms of the public’s ability to hold the government 
accountable? 
 
13. Do you think transparency is increasing or decreasing regarding GE food policy in Canada? 
 
14. How do you think transparency in decision-making at the federal level regarding this topic 
could be increased? 
 





16. Is there anything else you would like to add regarding how transparent the decision-making 
process of the Federal Government is with respect to the human consumption of 
biotechnology-produced animals? 
 
Interview Questions for Representatives from the Canadian Institute for 
Environmental Law and Policy (CIELAP) 
 
1. What has CIELAP done to increase transparency in GE food policy making in Canada? 
 
2. Why did CIELAP feel the need to undertake these projects? (for example – “A perspective 
and recommendations on biotechnology policy” written in 2008 by Holtz 
 
3. Did CIELAP experience any frustrating over the information the Federal Government was 
providing to the public concerning GE food policy making in Canada? 
 
4. Do you think CIELAPs efforts affected any GE food policy outcome? 
 
5. What are your thoughts on the government’s transparency initiatives towards GE food 
policies? 
 
6. Do you think that the decision-making behind GE food policies in Canada are becoming 
more or less transparent? 
 
7. In Sept 2010 CIELAP and The Canadian Council of Churches made a petition 
“accountability for labeling of GMOs” why did CIELAP find this necessary? 
 
8. Are you currently involved in or attempting to be involved in the decision-making regarding 





Appendix E: Consent Form 
By signing this consent form, you are not waiving your legal rights or releasing the 
investigator or involved institution from their legal and professional responsibilities.  
_______________________________________________________________________ 
I have read the information presented in the information letter about a research project 
being undertaken by Heather Lee of the Department of Environment and Resource Studies at the 
University of Waterloo. I have had the opportunity to ask any questions related to this project, to 
receive satisfactory answers to my questions, and any additional details I wanted. 
I am aware that I have the option of allowing my interview to be audio recorded to ensure 
an accurate recording of my responses.   
I am also aware that excerpts from the interview may be included in the thesis and/or 
publications to come from this research, with the understanding that without my consent 
quotations will be anonymous and information that could identify me will not appear in this 
research paper or any subsequent publication. Information that could identify me includes, but is 
not limited to, my name, position title, department name, and the name of my organization. 
I was informed that I may withdraw my consent without penalty by advising the 
researcher.   
This project has been reviewed by, and received ethics clearance through, the Office of 
Research Ethics at the University of Waterloo.  I was informed that if I have any comments or 
concerns resulting from my participation in this project, I may contact the Director, Office of 
Research Ethics at 519-888-4567 ext. 36005 or ssykes@uwaterloo.ca.  
 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this project. 
 
YES     NO     
 
I agree to have my interview audio recorded. 
 
YES    NO     
 
I agree to the use of information that could identify me to be used in this research paper or any 
subsequent publication.  
YES    NO     
 
 I agree to the use of quotations in this research project  
YES   NO 
 
I agree to the use of anonymous quotations in this research project and any publication that 
comes of this research. 





I agree to the use of direct quotations attributed to me only with my review and approval. 
 
YES NO I agree to the use of direct quotations without my review and approval. 
Participant Name: ____________________________ (Please print)   
Participant Signature: ____________________________  
Witness Name: ________________________________ (Please print) 
Witness Signature: ______________________________ 
Date: ____________________________ 
 
 
 
